Test,ID,GeneMasterName,Variant,Gender,DiseaseName,PredominantCancerSubtype,SyndromeMasterName,DiseaseType,Organ,FinalVerdict,NotesReAssn,EvidenceofAssociation,PredominantCancerSubtypeSource,ClinGenValidility,ClinGen Numeric,NCCN combined,NCCNRecommend,NCCNidentifier,GeneticHomeReference,OMIM,GeneCard,GeneReview,Completed,GraphInAsk2Me,HomuncCaNeo,HomuncBenign,ASk2me Asssociation,NEJM MHL and DICER1 paper,MedNeon_Extended,Akras_paper,Akras_paper_penetrance,Yadav_paper,AmbryGenetics,SPANISH_DiseaseName,CHINESE_DiseaseName,SPANISH_Gender,CHINESE_Gender,IfMetaanalysisInMasterTable,IfASK2MEBasedOnMetaanalysis,SourceRisk,Order,Concatenated,OldDiseaseName,OldPredominantCancerSubtype,OldDiseaseType,BreastGene,ColonGene,Z_Old_DiseaseName,Z_Inheritance,Z_AllellicInheritance
,,HRAS,,Either,Dysmorphic Feature,"Coarse facial features, curly or sparse, fine hair, loose, soft skin",,Benign,Face,,MedNeon (Kelly),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,MSI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,PMS3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,NDUFA10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,NHP2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,ERCC1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,MYBPC3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,,ALK,,Either,Adrenal Cortical Carcinoma,,,Cancer,Adrenal,9,MedNeon(Kelly) says increased risk.,,,,,,,,,,,,1,,,,,,,,,,,masa suprarrenal,肾上腺肿块,Masculino,男性,0,0,,90,,Adrenal mass,,Benign Disease,,1,Adrenal Cortical Carcinoma,,Mono
0,,ALK,,Either,Peripheral Nervous System Benign,Ganglioneuroma,,Benign,PNS,1,MedNeon(Kelly),,,,,,,,,,,,1,,,,,,1,1,Mod,,1,neuroblastoma,成神经细胞瘤,Masculino,男性,0,0,,,,Neuroblastoma,,Cancer,,,Neuroblastoma,,Mono
0,,FLCN,,Either,Parathyroid Neoplasm,Parathyroid Adenoma,,Neoplasm,Parathyroid,9,MedNeon(Kelly),,,,,,,,,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Parathyroid adenoma,,Cancer,,,Parathyroid Neoplasm,,Mono
0,,FLCN,,Either,Brain Tumor,Pituitary Adenoma,,Neoplasm,Pituitary,9,MedNeon(Kelly),,,,,,,,,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Pitutary adenoma,,Cancer,,,Pituitary Neoplasm,,Mono
0,,FLCN,,Either,Peripheral Nervous System Neoplasm,neural tissue tumor,,Neoplasm,PNS,9,MedNeon(Kelly),,,,,,,,,,,,,,,,,,1,,,,,,,Masculino,男性,0,0,,,,Schwannomatosis,,Cancer,,,Peripheral Nervous System Neoplasm,,Mono
0,,FLCN,,Either,Peripheral Nervous System Neoplasm,connective tissue nevus,,Neoplasm,PNS,9,MedNeon(Kelly),,,,,,,,,,,,,,,,,,1,,,,,,,Masculino,男性,0,0,,,,Schwannomatosis,,Cancer,,,Peripheral Nervous System Neoplasm,,Mono
0,,FLCN,,Either,Lipoma,,,Benign,Lipid,9,MedNeon(Kelly),,,,,,,,,,,,,,,,,,,,,,,,,Masculino,男性,,,,,,Subcutaneous Lipomatosis,,Benign Disease,,,Lipoma,,Mono
0,,FLCN,,Either,Thyroid (Benign),Multinodular Goiter,,Benign,Thyroid,9,MedNeon(Kelly),,,,,,,,,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Multinodular goiter,,Benign Disease,,,Thyroid (Benign),,Mono
0,,FLCN,,Either,Skin (Benign),focal cutaneous mucinosis,,Benign,Skin,9,MedNeon(Kelly),,,,,,,,,,,,,,,,,,,,,,,,,Masculino,男性,,,,,,Subcutaneous Lipomatosis,,Benign Disease,,,Lipoma,,Mono
,,HRAS,,Either,Developmental,Failure to thrive,,Benign,CNS,,MedNeon (Kelly),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,HRAS,,Either,Developmental,Intellectual Disability,,Benign,CNS,,MedNeon (Kelly),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,HRAS,,Either,Skin (Benign),Papillomata of the face and perianal region,,Benign,Skin,,MedNeon (Kelly),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,HRAS,,Either,Dysmorphic Feature,"Diffuse hypotonia and joint laxity, tight achilles tendons",,Benign,Connective Tissue,,MedNeon (Kelly),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,HRAS,,Either,Cardiovascular (Benign),"Cardiac hypertrophy, congenital heart defect, arrhythmia",,Benign,Heart,,MedNeon (Kelly),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,,PTCH21,,Either,Lung (Benign),Bronchiectasis,,Benign,Lung,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Lung cyst,,Cancer,,,Lung (Benign),,Mono
0,,RPS17,,Either,Metabolic,Cystic fibrosis,,Benign,Metabolic,1,Biallelic,,,,,,,,1,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Lung cyst,,Cancer,,,Cystic fibrosis,,Mono
1,,MUTYH,,Male,Prostate Cancer,,,Cancer,Prostate,9,https://ascopubs.org/doi/full/10.1200/PO.16.00039 There is no risk info for MUTYH,,,,,9,,9,,,,,1,,,,,,,,,,,próstata,前列腺,Masculino,男性,0,0,,,,Prostate cancer,,Cancer,,,Prostate Cancer,,Mono
,,ABRAXAS1,,Female,Ovarian Cancer,,,Cancer,Ovary,9,,,,,,,,,,,1,,1,,,,,,,,,,,,,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,,,Ovarian cancer,,Mono
0,,ATM,,Either,Bladder Cancer,,,Cancer,Urinary Bladder,9,,,,,,,,,1,,,,1,,,,,,,,,,,,,,,,,,,,,,Cancer,1,1,Melanoma,,Mono
0,,BLM,,Female,Breast Cancer,,,Cancer,Breast,9,Biallelic?,,,,,,,,,,1,,,,,,,,,,,,,,,,,0,0,,,,Breast cancer,,Cancer,,,Breast cancer,,Mono
0,,BLM,,Female,Ovarian Cancer,,,Cancer,Ovary,9,Biallelic?,,,,,,,,,,1,,,,,,,,,,,,,,,,,0,0,,,,,,Cancer,,,,,Mono
0,,BRCA1,,Either,Hepatobiliary Cancer,Cholangiocarcinoma,,Cancer,Bile Duct,9,,,,,,,,,1,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Cholangiocarcinoma,,Cancer,,,Hepatobiliary Cancer,,Mono
0,,BRCA2,,Either,Hepatobiliary Cancer,Cholangiocarcinoma,,Cancer,Bile Duct,9,,,,,,,,,1,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Cholangiocarcinoma,,Cancer,,,Hepatobiliary Cancer,,Mono
,,ANKRD26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,ARMC5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,ASXL1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,PHOXB2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,TRIM37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,TERT,,,Pancreas (Benign),Pancreatitis,,Benign,Pancreas,9,Ambry only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,MRE11A,,,Pancreas (Benign),Pancreatitis,,Benign,Pancreas,9,Ambry only,,,,,,,,,,,,1,,,,,,,,,,1,,,,,,,,,,,,,,,,,
,,RPS20,,,Pancreas (Benign),Pancreatitis,,Benign,Pancreas,9,Ambry only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RAD50,,,Pancreas (Benign),Pancreatitis,,Benign,Pancreas,9,Ambry only,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,ABRAXAS1,,,Pancreas (Benign),Pancreatitis,,Benign,Pancreas,9,Ambry only,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,,CFTR,,Either,Lung (Benign),Bronchiectasis,,Benign,Lung,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Lung cyst,,Cancer,,,Lung (Benign),,Mono
0,,CFTR,,Either,Cystic fibrosis,Metabolic,,Benign,Metabolic,1,Biallelic,,,,,,,,1,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Lung cyst,,Cancer,,,Cystic fibrosis,,Mono
,,CDC73,,Either,Uterus Neoplasm,Uterine Tumors,,Cancer,Uterus,1,ClinGen is definitive or moderate while NCCN is mute.,,,Mentioned,1,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,ATRX,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,CAP1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,CDC73,,Either,Uterus Neoplasm,Uterine Tumors,,Cancer,Uterus,1,ClinGen is definitive or moderate while NCCN is mute.,,,Mentioned,1,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,CDK12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,DMC1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,EME1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,EME2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,FAN1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
use_ambry,,KIF1B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
use_ambry,,LZTR1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,MUS81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,POLH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,PPP2R2A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,PTCH2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,POT1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RECQL4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,PTCS3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RAD52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RAD54L,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RBBP8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,SLC45A2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,SLX1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,TINF2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,TP53BP1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,TYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,WRAP53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,WWP1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,XPC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,XRCC3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,PALLD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,MRE11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,ABCC9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,ACTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,ACTN2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,AIP,,Either,Brain Tumor,Familial Isolated Pituitary Adenoma-somatotropinoma,,Neoplasm,Pituitary,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,,,,,,,,,,,,,,,,Brain Tumor,,
,,AR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,ATR,,Male,Prostate Cancer,,,Cancer,Prostate,9,27433846,,,,,9,,9,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,BCS1L,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,BRCA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,BUB1B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,CCND1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,CEP57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,CFTR,,Either,Pancreas (Benign),Pancreatitis,,Benign,Pancreas,1,Ambry only,,,,,,,,1,1,1,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,COX10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,COX15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,CPA1,,,Pancreas (Benign),Pancreatitis,,Benign,Pancreas,9,PMID: 23955596,,,,,,,,,,,,1,,,,,,,,,,1,,,,,,,,,,,,,,,,,
,,CSRP3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,CTC1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,CTF1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,CTFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,CTNND1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,CTRC,,,Pancreas (Benign),Pancreatitis,,Benign,Pancreas,9,Ambry only,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,CYLD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,DDB2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,DES,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,DKC1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,DSC2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,DSG2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,DSP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,EMD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,ENG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,ERCC2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,ERCC3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,ERCC4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,ERCC5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,EXT1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,EXT2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,EZH2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,FAH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,FANCB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,FANCD2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,FANCE,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,FANCF,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,FANCG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,FANCI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,FANCL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,FANCM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,FOXP3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,FOXRED1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,GATA1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,GJB6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,GLA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,IL1B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,IL1RN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,JUP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,KRAS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,LAMP2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,LDB3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,LDLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,LDLRAP1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,LKB1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,LMNA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,Lynch Gene,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,MC1R,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,MLH3,,,Pancreas (Benign),Pancreatitis,,Benign,Pancreas,9,Ambry only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,MYH7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,MYL2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,MYL3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,NDUFA12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,NDUFA2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,NDUFA9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,NDUFAF2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,NDUFAF6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,NDUFS3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,NDUFS4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,NDUFS7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,NDUFS8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,NOP10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,NTRK1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,PCSK9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,PKP2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,PLN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,PMS1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,PRKAG2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RAD51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RAD51B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RHBDF2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RNF43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RPL11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RPL26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RPL35A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RPL5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RPS10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RPS19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RPS24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RPS26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,RPS7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,SBDS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,SCN5A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,SGCD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,SIL1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,SKIV2L,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,SPINK1,,,Pancreas (Benign),Pancreatitis,,Benign,Pancreas,9,Ambry only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,SPRED1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,SURF1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,TAZ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,TCAP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,TMEM43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,TNNI3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,TNNT2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,TPM1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,TTC37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,VCL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,XK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,XPA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,XPC1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,PDGFRA,,Male,Prostate Cancer,,,Cancer,Prostate,0,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,FGFR3,,Male,Prostate Cancer,,,Cancer,Prostate,0,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,FLT3,,Male,Prostate Cancer,,,Cancer,Prostate,0,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,TRRAP,,Male,Prostate Cancer,,,Cancer,Prostate,0,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,FANCA,,Male,Prostate Cancer,,,Cancer,Prostate,9,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,ELAC2,,Male,Prostate Cancer,,,Cancer,Prostate,9,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,MITF,,Male,Prostate Cancer,,,Cancer,Prostate,0,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,EHBP1,,Male,Prostate Cancer,,,Cancer,Prostate,9,All refences point to polymorphism.  single nucleotide polymorphism in this gene is associated with an aggressive form of prostate cancer.,,,,,,,,,1,1,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,HPC1,,Male,Prostate Cancer,,,Cancer,Prostate,9,Polymorphism,,,,,,,,,1,1,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,PCAP,,Male,Prostate Cancer,,,Cancer,Prostate,9,,,,,,,,,,1,1,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,1,ATM,,Female,Breast Cancer,,,Cancer,Breast,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,,1,1,1,,,1,,1,1,Mod,Mod,1,mama,乳腺,Femenino,女性,1,1,Ask2Me,1,,Breast cancer,,Cancer,1,1,Breast Cancer,,Mono
0,2,ALK,,Either,Inflammatory Myofibroblastic Tumor,,,Benign,Wound healing,0,somatic,,,,,,,,2,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Inflammatory myofibroblastic tumor,,Cancer,,,Inflammatory Myofibroblastic Tumor,,Mono
,4,DICER1,,Either,Eye Neoplasm,ciliary body medulloepithelioma (CBME),,Neoplasm,Eye,9,,,,Mentioned,9,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,CBME,,
,4,BAP1,,Either,Breast Cancer,,,Cancer,Breast,0,"inconsistent, evidence for their inclusion in the spectrum of BAP1-TPDS malignancies Breast cancer: 9/95 (9.5%)",,,Mentioned,9,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Breast Cancer,,,,,Breast Cancer,,Mono
,4,SEC23B,,Either,Skin Cancer (Non-Melanoma),,,Cancer,Skin,9,,,,,,,,,,1,,,1,,,,,,,,,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,,,Cancer,,,Squamous Cell Carcinoma,,Mono
,5,DICER1,,Either,Kidney (Benign),Cystic Nephroma,,Benign,Kidney,1,73% of cystic nephromas,,,Mentioned,1,,,,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,cystic nephromas,,
,5,DICER1,,Either,Thyroid Neoplasm,Thyroid Adenoma,,Neoplasm,Thyroid,1,,,,Mentioned,1,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,Thyroid Adenoma,,
,5,DICER1,,Either,Kidney Cancer,Renal Sarcoma,,Cancer,Kidney,9,,,,Mentioned,9,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,Renal Sarcoma,,
,5,DICER1,,Either,Nasopharyngeal Neoplasm,nasal chondromesenchymal hamartoma (NCMH),,Neoplasm,Head and neck,9,,,,Mentioned,9,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,nasal chondromesenchymal hamartoma (NCMH),,
0,5,ATM,,Either,Colorectal Cancer,,,Cancer,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Moderate,1,9,9,9,,,,,1,1,,,1,,,1,Low,,1,colorrectal,结直肠,Masculino,男性,0,0,Ask2Me,3,,Colorectal cancer,,Cancer,1,1,Colorectal Cancer,,Mono
0,6,ALK,,Either,Sarcoma,Rhabdomyosarcoma,,Cancer,Soft Tissue,0,based on the Refrences somatic,,,,,,,,,,2,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Rhabdomyosarcoma,,Cancer,,,Sarcoma,,Mono
0,7,ATM,,Either,Gastric Cancer,,,Cancer,Gastric,1,"15928302 : stomach cancer (RR = 3.39, 95% CI = 0.86 to 13.4).",,,,,,,,1,,,,1,1,,,1,,,,,,1,gástrico,胃,Masculino,男性,0,0,Ask2Me,4,,Gastric cancer,,Cancer,1,1,Gastric Cancer,,Mono
0,11,ATM,,Either,Pancreatic Cancer,,,Cancer,Pancreas,1,NCCN management or identification is present. ClinGenSilent. 2992282,,,,,1,1,,1,,,,1,1,,,1,,1,1,Low,,1,páncreas,胰腺,Masculino,男性,0,0,Ask2Me,6,,Pancreatic cancer,,Cancer,1,1,Pancreatic Cancer,,Mono
1,13,ATM,,Male,Prostate Cancer,,,Cancer,Prostate,1,NCCN prevelance of 1.2,,,,,1,,1,,,,,1,,,,1,,,1,Low,,1,próstata,前列腺,Masculino,男性,0,0,Ask2Me,7,,Prostate cancer,,Cancer,1,1,Prostate Cancer,,Mono
0,14,CDKN1B,,Either,Colorectal Cancer,,,Cancer,Colorectal,0,Biallelic,,,Limited,0,,,,,,,,1,,,,,,,,,,1,colorrectal,结直肠,Masculino,男性,0,0,,,,Colorectal cancer,,Cancer,,,Colorectal Cancer,,Mono
1,15,BARD1,,Female,Breast Cancer,,,Cancer,Breast,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,1,,,1,,1,1,Low,Unclear,1,mama,乳腺,Femenino,女性,0,0,Ask2Me,8,,Breast cancer,,Cancer,1,,Breast Cancer,,Mono
1,17,BARD1,,Female,Ovarian Cancer,,,Cancer,Ovary,9,-1 (limited by lee21018GenIn),,,Limited,9,,,,1,,1,,1,1,,,1,,1,,,,1,ovario,卵巢,Femenino,女性,0,0,Ask2Me,9,,Ovarian cancer,,Cancer,1,,Ovarian Cancer,,Mono
0,21,BRCA1,,Either,Breast Cancer,,,Cancer,Breast,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,1,,,1,,,1,High,High,1,mama,乳腺,Masculino,男性,0,0,Ask2Me,11,,Breast cancer,,Cancer,1,,Breast Cancer,,Mono
1,23,BRCA1,,Female,Ovarian Cancer,,,Cancer,Ovary,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,1,,,1,,,1,Mod,,1,ovario,卵巢,Femenino,女性,1,1,Ask2Me,12,,Ovarian cancer,,Cancer,1,,Ovarian Cancer,,Mono
0,24,CDKN1B,,Either,Brain Tumor,Pituitary Adenoma,MEN4,Neoplasm,Pituitary,9,,,,,,,,,1,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Pitutary adenoma,,Cancer,,,Pituitary Neoplasm,,Mono
0,26,ACD,,Either,Leukemia,AML,,Cancer,Blood,,,,,,,,,,,,,,,,,,,,,1,Low,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,AML,Cancer,,,Leukemia,,Mono
0,27,BRCA1,,Either,Pancreatic Cancer,,,Cancer,Pancreas,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,9,1,1,1,1,1,1,1,1,1,,,1,,,,Low,,1,páncreas,胰腺,Masculino,男性,0,0,Ask2Me,14,,Pancreatic cancer,,Cancer,1,,Pancreatic Cancer,,Mono
0,31,BRCA2,,Either,Breast Cancer,,,Cancer,Breast,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,1,,,1,,,1,Low,High,1,mama,乳腺,Masculino,男性,0,0,Ask2Me,16,,Breast cancer,,Cancer,1,,Breast Cancer,,Mono
0,32,WRN,,Either,Melanoma,Acral lentiginous melanomas,,Cancer,Skin,,MedNeon(Kelly) Biallelic,,,,,,,,,,,,,,,,,,,,,,,melanoma,黑色素瘤,Masculino,男性,0,0,,,,Melanoma,,Cancer,,,Melanoma,,Mono
0,32,ACD,,Either,Melanoma,,,Cancer,Skin,,,,,,,,,,,,,,,,,,,,,1,Low,,1,melanoma,黑色素瘤,Masculino,男性,0,0,,,,Melanoma,,Cancer,,,Melanoma,,Mono
1,33,BRCA2,,Female,Ovarian Cancer,,,Cancer,Ovary,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,1,,,1,,,1,Mod,,1,ovario,卵巢,Femenino,女性,1,1,Ask2Me,17,,Ovarian cancer,,Cancer,1,,Ovarian Cancer,,Mono
0,34,ACD,,Either,Skin Cancer (Non-Melanoma),Squamous Cell Carcinoma,,Cancer,Skin,,,,,,,,,,,,,,,,,,,,,1,Low,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,Squamous cell carcinoma,,Cancer,,,Squamous Cell Carcinoma,,Mono
0,37,BRCA2,,Either,Pancreatic Cancer,,,Cancer,Pancreas,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,1,1,1,1,1,1,1,1,,,1,,,,Low,,1,páncreas,胰腺,Masculino,男性,0,0,Ask2Me,19,,Pancreatic cancer,,Cancer,1,,Pancreatic Cancer,,Mono
0,38,ALK,,Either,Peripheral Nervous System Cancer,Ganglioneuroblastoma,,Cancer,PNS,1,,,,,,,,,,,,,1,,,,,,1,1,Mod,,1,neuroblastoma,成神经细胞瘤,Masculino,男性,0,0,,,,Neuroblastoma,,Cancer,,,Neuroblastoma,,Mono
0,38,ALK,,Either,Peripheral Nervous System Cancer,Neuroblastoma,,Cancer,PNS,1,MedNeon(Kelly),,,Definitive,1,,,,1,1,1,1,1,,,,,,1,1,Mod,,1,neuroblastoma,成神经细胞瘤,Masculino,男性,0,0,,,,Neuroblastoma,,Cancer,,,Neuroblastoma,,Mono
1,39,BRCA2,,Male,Prostate Cancer,,,Cancer,Prostate,1,NCCN prevelance of 5.3,,,Mentioned,1,1,1,1,1,1,,1,1,,,,1,,,1,Mod,,1,próstata,前列腺,Masculino,男性,0,0,Ask2Me,20,,Prostate cancer,,Cancer,1,,Prostate Cancer,,Mono
1,41,BRIP1,,Female,Ovarian Cancer,,,Cancer,Ovary,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,,1,,1,1,,,1,,1,1,Low,,1,ovario,卵巢,Femenino,女性,0,0,Ask2Me,21,,Ovarian cancer,,Cancer,,,Ovarian Cancer,,Mono
1,43,CDH1,,Female,Breast Cancer,Invasive Lobular Breast Cancer,,Cancer,Breast,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,,1,1,1,,,1,,,1,High,High,1,mama,乳腺,Femenino,女性,0,0,Ask2Me,22,,Breast cancer,Lobular breast cancer,Cancer,1,,Breast Cancer,,Mono
0,47,MLH1,,Either,Skin (Benign),Keratoacanthoma,,Benign,Skin,1,,,,,,1,,1,1,1,,,1,,,,,,,,,,,queratoacantoma,角化棘皮瘤,Masculino,男性,0,0,,24,,Keratoacanthoma,,Benign Disease,,1,Skin (Benign),,Mono
0,50,BLM,,Either,Colorectal Cancer,,,Cancer,Colorectal,9,NCCN uncertain,,,,,9,,9,,,,,,,,,,,,1,Low,,1,colorrectal,结直肠,Masculino,男性,0,0,,,,Colorectal cancer,,Cancer,,,Colorectal Cancer,,Mono
0,51,MLH1,,Either,Duodenum Cancer,,,Cancer,Duodenum,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,,,,,1,1,,,1,,,1,Low,,1,intestino delgado,小肠,Masculino,男性,0,0,Ask2Me,26,,Small Intestine,,Cancer,,1,Duodenal Cancer,,Mono
0,55,MLH1,,Either,Sebaceous Adenoma,,,Neoplasm,Skin,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,1,1,,,1,,,,,,,,,,1,adenoma sebáceo,皮脂腺腺瘤,Masculino,男性,0,0,,28,,Sebaceous adenoma,,Benign Disease,,1,Sebaceous Adenoma,,Mono
0,59,MLH1,,Either,Hepatobiliary Cancer,,,Cancer,Liver,1,Clingen:The risk of cancer in LS by age 70: biliary tract=1-2%,,,Mentioned,1,1,,1,,,,1,1,,,,,,,1,Low,,,hepatobiliar,肝,Masculino,男性,0,0,,30,,Hepatobiliary,,Cancer,,1,Hepatobiliary Cancer,,Mono
0,63,MLH1,,Either,Brain Tumor,Glioblastoma Multiforme,,Cancer,Brain,1,Clingen:The risk of cancer in LS by age 70: brain =3.5% and NCCN,,,Mentioned,1,1,1,1,1,,,,1,1,,,1,,,1,Low,,1,cerebro,脑,Masculino,男性,0,0,Ask2Me,32,,Brain Tumor,glioblastoma multiforme,Cancer,,1,Brain Tumor,,Mono
0,67,MSH2,,Either,Skin (Benign),Keratoacanthoma,,Benign,Skin,1,,,,,,1,,1,1,1,,,1,,,,,,,,,,,queratoacantoma,角化棘皮瘤,Masculino,男性,0,0,,34,,Keratoacanthoma,,Benign Disease,,1,Skin (Benign),,Mono
0,71,MSH2,,Either,Duodenum Cancer,,,Cancer,Duodenum,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,1,1,,,1,1,,,1,,,1,Low,,1,intestino delgado,小肠,Masculino,男性,0,0,Ask2Me,36,,Small Intestine,,Cancer,,1,Duodenal Cancer,,Mono
0,77,MSH2,,Either,Hepatobiliary Cancer,,,Cancer,Liver,1,Clingen:The risk of cancer in LS by age 70: biliary tract=1-2%,,,Mentioned,1,1,,1,1,,,,1,,,,,,,1,Low,,,hepatobiliar,肝,Masculino,男性,0,0,,39,,Hepatobiliary,,Cancer,,1,Hepatobiliary Cancer,,Mono
0,80,CASR,,Either,Endocrine Abnormalities,Autosomal Dominant Hypocalcemia Type 1,,Benign,Endocrine,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Hypocalcemia,,Benign Disease,,,Hypocalcemia,,Mono
0,81,MSH2,,Either,Brain Tumor,Glioblastoma Multiforme,,Cancer,Brain,1,Clingen:The risk of cancer in LS by age 70: brain =3.5%,,,Mentioned,1,1,1,1,1,,,,1,1,,,1,,,1,Low,,1,cerebro,脑,Masculino,男性,0,0,Ask2Me,41,,Brain Tumor,glioblastoma multiforme,Cancer,,1,Brain Tumor,,Mono
0,84,CASR,,Either,Endocrine Abnormalities,Familial Isolated Hyperparathyroid,,Benign,Parathyroid,1,,,,,,,,,1,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Hypoparathyroidism,,Benign Disease,,,Hypoparathyroid,,Mono
0,85,MSH6,,Either,Skin (Benign),Keratoacanthoma,,Benign,Skin,1,,,,,,1,,1,1,,,,1,,,,,,,,,,,queratoacantoma,角化棘皮瘤,Masculino,男性,0,0,,43,,Keratoacanthoma,,Benign Disease,,1,Skin (Benign),,Mono
0,87,MSH6,,Either,Small Intestine Cancer,,,Cancer,Small Bowel,9,only one source,,,Mentioned,1,,,,1,,,,1,1,,,1,,,1,Low,,,intestino delgado,小肠,Masculino,男性,0,0,Ask2Me,45,,Small Intestine,,Cancer,,1,Small Intestine Cancer,,Mono
0,90,CASR,,Either,Kidney (Benign),Kidney Stone,,Benign,Kidney,1,,,,,,,,,1,1,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Kidney stones,,Benign Disease,,,Kidney (Benign),,Mono
0,91,MSH6,,Either,Sebaceous Adenoma,,,Neoplasm,Skin,1,,,,,,1,,1,1,,,,1,,,,,,,,,,,adenoma sebáceo,皮脂腺腺瘤,Masculino,男性,0,0,,47,,Sebaceous adenoma,,Benign Disease,,1,Sebaceous Adenoma,,Mono
0,94,SEC23B,,Either,Central Nervous System (Benign),Epileptic encephalopathy,,Benign,CNS,0,,,,,,,,,,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Epilepsy,,Benign Disease,,,Epilepsy,,Mono
0,94,CASR,,Either,Central Nervous System (Benign),Epilepsy,,Benign,CNS,0,,,,,,,,,,,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Epilepsy,,Benign Disease,,,Epilepsy,,Mono
0,95,MSH6,,Either,Hepatobiliary Cancer,,,Cancer,Liver,1,Clingen:The risk of cancer in LS by age 70: biliary tract=1-2%,,,Mentioned,1,,,,1,,,,1,,,,,,,1,Low,,,hepatobiliar,肝,Masculino,男性,0,0,,49,,Hepatobiliary,,Cancer,,1,Hepatobiliary Cancer,,Mono
0,96,CEBPA,,Either,Leukemia,AML,,Cancer,Blood,,,,,Definitive,1,1,,1,1,1,1,1,1,,,,,,1,1,High,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,AML,Cancer,,,Leukemia,,Mono
0,99,MSH6,,Either,Brain Tumor,Glioblastoma Multiforme,,Cancer,Brain,1,Clingen:The risk of cancer in LS by age 70: brain =3.5%,,,Mentioned,1,1,1,,1,,,1,1,1,,,1,,,1,Low,,1,cerebro,脑,Masculino,男性,0,0,Ask2Me,51,,Brain Tumor,glioblastoma multiforme,Cancer,,1,Brain Tumor,,Mono
0,102,CDC73,,Either,Parathyroid Carcinoma,,,Cancer,Parathyroid,1,ClinGen is definitive or moderate while NCCN is mute.,,,Mentioned,1,,,,1,1,1,1,1,,,,,,,1,Low,,1,,,Masculino,男性,0,0,,,,Parathyroid tumor,,Cancer,,,Parathyroid Carcinoma,,Mono
0,105,PMS2,,Either,Brain Tumor,Glioblastoma Multiforme,,Cancer,Brain,9,NCCN: Not enough evidence  Clingen:The risk of cancer in LS by age 70: brain =3.5%,,,Mentioned,1,1,1,,1,,,,1,,,,,,,1,Low,,,cerebro,脑,Masculino,男性,0,0,,,,Brain Tumor,,Cancer,,1,Brain Tumor,,Mono
0,106,CDKN1B,,Either,Neuroendocrine,Pancreatic Neuroendocrine Tumor,MEN4,Neoplasm,Pancreas,1,,,,Mentioned,1,,,,,,,,1,,,,,,,1,Low,,1,,,Masculino,男性,0,0,,,,Pancreatic neuroendocrine tumor,,Cancer,,,Neuroendocrine,,Mono
0,109,PMS2,,Either,Hepatobiliary Cancer,,,Cancer,Liver,9,NCCN: Not well established Clingen:The risk of cancer in LS by age 70: biliary tract=1-2%,,,Mentioned,1,9,,9,1,,,1,1,,,,,,,1,Low,,,hepatobiliar,肝,Masculino,男性,0,0,,,,Hepatobiliary,,Cancer,,1,Hepatobiliary Cancer,,Mono
0,110,CDKN1C,,Either,Peripheral Nervous System Cancer,Neuroblastoma,,Cancer,PNS,0,,,,,,,,,,,,,1,,,,,,,1,Low,,,,,Masculino,男性,0,0,,,,Neuroblastoma,,Cancer,,,Neuroblastoma,,Mono
0,112,DICER1,,Either,Sarcoma,Embryonal Rhabdomyosarcoma,,Cancer,Soft Tissue,1,,,,Mentioned,9,,,,,1,1,,1,,,,,,,1,High,,1,,,Masculino,男性,0,0,,,,Embryonal rhabdomyosarcoma,,Cancer,,,Sarcoma,,Mono
0,113,PMS2,,Either,Skin (Benign),Keratoacanthoma,,Benign,Skin,1,,,,,,1,,1,,,,1,1,,,,,,,,,,,queratoacantoma,角化棘皮瘤,Masculino,男性,0,0,,,,Keratoacanthoma,,Benign Disease,,1,Skin (Benign),,Mono
0,116,DICER1,,Either,Wilms Tumor,Nephroblastoma,,Cancer,Kidney,1,PMID: 31067372,,,Mentioned,1,,,,,1,1,1,1,,,,,1,,1,Low,,,riñón,肾,Masculino,男性,0,0,,,,Cystic nephroma,nephroblastoma,Cancer,,,Nephroblastoma,,Mono
0,117,PMS2,,Either,Sebaceous Adenoma,,,Neoplasm,Skin,1,,,,,,1,,1,,,,1,1,,,,,,,,,,,adenoma sebáceo,皮脂腺腺瘤,Masculino,男性,0,0,,,,Sebaceous adenoma,,Benign Disease,,1,Sebaceous Adenoma,,Mono
0,119,PMS2,,Either,Sebaceous Cancer,,,Cancer,Skin,1,,,,,,1,,1,,,,1,1,,,,,,,1,Low,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,Sebaceous carcinoma,,Cancer,,1,Sebaceous Cancer,,Mono
0,124,DICER1,,Either,Peripheral Nervous System Cancer,Neuroblastoma,,Cancer,PNS,9,PMID: 31067372,,,,,,,,,,,,1,,,,,1,,1,Low,,,neuroblastoma,成神经细胞瘤,Masculino,男性,0,0,,,,Neuroblastoma,,Cancer,,,Neuroblastoma,,Mono
0,125,PMS2,,Either,Small Intestine Cancer,,,Cancer,Small Bowel,9,NCCN: Not well established.  ClinGenSilent.,,,,,9,,9,1,,,1,1,,,,,,,1,Low,,,intestino delgado,小肠,Masculino,男性,0,0,,,,Small Instestine,,Cancer,,1,Small Intestine Cancer,,Mono
1,128,DICER1,,Female,Ovarian Neoplasm,Sex Cord Tumor,,Neoplasm,Ovary,1,Check Dicer paper NEJM,,,Mentioned,1,,,,1,1,1,1,1,,,,,,,1,High,,1,ovario,卵巢,Femenino,女性,0,0,,,,Ovarian cancer,Sertoli-Leydig cell tumors,Cancer,,,Ovarian Cancer,,Mono
0,129,EPCAM,,Either,Brain Tumor,Glioblastoma Multiforme,,Cancer,Brain,1,Clingen:The risk of cancer in LS by age 70: brain =3.5%,,,Mentioned,1,1,1,1,,,,1,1,,,,,,,1,Low,,,cerebro,脑,Masculino,男性,0,0,,66,,Brain Tumor,,Cancer,,1,Brain Tumor,,Mono
1,131,EPCAM,,Female,Endometrial Cancer,,Lynch Syndrome,Cancer,Uterus,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,,,,1,1,,,,,,,1,High,,,endometrio,子宫内膜,Femenino,女性,0,0,,67,,Endometrial cancer,,Cancer,,1,Endometrial Cancer,,Mono
0,132,DICER1,,Either,Brain Tumor,Pineoblastoma,,Cancer,Brain,9,,,,Mentioned,9,,,,,,,,1,,,,,,,1,High,,1,,,Masculino,男性,0,0,,,,Pineoblastoma,,Cancer,,,Brain Tumor,,Mono
0,132,DICER1,,Either,Brain Tumor,Medulloblastoma,,Cancer,Brain,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Pineoblastoma,,Cancer,,,Brain Tumor,,Mono
0,134,DICER1,,Either,Brain Tumor,Pituitary Blastoma,,Neoplasm,Pituitary,9,,,,Mentioned,9,,,,,,,,1,,,,,,,1,High,,1,,,Masculino,男性,0,0,,,,Pituitary blastoma,,Cancer,,,Pituitary Neoplasm,,Mono
0,135,EPCAM,,Either,Gastric Cancer,,Lynch Syndrome,Cancer,Gastric,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,,1,,,,1,1,,,,,,,1,,,,gástrico,胃,Masculino,男性,0,0,,69,,Gastric cancer,,Cancer,,1,Gastric Cancer,,Mono
0,137,EPCAM,,Either,Hepatobiliary Cancer,,,Cancer,Liver,1,Clingen:The risk of cancer in LS by age 70: biliary tract=1-2%,,,Mentioned,1,1,,1,,,,1,1,,,,,,,1,Low,,,hepatobiliar,肝,Masculino,男性,0,0,,70,,Hepatobiliary,,Cancer,,1,Hepatobiliary Cancer,,Mono
0,138,DICER1,,Either,Liver (Benign),Mesenchymal Hamartoma Of The Liver,,Benign,Liver,9,PMID: 31067372,,,,,,,,,,,,1,,,,,1,,,,,,,,Masculino,男性,0,0,,,,Mesenchymal hamartoma of the liver,,Cancer,,,Liver(Benign),,Mono
0,141,EPCAM,,Either,Skin (Benign),Keratoacanthoma,,Benign,Skin,1,,,,,,1,,1,,,,1,1,,,,,,,,,,,queratoacantoma,角化棘皮瘤,Masculino,男性,0,0,,72,,Keratoacanthoma,,Benign Disease,,1,Skin (Benign),,Mono
0,142,DICER1,,Either,Lung Cancer,Pleuropulmonary blastoma,,Cancer,Lung,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,1,,,,,1,1,1,High,,1,,,Masculino,男性,0,0,,,,Pleuropulmonary blastoma,Pleuropulmonary blastoma,Cancer,,,Lung Cancer,,Mono
1,145,EPCAM,,Female,Ovarian Cancer,,Lynch Syndrome,Cancer,Ovary,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,,,,,1,,,,,,,1,Low,,,ovario,卵巢,Femenino,女性,0,0,,74,,Ovarian cancer,,Cancer,,1,Ovarian Cancer,,Mono
0,146,DICER1,,Either,Thyroid (Benign),Multinodular Goiter,,Benign,Thyroid,1,PMID: 31067372,,,Definitive,1,,,,1,1,1,1,1,,,,,1,,,,,1,,,Masculino,男性,0,0,,,,Multinodular goiter,,Benign Disease,,,Thyroid (Benign),,Mono
0,146,NKX2-1,,Either,Thyroid (Benign),Multinodular Goiter,,Benign,Thyroid,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Multinodular goiter,,Benign Disease,,,Thyroid (Benign),,Mono
0,146,NKX2-1,,Either,Lung (Benign),neonatal respiratory distress,CAHTP,Benign,Lung,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Multinodular goiter,,Benign Disease,,,respiratory distress,,Mono
0,149,EPCAM,,Either,Pancreatic Cancer,,,Cancer,Pancreas,1,Clingen:The risk of cancer in LS by age 70: brain =3.5%Clingen:The risk of cancer in LS by age 70:  pancreas=1-4%,,,Mentioned,1,1,1,1,,,,,1,,,,,,,1,Low,,,páncreas,胰腺,Masculino,男性,0,0,,76,,Pancreatic cancer,,Cancer,,1,Pancreatic Cancer,,Mono
0,150,SEC23B,,Either,GI Neoplasm,Hamartomatous Polyps,,Neoplasm,GI,0,,,,,,,,,,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,GI hamartoma,,Cancer,,,GI Hamartoma,,Mono
0,150,DICER1,,Either,GI Neoplasm,Hamartomatous Polyps,,Neoplasm,GI,0,PMID: 31067372,,,,,,,,,,,,1,,,,,1,,,,,,,,Masculino,男性,0,0,,,,GI hamartoma,,Cancer,,,GI Hamartoma,,Mono
1,151,EPCAM,,Male,Prostate Cancer,,,Cancer,Prostate,9,NCCN: Not well established NCCN : very low no of mutation carriers,,,Mentioned,1,9,9,,,,,,1,,,,,,,,,,,próstata,前列腺,Masculino,男性,0,0,,77,,Prostate cancer,,Cancer,,1,Prostate Cancer,,Mono
0,154,DICER1,,Either,Gastrointestinal (Benign),Intussusception,,Benign,Small Bowel,0,PMID: 31067372,,,,,,,,,,,,1,,,,,1,,,,,,,,Masculino,男性,0,0,,,,Intussusception,,Benign Disease,,,Intussusception,,Mono
0,155,EPCAM,,Either,Sebaceous Adenoma,,,Neoplasm,Skin,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,,,,,1,,,,,,,,,,,adenoma sebáceo,皮脂腺腺瘤,Masculino,男性,0,0,,79,,Sebaceous adenoma,,Benign Disease,,1,Sebaceous Adenoma,,Mono
0,157,EPCAM,,Either,Sebaceous Cancer,,,Cancer,Skin,1,,,,,,1,,1,,,,1,1,,,,,,,1,Low,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,80,,Sebaceous carcinoma,,Cancer,,1,Sebaceous Cancer,,Mono
0,158,DICER1,,Either,Thyroid Cancer,Thyroid cancer differentiated,,Cancer,Thyroid,1,PMID: 31067372,,,Mentioned,1,,,,1,1,,,1,,,,,1,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,,,Thyroid Cancer,,Mono
0,161,APC,,Either,Bone Neoplasm,Osteoma,,Neoplasm,Bone,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,,1,,1,1,,1,,,,,,,,,,,osteoma,骨瘤,Masculino,男性,0,0,,82,,Osteoma,,Neoplasm,,1,Bone Neoplasm,,Mono
0,162,DICER1,,Either,Skin (Benign),Dysplastic Nevus,,Benign,Skin,9,PMID: 31067372,,,,,,,,,,,,1,,,,,1,,,,,,,,Masculino,男性,0,0,,,,Dysplastic nevus,,Benign Disease,,,Skin (Benign),,Mono
0,165,APC,,Either,Teeth (Benign),Supranummary teeth (Odontoma),,Benign,Head and neck,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,,1,,1,,,1,,,,,,,,,,,anomalía dental,牙齿异常,Masculino,男性,0,0,,84,,Dental abnormality,,Benign Disease,,1,Dental Abnormality,,Mono
0,166,DICER1,,Either,Gastrointestinal (Benign),Meckel’s Diverticulum,,Benign,Small Bowel,0,PMID: 31067372,,,,,,,,,,,,1,,,,,1,,,,,,,,Masculino,男性,0,0,,,,Meckel’s diverticulum,,Benign Disease,,,Meckel’s Diverticulum,,Mono
0,169,APC,,Either,CHRPE,Congenital retinal pigment epithelial hypertrophy,,Benign,Eye,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,,1,,1,,,1,,,,,,,,,,,hipertrofia congénita del epitelio pigmentario de la retina,先天性视网膜色素上皮肥大,Masculino,男性,0,0,,86,,Congenital hypertrophy of the retinal pigment epithelium (CHRPE),,Benign Disease,,1,CHRPE,,Mono
0,170,DICER1,,Either,Developmental,Global Development Delay,,Benign,Developmental,9,,,,,,,,,,,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Global Development delay,,Benign Disease,,,Global Development Delay,,Mono
0,177,APC,,Either,Adrenal Neoplasm,Primary Macronodular Adrenal Hyperplasia,,Neoplasm,Adrenal,1,NLP-GHR only PMID: 9293929 PMID: 29377868,,,Mentioned,1,,,,1,,,,1,,,,,,,,,,,masa suprarrenal,肾上腺肿块,Masculino,男性,0,0,,90,,Adrenal mass,,Benign Disease,,1,Adrenal Hyperplasia,,Mono
0,181,APC,,Either,Hepatobiliary Cancer,Hepatoblastoma,,Cancer,Liver,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,1,1,,1,,1,1,,,,,,,1,Low,,1,hepatoblastoma,肝母细胞瘤,Masculino,男性,0,0,,92,,Hepatoblastoma,,Cancer,,1,Liver Cancer,,Mono
0,182,EGFR,,Either,Brain Tumor,Glioblastoma Multiforme,,Cancer,Brain,0,,,,,,,,,,,1,,1,,,,,,,1,Low,,1,cerebro,脑,Masculino,男性,0,0,,,,Brain Tumor,glioblastoma multiforme,Cancer,,,Brain Tumor,,Mono
0,188,EGFR,,Either,Lung Cancer,NSCLC,,Cancer,Lung,1,,,,Definitive,1,,,,1,1,1,1,1,,,,,,1,1,Low,,1,pulmonar,肺,Masculino,男性,0,0,,,,Lung,NSCLC,Cancer,,,Lung Cancer,,Mono
0,192,ETV6,,Either,Leukemia,AML,,Cancer,Blood,,,,,,,,,,1,1,1,1,,,,,,,,1,Low,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,AML,Cancer,,,Leukemia,,Mono
0,193,APC,,Either,Duodenum Cancer,,,Cancer,Duodenum,1,Clingen: lifetime risk of duodenal cancers has been estimated at 3-12%,,,Mentioned,1,1,1,1,,,,,1,,,,,,,,,,,duodenal,十二指肠,Masculino,男性,0,0,,98,,Duodenal cancer,,Cancer,,1,Duodenum Cancer,,Mono
0,195,BARD1,,Either,Peripheral Nervous System Cancer,Neuroblastoma,,Cancer,PNS,0,somatic,,,,,,,,1,,,,1,,,,,,,,,,1,neuroblastoma,成神经细胞瘤,Masculino,男性,0,0,,99,,Neuroblastoma,,Cancer,1,,Neuroblastoma,,Mono
0,196,FANCC,,Either,Leukemia,AML,,Cancer,Blood,,,,,,,,,,,,,,,,,,,,,1,High,,1,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,AML,Cancer,,,Leukemia,,Mono
0,198,FANCC,,Either,Skin Cancer (Non-Melanoma),Squamous Cell Carcinoma,,Cancer,Skin,,,,,,,,,,,,,,,,,,,,,1,Low,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,Squamous cell carcinoma,,Cancer,,,Squamous Cell Carcinoma,,Mono
0,201,BRCA1,,Either,Melanoma,,,Cancer,Skin,0,"PMID: 23910109,PMID: 30286154",,,,,,,,,,,,1,,,,,,,1,Low,,1,melanoma,黑色素瘤,Masculino,男性,0,0,,102,,Melanoma,,Cancer,1,,Melanoma,,Mono
0,204,FH,,Either,Kidney Cancer,"Renal Cell Carcinoma, Aggressive",,Cancer,Kidney,,"ClinGen:Genetic prevalence is unknown. FH is the only gene known to be associated with hereditary leiomyomatosis and renal cell cancer (HLRCC), and 70% to 90% of individuals with clinically diagnosed HLRCC have identifiable sequence variants in FH.",,,Mentioned,1,,,,1,1,1,,,,,,,,1,1,Low,,1,riñón,肾,Masculino,男性,0,0,,,,Kidney,renal cell carcinoma,Cancer,,,Kidney Cancer,,Mono
0,206,FH,,Either,Sarcoma,Cutaneous Leiomyosarcoma,,Neoplasm,Skin,1,"ClinGen:Genetic prevalence is unknown. FH is the only gene known to be associated with hereditary leiomyomatosis and renal cell cancer (HLRCC), and 70% to 90% of individuals with clinically diagnosed HLRCC have identifiable sequence variants in FH.",,,Mentioned,1,,,,1,1,1,1,,,,,,,1,1,Low,,1,,,Masculino,男性,0,0,,,,Leiomyosarcoma,,Cancer,,,Sarcoma,,Mono
0,213,SEC23B,,Either,Skin (Benign),Trichilemmoma,,Benign,Skin,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,108,,,,Benign Disease,,,Hair (Benign),,Mono
0,213,CDK4,,Either,Skin (Benign),Atypical Nevi,,Benign,Skin,1,,,,,,,,,1,,,,1,,,,,,,,,,,nevos atípicos,非典型痣,Masculino,男性,0,0,,108,,Atypical nevi,,Benign Disease,,,Skin (Benign),,Mono
0,214,FLCN,,Either,Colorectal Cancer,,,Cancer,Colorectal,9,MedNeon(Kelly) Priliminary evidence,,,,,,,,2,2,1,1,,,,,,,1,1,Low,,1,colorrectal,结直肠,Masculino,男性,0,0,,,,Colorectal cancer,,Cancer,,,Colorectal Cancer,,Mono
0,215,CDKN2A,p14,Either,Sarcoma,,,Cancer,Soft Tissue,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,sarcoma,肉瘤,Masculino,男性,0,0,,109,,Sarcoma,,Cancer,,,Sarcoma,,Mono
0,218,FLCN,,Either,Kidney Cancer,"Renal Cell Carcinoma, hybrid oncocytic tumor, chromophobe renal cell carcinoma, clear cell renal carcinoma, renal cell oncocytoma, papillary renal carcinoma",,Cancer,Kidney,,,,,,,,,,2,2,1,1,,,,,,,,1,Low,,1,riñón,肾,Masculino,男性,0,0,,,,Kidney,renal cell carcinoma,Cancer,,,Kidney Cancer,,Mono
0,219,CDKN2A,p16,Either,Sarcoma,,,Cancer,Soft Tissue,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,sarcoma,肉瘤,Masculino,男性,0,0,,111,,Sarcoma,,Cancer,,,Sarcoma,,Mono
0,222,GALNT12,,Either,Colorectal Cancer,,,Cancer,Colorectal,,ClinGen and NCCN disagree,,,Limited,9,1,,1,1,1,1,1,,,,,,,1,1,Low,,1,colorrectal,结直肠,Masculino,男性,0,0,,,,Colorectal cancer,,Cancer,,,Colorectal Cancer,,Mono
0,225,EPCAM,,Either,Kidney Cancer,Renal Pelvis,,Cancer,Kidney,1,,,,,,1,1,,,,,,1,,,,,,,,,,,riñón,肾,Masculino,男性,0,0,,114,,Kidney,,Cancer,,1,Kidney Cancer,,Mono
0,226,GATA2,,Either,Leukemia,CMML,,Cancer,Blood,,,,,,,,,,1,,,,,,,,,,,1,Low,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,CMML,Cancer,,,Leukemia,,Mono
0,228,GATA2,,Either,Leukemia,AML,,Cancer,Blood,,,,,,,,,,1,1,1,1,,,,,,,,1,High,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,AML,Cancer,,,Leukemia,,Mono
0,229,MLH1,,Either,Ureter Cancer,,,Cancer,Ureter,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,,,,,1,,,,,,,1,Low,,1,uréter,输尿管,Masculino,男性,0,0,,116,,Ureter,,Cancer,,1,Ureter Cancer,,Mono
0,236,GPC3,,Either,Wilms Tumor,Nephroblastoma,,Cancer,Kidney,,MedNeon (Kelly) X- linked recessive,,,,,,,,,2,1,1,,,,,,,1,1,,,,riñón,肾,Masculino,男性,0,0,,,,Kidney,nephroblastoma,Cancer,,,Kidney Cancer,,Mono
0,237,MSH2,,Either,Ureter Cancer,,,Cancer,Ureter,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,1,1,,,,,1,,,,,,,1,Mod,,1,uréter,输尿管,Masculino,男性,0,0,,120,,Ureter,,Cancer,,1,Ureter Cancer,,Mono
0,238,GPC3,,Either,Hepatobiliary Cancer,Hepatocellular Cancer,,Cancer,Liver,,MedNeon (Kelly) X- linked recessive,,,,,,,,,,,,,,,,,,,1,,,,Hígado,肝,Masculino,男性,0,0,,,,Liver,,Cancer,,,Hepatocellular Cancer,,Mono
0,241,MSH2,,Either,Kidney Cancer,Renal Pelvis,,Cancer,Kidney,1,,,,,,1,1,,,,,,1,,,,,,,,,,1,riñón,肾,Masculino,男性,0,0,,122,,Kidney,,Cancer,,1,Kidney Cancer,,Mono
0,244,GPC3,,Either,Simpson-Golabi-Behmel syndrome,"characteristic facies, cognitive impairment, pre- and postnatal overgrowth, macrosomia, and skeletal, genitourinary, cardiac, and renal anomalies",,Syndrome,,,MedNeon (Kelly) X- linked recessive,,,,,,,,,,,,,,,,,,1,1,,,,neuroblastoma,成神经细胞瘤,Masculino,男性,0,0,,,,Neuroblastoma,,Cancer,,,Neuroblastoma,,Mono
0,244,GPC3,,Either,Peripheral Nervous System Cancer,Neuroblastoma,,Cancer,PNS,,MedNeon (Kelly) X- linked recessive,,,,,,,,,,,,,,,,,,1,1,,,,neuroblastoma,成神经细胞瘤,Masculino,男性,0,0,,,,Neuroblastoma,,Cancer,,,Neuroblastoma,,Mono
0,245,MSH6,,Either,Ureter Cancer,,,Cancer,Ureter,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,,,,,1,,,,,,,1,Low,,,uréter,输尿管,Masculino,男性,0,0,,124,,Ureter,,Cancer,,1,Ureter Cancer,,Mono
0,249,MSH6,,Either,Kidney Cancer,Renal Pelvis,,Cancer,Kidney,1,,,,,,1,1,,,,,,1,,,,,,,,,,,riñón,肾,Masculino,男性,0,0,,126,,Kidney,,Cancer,,1,Kidney Cancer,,Mono
0,253,PMS2,,Either,Upper Urinary Tract Cancer,,,Cancer,Upper Urinary Tract,9,NCCN: Not well established Clingen:The risk of cancer in LS by age 70: upper urinary tract=6%,,,Mentioned,1,,,,1,,,1,1,,,,,,,1,Low,,,uréter,输尿管,Masculino,男性,0,0,,,,Ureter,,Cancer,,1,Upper Urinary Tract Cancer,,Mono
0,257,PMS2,,Either,Kidney Cancer,Renal Pelvis,,Cancer,Kidney,1,,,,,,1,1,,,,,,1,,,,,,,,,,,riñón,肾,Masculino,男性,0,0,,,,Kidney,,Cancer,,1,Kidney Cancer,,Mono
0,259,NBN,,Either,Colorectal Cancer,,,Cancer,Colorectal,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,colorrectal,结直肠,Masculino,男性,0,0,,131,,Colorectal cancer,,Cancer,1,,Colorectal Cancer,,Mono
0,263,NBN,,Either,Gastric Cancer,,,Cancer,Gastric,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,gástrico,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,1,,Gastric Cancer,,Mono
0,268,KIT,,Either,GIST,,,Neoplasm,Small Bowel,,,,,,,,,,1,,,,,,,,,,1,1,High,,,,,Masculino,男性,0,0,,,,Gastrointestinal Stromal Tumor,,Cancer,,,GIST,,Mono
0,271,CDKN2A,p16,Either,Skin (Benign),Atypical Nevi,,Benign,Skin,0,,,,,,,,,,,,,1,,,,,,,,,,,nevos atípicos,非典型痣,Masculino,男性,0,0,,137,,Atypical nevi,,Benign Disease,,,Skin (Benign),,Mono
0,272,MAX,,Either,Pheochromocytoma/Paraganglioma,Paraganglioma,,Neoplasm,Nerve,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,,,1,1,,,,,,,1,1,High,,,,,Masculino,男性,0,0,,,,Paraganglioma,,Neoplasm,,,Neuroendocrine,,Mono
0,274,MET,,Either,Kidney Cancer,Renal Cell Carcinoma,,Cancer,Kidney,,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,,,,,,,1,1,Mod,,,riñón,肾,Masculino,男性,0,0,,,,Kidney,renal cell carcinoma,Cancer,,,Kidney Cancer,,Mono
1,277,MUTYH-Biallelic,,Female,Breast Cancer,,,Cancer,Breast,0,-1 (No reported evidence by lee21018GenIn),,,No Reported Evidence,0,,,,,,,,1,,,,,,,,,,1,mama,乳腺,Femenino,女性,0,0,,140,,Breast cancer,,Cancer,,1,Breast Cancer,,Mono
0,279,MUTYH-Biallelic,,Either,Skin (Benign),Pilomatrixoma,,Benign,Skin,1,Clingen: still not clear if the lifetime risk of these malignancies is increased.,,,Definitive,1,,,,,2,1,1,1,,,,,,,,,,,piel,皮肤,Masculino,男性,0,0,,141,,Pilomatrixoma,,Cancer,,1,Skin (Benign),,Mono
0,280,MITF,,Either,Kidney Cancer,Renal Cell Carcinoma,,Cancer,Kidney,0,,,,,,,,,,,,,,,,,,,,1,Low,,,riñón,肾,Masculino,男性,0,0,,,,Kidney,renal cell carcinoma,Cancer,,,Kidney Cancer,,Mono
0,283,MUTYH-Biallelic,,Either,CHRPE,Congenital retinal pigment epithelial hypertrophy,,Benign,Eye,1,Clingen: Rare,,,Mentioned,1,,,,,,,,1,,,,,,,,,,,hipertrofia congénita del epitelio pigmentario de la retina,先天性视网膜色素上皮肥大,Masculino,男性,0,0,,145,,Congenital hypertrophy of the retinal pigment epithelium (CHRPE),,Benign Disease,,1,CHRPE,,Biallelic
0,284,MITF,,Either,Melanoma,,,Cancer,Skin,,,,,,,,,,1,,1,1,,,,,,,1,1,Low,,,melanoma,黑色素瘤,Masculino,男性,0,0,,,,Melanoma,,Cancer,,,Melanoma,,Mono
0,286,MRE11A,,Either,Breast Cancer,,,Cancer,Breast,0,,,,Disputed,0,,,,1,,,,1,,,,,,1,1,Low,,,mama,乳腺,Masculino,男性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
0,287,MUTYH-Biallelic,,Either,Duodenum Cancer,,,Cancer,Duodenum,1,Clingen: The lifetime risk of duodenal cancer in MAP has been estimated to be 4-5%,,,Mentioned,1,1,1,1,,,,,1,,,,,,,,,,,duodenal,十二指肠,Masculino,男性,0,0,,147,,Duodenal cancer,,Cancer,,1,Duodenal Cancer,,Biallelic
1,290,MRE11A,,Female,Ovarian Cancer,,,Cancer,Ovary,0,,,,Disputed,0,,,,1,,,,1,,,,,,,1,Low,,,mama,乳腺,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,,,Ovarian Cancer,,Mono
0,291,MUTYH-Biallelic,,Either,Bone (Benign),Jaw Lesions,,Benign,Bone,9,,,,,,,,,,,,,1,,,,,,,,,,,quiste mandibular,颌骨囊肿,Masculino,男性,0,0,,149,,Jaw-bone cyst,,Benign Disease,,1,Jaw Lesions,,Biallelic
0,295,PALB2,,Either,Breast Cancer,,,Cancer,Breast,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,,1,,1,1,1,1,1,,,1,,,,,,,mama,乳腺,Masculino,男性,0,0,,151,,Breast cancer,,Cancer,1,,Breast Cancer,,Mono
0,298,NF1,,Either,Brain Tumor,Astrocytoma,,Cancer,Brain,1,PMID: 19937438,,,,,,,,,1,,,1,1,,,1,,,,,,,cerebro,脑,Masculino,男性,0,0,Ask2Me,153,,Brain Tumor,Astrocytoma/Optic Glioma,Cancer,1,,Brain Tumor,,Mono
0,299,NF2,,Either,Brain Tumor,Meningioma,,Neoplasm,Brain,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,,,,,,,,1,Low,,,leucemia,白血病,Masculino,男性,0,0,,,,Meningioma,,Benign Disease,,,Brain Tumor,,Mono
0,305,NF2,,Either,Brain Tumor,Glioblastoma Multiforme,,Cancer,Brain,,,,,,,,,,1,,1,1,,,,,,,,1,Low,,,cerebro,脑,Masculino,男性,0,0,,,,Brain Tumor,glioblastoma multiforme,Cancer,,,Brain Tumor,,Mono
0,306,NF1,,Either,Brain Tumor,Optic Glioma,,Cancer,Eye,1,,,,Mentioned,1,1,1,1,,1,,,1,,,,,,,1,Low,,,gliomas de la vía óptica,视神经胶质瘤,Masculino,男性,0,0,,157,,Optic pathway gliomas,,Benign Disease,1,,Optic pathway gliomas,,Mono
0,311,PARK2,,Either,Lung Cancer,,,Cancer,Lung,,,,,,,,,,,,,,,,,,,,,1,Mod,,,pulmonar,肺,Masculino,男性,0,0,,,,Lung,,Cancer,,,Lung Cancer,,Mono
0,316,EPCAM,,Either,Small Intestine Cancer,,,Cancer,Small Bowel,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,,,,1,1,,,,,,,1,Low,,,intestino delgado,小肠,Masculino,男性,0,0,,162,,Small Instestine,,Cancer,,1,Small Intestine Cancer,,Mono
0,317,PDGFRA,,Either,GIST,,,Neoplasm,Small Bowel,,,,,,,,,,1,1,1,1,,,,,,,1,1,High,,,,,Masculino,男性,0,0,,,,Gastrointestinal Stromal Tumor,,Cancer,,,GIST,,Mono
0,319,PDGFRA,,Either,Leukemia,Chronic Eosinophilic Leukemia,,Cancer,Blood,,,,,,,,,,1,,1,,,,,,,,,1,High,,,leucemia,白血病,Masculino,男性,0,0,,,,Eosinophilic leukemia,CEL,Cancer,,,Leukemia,,Mono
0,320,EPCAM,,Either,Ureter Cancer,,,Cancer,Ureter,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,1,1,,,,1,1,,,,,,,1,Low,,,uréter,输尿管,Masculino,男性,0,0,,164,,Ureter,,Cancer,,1,Ureter Cancer,,Mono
0,322,MSH2,,Either,Gastric Cancer,,Lynch Syndrome,Cancer,Gastric,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,,1,1,,,,1,1,,,1,,,1,Low,,1,gástrico,胃,Masculino,男性,0,0,Ask2Me,165,,Gastric cancer,,Cancer,,1,Gastric Cancer,,Mono
0,323,PHOX2B,,Either,Peripheral Nervous System Cancer,Neuroblastoma,,Cancer,PNS,,,,,,,,,,1,1,1,1,,,,,,,1,1,Mod,,,neuroblastoma,成神经细胞瘤,Masculino,男性,0,0,,,,Neuroblastoma,,Cancer,,,Neuroblastoma,,Mono
0,326,MSH2,,Either,Sebaceous Adenoma,,,Neoplasm,Skin,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,1,1,,,1,,,,,,,,,,,adenoma sebáceo,皮脂腺腺瘤,Masculino,男性,0,0,,167,,Sebaceous adenoma,,Benign Disease,,1,Sebaceous Adenoma,,Mono
0,329,PMS2P1,,Either,Hepatobiliary Cancer,Cholangiocarcinoma,,Cancer,Bile Duct,,,,,,,,,,,,,,,,,,,,,1,,,,hepatobiliar,肝,Masculino,男性,0,0,,,,Bile duct,,Cancer,,,Hepatobiliary Cancer,,Mono
0,330,MSH6,,Either,Sebaceous Cancer,,,Cancer,Skin,1,,,,,,1,,1,1,,,,1,,,,,,,1,Low,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,169,,Sebaceous carcinoma,,Cancer,,1,Sebaceous Cancer,,Mono
0,331,PRKAR1A,,Either,CNS Tumor,"Schwannoma, Psammomatous melanotic schwannomas",,Neoplasm,CNS,1,PMID:30428497,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Osteochondromyxoma,,Cancer,,,Schwannoma,,Mono
0,331,PRKAR1A,,Either,Bone Neoplasm,Osteochondromyxoma,,Neoplasm,Bone,1,PMID:30428497,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Osteochondromyxoma,,Cancer,,,Bone Neoplasm,,Mono
0,332,APC,,Either,Pancreatic Cancer,,,Cancer,Pancreas,1,Clingen: Lifetime pancreatic cancer risk to age 80 in individuals with FAP was estimated at 1-2%,,,Mentioned,1,1,,1,,1,,,1,,,,,,,1,Low,,,páncreas,胰腺,Masculino,男性,0,0,,170,,Pancreatic cancer,,Cancer,,1,Pancreatic Cancer,,Mono
0,335,PTCH1,,Either,Skin Cancer (Non-Melanoma),Basal Cell Carcinoma,,Cancer,Skin,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,1,,,,,,1,1,High,,1,hepatobiliar,肝,Masculino,男性,0,0,,,,Skin Cancer,basal cell carcinoma,Cancer,,,Skin Cancer (Non-Melanoma),,Mono
0,338,PTCH1,,Either,Thyroid Cancer,Papillary Thyroid Cancer,,Cancer,Thyroid,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,1,1,,1,,,1,,,,,,,1,Low,,1,tiroides,甲状腺,Masculino,男性,0,0,,173,,Thyroid cancer,,Cancer,,,Thyroid Cancer,,Mono
0,341,PTCH1,,Either,Brain Tumor,Medulloblastoma,,Cancer,Brain,0,,,,,,,,,2,,1,,1,,,,,,,1,Low,,,cerebro,脑,Masculino,男性,0,0,,,,Brain Tumor,medulloblastoma,Cancer,,,Brain Tumor,,Mono
0,342,APC,,Either,Small Intestine Cancer,,,Cancer,Small Bowel,1,Clingen: Surveillance for gastric and proximal small bowel tumors with esophagogastroduodenoscopy using forward and side-viewing endoscopes should begin at age 20 to 30.,,,Mentioned,1,1,1,1,,1,,,1,,,,,,,1,Mod,,,intestino delgado,小肠,Masculino,男性,0,0,,175,,Small Instestine,,Cancer,,1,Small Intestine Cancer,,Mono
0,346,ATM,,Either,Lymphoma,Mantle Cell,,Cancer,Nodes,0,"Biallelic? 9463314, 11208881, 10706620, 16956411",,,,,,,,,2,1,,1,,,,,,,1,Mod,,1,linfoma,淋巴瘤,Masculino,男性,0,0,,177,,Lymphoma,,Cancer,1,1,Lymphoma,,Biallellic
0,350,BAP1,,Either,Lung Cancer,Non-Small Cell Lung Adenocarcinoma,,Cancer,Lung,9,"Clingen: inconsistent, evidence for their inclusion in the spectrum of BAP1-TPDS malignancies",,,Mentioned,9,,,,,,1,,1,,,,,,,,,,,gástrico,胃,Masculino,男性,0,0,,179,,Mesothelioma,,Cancer,,,Mesothelioma,,Mono
0,350,BAP1,,Either,Mesothelioma,Peritoneal,,Cancer,Mesothelium,1,Clingen: prevalence of germline mutations in individuals with BAP1 associated cancers include: malignant mesothelioma (6%),,,Mentioned,1,1,,1,1,1,1,,1,,,,,,,1,Low,,1,gástrico,胃,Masculino,男性,0,0,,179,,Mesothelioma,,Cancer,,,Mesothelioma,,Mono
0,354,BAP1,,Either,Skin Cancer (Non-Melanoma),Basal Cell Carcinoma,,Cancer,Skin,1,Basal cell carcinoma: 11/174 (6.3%),,,Mentioned,1,,,,1,,,,1,,,,,,,1,Low,,1,hepatobiliar,肝,Masculino,男性,0,0,,181,,Basal cell carcinoma,basal cell carcinoma,Cancer,,,Skin Cancer (Non-Melanoma),,Mono
1,356,NF1,,Female,Breast Cancer,,,Cancer,Breast,1,Clingen: Substantially increased risk of developing breast cancer before age 50 years with estimated risk at least three times greater than the general population,,,Mentioned,1,1,1,1,,,,,1,1,,,1,,,1,Low,Unclear,,mama,乳腺,Femenino,女性,0,0,Ask2Me,187,,Breast cancer,,Cancer,1,,Breast Cancer,,Mono
0,357,RECQL,,Female,Breast Cancer,,,Cancer,Breast,1,ClinGenis definitive or moderate while NCCN is mute.,,,Moderate,1,,,,,,,,1,,,,,,,,,,,mama,乳腺,Masculino,男性,0,0,,,,Breast cancer,,Cancer,1,,Breast Cancer,,Mono
0,360,NF1,,Either,Neurofibroma,,,Neoplasm,Nerve,1,,,,Mentioned,1,1,1,1,1,1,1,1,1,,,,,,,,,,1,neurofibroma,神经纤维瘤,Masculino,男性,0,0,,189,,Neurofibroma,,Neoplasm,1,,Neurofibromas,,Mono
1,362,RAD51D,,Male,Prostate Cancer,,,Cancer,Prostate,1,NCCN prevelance of 0.4,,,,,1,,1,,,,,1,,,,,,,,,,,próstata,前列腺,Masculino,男性,0,0,,190,,Prostate cancer,,Cancer,,,Prostate Cancer,,Mono
0,364,RB1,,Either,Retinoblastoma,Retinoblastoma,,Cancer,Eye,,,,,,,,,,1,1,1,1,,,,,,,1,1,High,,1,,,Masculino,男性,0,0,,191,,Retinoblastoma,,Cancer,,,Retinoblastoma,,Mono
0,370,SDHB,,Either,Pheochromocytoma/Paraganglioma,Paraganglioma,,Neoplasm,Nerve,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,1,1,1,1,1,1,,,,,,1,1,High,,1,próstata,前列腺,Masculino,男性,0,0,,194,,Paraganglioma,,Neoplasm,,,Neuroendocrine,,Mono
1,371,RECQL,,Female,Ovarian Cancer,,,Cancer,Ovary,0,-1,,,No Reported Evidence,0,,,,,,,,1,,,,,,,,,,,ovario,卵巢,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,1,,Ovarian Cancer,,Mono
0,374,SDHB,,Either,Pheochromocytoma/Paraganglioma,Pheochromocytoma,,Neoplasm,Adrenal,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,1,1,1,1,1,1,,,,,,1,1,High,,1,adenoma sebáceo,皮脂腺腺瘤,Masculino,男性,0,0,,196,,Pheochromocytoma,,Cancer,,,Neuroendocrine,,Mono
0,375,RUNX1,,Either,Leukemia,AML,,Cancer,Blood,,,,,,,,,,1,1,1,1,,,,,,,1,1,Low,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,AML,Cancer,,,Leukemia,,Mono
0,376,SDHC,,Either,Pheochromocytoma/Paraganglioma,Paraganglioma,,Neoplasm,Nerve,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,,,,,,,1,1,Mod,,1,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,197,,Paraganglioma,,Neoplasm,,,Neuroendocrine,,Mono
0,379,RET,,Either,Pheochromocytoma/Paraganglioma,Paraganglioma,,Neoplasm,Nerve,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,,,,1,,,,,,,1,Mod,,,,,Masculino,男性,0,0,,,,Paraganglioma,,Neoplasm,,,Neuroendocrine,,Mono
0,382,SDHC,,Either,Pheochromocytoma/Paraganglioma,Pheochromocytoma,,Neoplasm,Adrenal,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,,1,1,,,,,,,1,1,Mod,,1,intestino delgado,小肠,Masculino,男性,0,0,,200,,Pheochromocytoma,,Cancer,,,Neuroendocrine,,Mono
0,383,RET,,Either,Parathyroid (Benign),Primary Hyperparathyroidism,MEN2A,Benign,Parathyroid,1,Clingen:Penetrance dependent on variant.Highest penetrance genotype for PHPT is up to 30%.Penetrance in patients with moderate risk variants may be as low as 2% .,,,Mentioned,1,1,1,1,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,,,Parathyroid,,Mono
0,383,RET,,Either,Kidney (Benign),Renal malformations (Renal Agenesis),,Benign,Kidney,1,Clingen:renal malformations have also been reported,,,Mentioned,1/9,,,,,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,,,Renal malformations,,Mono
0,383,RET,,Either,Skin (Benign),Cutaneous Lichen Amyloidosis,,Benign,Skin,1,,,,Mentioned,1,1,,1,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,,,Cutaneous Lichen Amyloidosis,,Mono
0,383,RET,,Either,Parathyroid Neoplasm,Parathyroid Adenoma,MEN2A,Neoplasm,Parathyroid,1,,,,,,1,1,1,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,,,Parathyroid,,Mono
0,383,RET,,Either,Thyroid Cancer,Medullary Thyroid Cancer,MEN2A/MEN2B,Cancer,Thyroid,1,"Clingen:Penetrance of individual manifestations vary by risk. In classical MEN2A, almost all (90-100%) patients develop MTC",,,Mentioned,1,1,1,1,1,1,1,1,1,,,,,,,1,High,,,tiroides,甲状腺,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,,,Thyroid Cancer,,Mono
0,385,RPS20,,Either,Colorectal Cancer,,,Cancer,Colorectal,9,Clingen disagrees,,,Limited,9,,,,,1,1,,,,,,,,1,1,Mod,,,colorrectal,结直肠,Masculino,男性,0,0,,,,Colorectal cancer,,Cancer,,,Colorectal Cancer,,Mono
0,386,SDHD,,Either,Pheochromocytoma/Paraganglioma,Paraganglioma,,Neoplasm,Nerve,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,1,1,1,1,1,1,,,,,,1,1,High,,,uréter,输尿管,Masculino,男性,0,0,,202,,Paraganglioma,,Neoplasm,,,Neuroendocrine,,Mono
0,388,SDHD,,Either,Pheochromocytoma/Paraganglioma,Pheochromocytoma,,Neoplasm,Adrenal,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,1,1,1,1,1,1,,,,,,1,1,High,,,cerebro,脑,Masculino,男性,0,0,,203,,Pheochromocytoma,,Cancer,,,Neuroendocrine,,Mono
0,394,SDHB,,Either,Thyroid Cancer,,,Cancer,Thyroid,1,,,,Mentioned,1,,,,1,,1,,1,,,,,,,,,,1,tiroides,甲状腺,Masculino,男性,0,0,,206,,Thyroid cancer,,Cancer,,,Thyroid Cancer,,Mono
0,395,SDHA,,Either,GIST,,,Neoplasm,Small Bowel,1,,,,Mentioned,1,,,,1,1,,,,,,,,,1,1,Low,,,,,Masculino,男性,0,0,,,,Gastrointestinal Stromal Tumor,,Cancer,,,GIST,,Mono
0,397,SDHA,,Either,Pheochromocytoma/Paraganglioma,Paraganglioma,,Neoplasm,Nerve,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,,,,,,,1,1,Mod,,,,,Masculino,男性,0,0,,,,Paraganglioma,,Neoplasm,,,Neuroendocrine,,Mono
0,398,SDHD,,Either,Thyroid Cancer,,,Cancer,Thyroid,1,,,,Mentioned,1,,,,1,,,,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,208,,Thyroid cancer,,Cancer,,,Thyroid Cancer,,Mono
1,400,SDHD,,Female,Breast Cancer,,,Cancer,Breast,0,,,,,,,,,1,,,,1,,,,,,,,,,,mama,乳腺,Femenino,女性,0,0,,209,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
0,403,SDHAF2,,Either,Pheochromocytoma/Paraganglioma,Paraganglioma,,Neoplasm,Nerve,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,,,,,,,1,1,High,,,,,Masculino,男性,0,0,,,,Paraganglioma,,Neoplasm,,,Neuroendocrine,,Mono
0,404,VHL,,Either,Pheochromocytoma/Paraganglioma,Pheochromocytoma,,Neoplasm,Adrenal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,,1,1,1,1,1,,,,,,,,1,Low,,1,,,Masculino,男性,0,0,,211,,Pheochromocytoma,,Neoplasm,,,Neuroendocrine,,Mono
0,407,SMARCA4,,Either,Sarcoma,Rhabdoid,,Cancer,Soft Tissue,,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,,,,,,,,1,Low,,,,,Masculino,男性,0,0,,,,Rhabdoid,,Cancer,,,Sarcoma,,Mono
0,408,VHL,,Either,Kidney Neoplasm,Renal Angioma,,Neoplasm,Kidney,1,Clingen:retinal angiomas=70%,,,Mentioned,1,,,,,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,213,,Kidney,ClearCell Carcinoma,Cancer,,,Kidney Cancer,,Mono
0,408,VHL,,Either,Kidney Cancer,Renal Cell Carcinoma,,Cancer,Kidney,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Mentioned,1,1,,1,1,2,1,1,,,,,,,,1,Mod,,1,,,Masculino,男性,0,0,,213,,Kidney,ClearCell Carcinoma,Cancer,,,Kidney Cancer,,Mono
1,409,SMARCA4,,Female,Ovarian Cancer,,,Cancer,Ovary,,,,,,,,,,,,1,,,,,,,,1,1,Low,,,ovario,卵巢,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,,,Ovarian Cancer,,Mono
0,411,SMARCA4,,Either,Colorectal Cancer,,,Cancer,Colorectal,9,-1,,,Limited,9,,,,,,,,,,,,,,,1,Mod,,,colorrectal,结直肠,Masculino,男性,0,0,,,,Colorectal cancer,,Cancer,,,Colorectal Cancer,,Mono
0,412,APC,,Either,Soft Tissue Neoplasm,Desmoid,,Neoplasm,Soft tissue,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,,1,1,1,1,1,1,,,,,,,,,,1,tumor desmoide,硬纤维瘤,Masculino,男性,0,0,,215,,Desmoid tumor,,Neoplasm,,1,Desmoid,,Mono
0,415,SMARCB1,,Either,Sarcoma,Rhabdoid,,Cancer,Soft Tissue,,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,,,,,,,,1,Low,,,,,Masculino,男性,0,0,,,,Rhabdoid,,Cancer,,,Sarcoma,,Mono
0,416,BAP1,,Either,Skin (Benign),Spitz Nevus (Atypical),,Benign,Skin,1,,,,Mentioned,1,,,,1,,,,1,,,,,,,,,,,páncreas,胰腺,Masculino,男性,0,0,,217,,Atypical spitz tumor,,Benign Disease,,,Skin (Benign),,Mono
0,420,CDH1,,Either,Dysmorphic Feature,"Flat face , High forehead , Asymmetric face (in some patients), High anterior hairline",BLEPHAROCHEILODONTIC SYNDROME 1,Benign,Face,1,"OMIM only PMID-28301459,24719364",,,,,,,,,1,,,1,,,,,,,,,,,hendidura orofacial,口面裂,Masculino,男性,0,0,,220,,Orofacial clefting,,Benign Disease,1,,Facial Deformities,,Mono
0,420,CDH1,,Either,Eye (Benign),"Hypertelorism 
- Ectropion of lower eyelids
- Lagophthalmia
- Megaloblepharon
- Distichiasis",BLEPHAROCHEILODONTIC SYNDROME 1,Benign,Eye,1,"PMID-28301459,24719364",,,,,,,,1,1,,,1,,,,,,,,,,,hendidura orofacial,口面裂,Masculino,男性,0,0,,220,,Orofacial clefting,,Benign Disease,1,,Eye deformity,,Mono
0,420,CDH1,,Either,Nose (Benign),Choanal atresia,BLEPHAROCHEILODONTIC SYNDROME 1,Benign,Head and neck,1,"OMIM only PMID-28301459,24719364",,,,,,,,,1,,,1,,,,,,,,,,,hendidura orofacial,口面裂,Masculino,男性,0,0,,220,,Orofacial clefting,,Benign Disease,1,,Nose (Benign),,Mono
0,420,CDH1,,Either,Teeth (Benign),"Conical teeth
- Hypodontia
- Delayed dentition",BLEPHAROCHEILODONTIC SYNDROME 1,Benign,Head and neck,1,"OMIM only PMID-28301459,24719364",,,,,,,,,1,,,1,,,,,,,,,,,hendidura orofacial,口面裂,Masculino,男性,0,0,,220,,Orofacial clefting,,Benign Disease,1,,Teeth (Benign),,Mono
0,420,CDH1,,Either,Bone (Benign),"Clinodactyly 
- Syndactyly",BLEPHAROCHEILODONTIC SYNDROME 1,Benign,Hand,1,"OMIM only PMID-28301459,24719364",,,,,,,,,1,,,1,,,,,,,,,,,hendidura orofacial,口面裂,Masculino,男性,0,0,,220,,Orofacial clefting,,Benign Disease,1,,Hand (Benign),,Mono
0,420,CDH1,,Either,Gastrointestinal (Benign),Imperforate anus,BLEPHAROCHEILODONTIC SYNDROME 1,Benign,Colorectal,1,"OMIM only PMID-28301459,24719364",,,,,,,,,1,,,1,,,,,,,,,,,hendidura orofacial,口面裂,Masculino,男性,0,0,,220,,Orofacial clefting,,Benign Disease,1,,Imperforate anus,,Mono
0,420,CDH1,,Either,Nails (Benign),Hypoplastic nails,BLEPHAROCHEILODONTIC SYNDROME 1,Benign,Nails,1,"OMIM only PMID-28301459,24719364",,,,,,,,,1,,,1,,,,,,,,,,,hendidura orofacial,口面裂,Masculino,男性,0,0,,220,,Orofacial clefting,,Benign Disease,1,,Nails (Benign),,Mono
0,420,CDH1,,Either,Hair (Benign),"Distichiasis
- Sparse hair",BLEPHAROCHEILODONTIC SYNDROME 1,Benign,Hair,1,"OMIM only PMID-28301459,24719364",,,,,,,,,1,,,1,,,,,,,,,,,hendidura orofacial,口面裂,Masculino,男性,0,0,,220,,Orofacial clefting,,Benign Disease,1,,Hair (Benign),,Mono
0,420,CDH1,,Either,Central Nervous System (Benign),Neural tube defect,,Benign,CNS,9,"OMIM only PMID-28301459,24719364",,,,,,,,,1,,,1,,,,,,,,,,,hendidura orofacial,口面裂,Masculino,男性,0,0,,220,,Orofacial clefting,,Benign Disease,1,,Neural tube defect,,Mono
0,420,CDH1,,Either,Thyroid (Benign),Thyroid hypoplasia,,Benign,Thyroid,9,"OMIM only PMID-28301459,24719364",,,,,,,,,,1,,1,,,,,,,,,,,hendidura orofacial,口面裂,Masculino,男性,0,0,,220,,Orofacial clefting,,Benign Disease,1,,Thyroid hypoplasia,,Mono
0,420,CDH1,,Either,Oropharynx (Benign),cleft palate,BLEPHAROCHEILODONTIC SYNDROME 1,Benign,Oropharynx,1,28301459,,,,,,,,1,1,1,1,1,,,,,,,,,,1,hendidura orofacial,口面裂,Masculino,男性,0,0,,220,,Orofacial clefting,,Benign Disease,1,,Orofacial Cleft,,Mono
0,421,SMARCE1,,Either,Brain Tumor,Meningioma,,Neoplasm,Brain,,,,,,,,,,,1,1,1,,,,,,,1,1,Low,,,leucemia,白血病,Masculino,男性,0,0,,,,Meningioma,,Benign Disease,,,Brain Tumor,,Mono
0,423,SUFU,,Either,Skin Cancer (Non-Melanoma),Basal Cell Carcinoma,,Cancer,Skin,1,,,,,,,,,,1,1,,,,,,,,,1,High,,,hepatobiliar,肝,Masculino,男性,0,0,,,,Skin Cancer,basal cell carcinoma,Cancer,,,Skin Cancer (Non-Melanoma),,Mono
0,424,MEN1,,Either,Neuroendocrine,Anterior Pituitary Neuroendocrine Tumors,,Neoplasm,Pituitary,1,Clingen: penetrance pituitary adenoma (30–55%),,,Mentioned,1,1,1,1,1,1,,1,1,,,,,,,,,,1,adenoma sebáceo,皮脂腺腺瘤,Masculino,男性,0,0,,222,,Anterior pituitary tumor,,Cancer,,,Pituitary Neoplasm,,Mono
0,427,SUFU,,Either,Brain Tumor,Medulloblastoma,,Cancer,Brain,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,,,,,,,1,1,Low,,,cerebro,脑,Masculino,男性,0,0,,,,Brain Tumor,medulloblastoma,Cancer,,,Brain Tumor,,Mono
0,431,SUFU,,Either,Brain Tumor,Meningioma,,Neoplasm,Brain,1,,,,,,,,,1,1,1,1,,,,,,,,1,Low,,,leucemia,白血病,Masculino,男性,0,0,,,,Brain Tumor,Meningioma,Benign Disease,,,Brain Tumor,,Mono
0,432,NF1,,Either,Lung Cancer,,,Cancer,Lung,0,somatic?,,,,,,,,1,,,,1,,,,,,,,,,,pulmonar,肺,Masculino,男性,0,0,,226,,Lung cancer,,Cancer,1,,Lung Cancer,,Mono
0,436,NF1,,Either,Leukemia,Juvenile myelomonocytic leukemia,,Cancer,Blood,1,"PMID: 30670449, 27322988 ,25564399, 23832011, 9713168",,,,,,,,1,1,1,1,1,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,228,,Leukemia,AML,Cancer,1,,Leukemia,,Mono
0,436,NF1,,Either,Eye (Benign),"Glaucoma
- Hypertelorism 
- Hyperreflective choroidal spots",,Benign,Eye,9,,,,,,,,,,1,,,1,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,228,,Leukemia,AML,Cancer,1,,Glaucoma,,Mono
0,436,NF1,,Either,Blood Vessel (Benign),"Renal artery stenosis
- Hypertension",,Benign,Blood Vessel,9,,,,,,,,,,1,,,1,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,228,,Leukemia,AML,Cancer,1,,Renal artery stenosis,,Mono
0,436,NF1,,Either,Bone (Benign),"Scoliosis and Bone Dysplasia
- Spina bifida",,Benign,Bone,1,Clingen: Bony dysplasia of the long bones and sphenoid wing and Scoliosis,,,Mentioned,1,,,,,1,,,1,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,228,,Leukemia,AML,Cancer,1,,Spine Deformity,,Mono
0,436,NF1,,Either,Brain Tumor,Meningioma,,Neoplasm,Brain,9,,,,,,,,,,1,,,1,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,228,,Leukemia,AML,Cancer,1,,Brain Tumor,,Mono
0,436,NF1,,Either,Brain Tumor,Hypothalamic tumor,,Benign,Brain,9,,,,,,,,,,1,,,1,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,228,,Leukemia,AML,Cancer,1,,Brain Tumor,,Mono
0,436,NF1,,Either,Neuroendocrine,Duodenal Carcinoid,,Neoplasm,Duodenum,9,,,,,,,,,,1,,,1,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,228,,Leukemia,AML,Cancer,1,,Neuroendocrine,,Mono
0,436,NF1,,Either,Parathyroid Neoplasm,Parathyroid Adenoma,,Neoplasm,Parathyroid,9,,,,,,,,,,1,,,1,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,228,,Leukemia,AML,Cancer,1,,Parathyroid adenoma,,Mono
0,436,NF1,,Either,Dysmorphic Feature,"Abnormal Facies, Webbed neck , Midface hypoplasia 
- Prominent nasolabial folds
- Low-set ears
- Posteriorly rotated ears",,Benign,Face,9,,,,,,,,,,1,,,1,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,228,,Leukemia,AML,Cancer,1,,Abnormal Facies,,Mono
0,436,NKX2-1,,Either,Central Nervous System (Benign),Chorea,CAHTP,Benign,CNS,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,228,,Leukemia,AML,Cancer,,,Chorea,,Mono
0,437,TERC,,Either,Leukemia,AML,,Cancer,Blood,,,,,,,,,,,,,,,,,,,,,1,Low,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,AML,Cancer,,,Leukemia,,Mono
1,438,STK11,,Female,Cervical Cancer,Cervical Adenoma Malignum,,Cancer,Cervix,1,Clingen: RR=20.3 for gynecological/breast cancer ; Lifetime risk: 10% cervix,,,Mentioned,1,1,1,1,2,,,,1,,,,,,,1,Low,,,cervical,宫颈,Femenino,女性,0,0,,230,,Cervical cancer,,Cancer,1,1,Cervical Cancer,,Mono
0,440,MSH2,,Either,Sebaceous Cancer,,,Cancer,Skin,1,,,,,,1,,1,1,1,,,1,,,,,,,1,Low,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,231,,Sebaceous carcinoma,,Cancer,,1,Sebaceous Cancer,,Mono
0,441,TERC,,Either,Skin Cancer (Non-Melanoma),Squamous Cell Carcinoma,,Cancer,Skin,,,,,,,,,,,,,,,,,,,,,1,High,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,Squamous cell carcinoma,,Cancer,,,Squamous Cell Carcinoma,,Mono
0,442,NF1,,Either,GIST,,,Neoplasm,Small Bowel,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,1,1,,,,,1,,,,,,,,,,,tumor del estroma gastrointestinal,胃肠道间质瘤,Masculino,男性,0,0,,232,,Gastrointestinal Stromal Tumor,,Cancer,1,,GIST,,Mono
0,444,NF1,,Either,Pheochromocytoma/Paraganglioma,Pheochromocytoma,,Neoplasm,Adrenal,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,,1,,,1,,,,,,,1,Low,,1,feocromocitoma,嗜铬细胞瘤,Masculino,男性,0,0,,233,,Pheochromocytoma,,Cancer,1,,Neuroendocrine,,Mono
0,445,TERT,,Either,Leukemia,AML,,Cancer,Blood,,,,,,,,,,1,1,,1,,,,,,,,1,Low,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,AML,Cancer,,,Leukemia,,Mono
0,447,TERT,,Either,Melanoma,,,Cancer,Skin,,,,,,,,,,1,1,1,1,,,,,,,1,1,Low,,,melanoma,黑色素瘤,Masculino,男性,0,0,,,,Melanoma,,Cancer,,,Melanoma,,Mono
0,450,RB1,,Either,Melanoma,,,Cancer,Skin,,,,,,,,,,1,,,,,,,,,,,1,Low,,,,,Masculino,男性,0,0,,236,,Melanoma,,Cancer,,,Melanoma,,Mono
0,451,TERT,,Either,Skin Cancer (Non-Melanoma),Squamous Cell Carcinoma,,Cancer,Skin,,,,,,,,,,,,,,,,,,,,,1,Low,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,Squamous cell carcinoma,,Cancer,,,Squamous Cell Carcinoma,,Mono
0,454,WRN,,Either,Sarcoma,Osteosarcoma,,Cancer,Bone,,MedNeon(Kelly) Biallelic,,,,,,,,,,,,,,,,,,,,,,1,osteosarcoma,骨肉瘤,Masculino,男性,0,0,,238,,Osteosarcoma,,Cancer,,,Sarcoma (Bone),,Mono
0,454,WRN,,Either,Sarcoma,,,Cancer,Soft Tissue,,MedNeon(Kelly) Biallelic,,,,,,,,,,,,,,,,,,,,,,1,osteosarcoma,骨肉瘤,Masculino,男性,0,0,,238,,Osteosarcoma,,Cancer,,,Sarcoma (Bone),,Mono
0,454,RB1,,Either,Sarcoma,Osteosarcoma,,Cancer,Bone,,,,,,,,,,1,1,1,1,,,,,,,,1,,,1,osteosarcoma,骨肉瘤,Masculino,男性,0,0,,238,,Osteosarcoma,,Cancer,,,Sarcoma (Bone),,Mono
0,455,EGLN1,,Either,Pheochromocytoma/Paraganglioma,Paraganglioma,,Neoplasm,Nerve,1,,,,,,,,,1,,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Paraganglioma,,Neoplasm,,,Neuroendocrine,,Mono
0,455,TMEM127,,Either,Pheochromocytoma/Paraganglioma,Paraganglioma,,Neoplasm,Nerve,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,,,,,,,,,1,1,Low,,,,,Masculino,男性,0,0,,,,Paraganglioma,,Neoplasm,,,Neuroendocrine,,Mono
0,458,RB1,,Either,Brain Tumor,Pineoblastoma,,Cancer,Brain,,,,,,,,,,1,,,,,,,,,,,,,,,cerebro,脑,Masculino,男性,0,0,,240,,Brain Tumor,Pinealoblastoma,Cancer,,,Brain Tumor,,Mono
0,459,TSC1,,Either,Central Nervous System (Benign),Cortical Dysplasia,,Benign,Brain,,,,,,,,,,1,2,1,1,,,,,,,,1,Low,,,cerebro,脑,Masculino,男性,0,0,,,,Cortical dysplasia,,Neoplasm,,,Cortical Dysplasia,,Mono
0,462,RB1,,Either,Sarcoma,Soft Tissue Sarcoma,,Cancer,Soft Tissue,,,,,,,,,,,,,,,,,,,,,1,Low,,,,,Masculino,男性,0,0,,242,,Soft Tissue Sarcoma,,Cancer,,,Sarcoma,,Mono
0,463,TSC1,,Either,Kidney Cancer,Renal Cell Carcinoma,,Cancer,Kidney,,,,,,,,,,,,,,,,,,,,,1,Low,,,riñón,肾,Masculino,男性,0,0,,,,Kidney cancer,renal cell carcinoma,Cancer,,,Kidney Cancer,,Mono
0,466,TSC1,,Either,Lung Cancer,,,Cancer,Lung,,,,,,,,,,,,,,,,,,,,,1,Low,,,pulmonar,肺,Masculino,男性,0,0,,,,Lung cancer,,Cancer,,,Lung Cancer,,Mono
0,467,STK11,,Either,Lung Cancer,,,Cancer,Lung,1,Clingen Lifetime risk:  15-17% lung,,,Mentioned,1,1,1,1,1,1,1,,1,,,,,,,1,Mod,,,pulmonar,肺,Masculino,男性,0,0,,245,,Lung cancer,,Cancer,1,1,Lung Cancer,,Mono
0,470,TSC2,,Either,Lung Cancer,,,Cancer,Lung,,,,,,,,,,,,,,,,,,,,,1,Low,,,pulmonar,肺,Masculino,男性,0,0,,,,Lung cancer,,Cancer,,,Lung Cancer,,Mono
0,471,STK11,,Either,GI Neoplasm,Hamartomatous Polyps,,Neoplasm,GI,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Mentioned,1,1,1,1,1,,1,,1,,,,,,,,,,1,pólipos hamartomatosos gastrointestinales,胃肠道错构瘤息肉,Masculino,男性,0,0,,247,,Gastrointestinal hamartomatous polyps,,Neoplasm,1,1,GI Neoplasm,,Mono
0,473,TP53,,Either,Lung Cancer,,,Cancer,Lung,9,,,,,,,,,2,1,,,1,,,,,,,,,,1,pulmonar,肺,Masculino,男性,0,0,,248,,Lung cancer,,Cancer,1,1,Lung Cancer,,Mono
0,474,TSC2,,Either,Central Nervous System (Benign),Cortical Dysplasia,,Benign,Brain,,,,,,,,,,,2,1,1,,,,,,,,1,Low,,,cerebro,脑,Masculino,男性,0,0,,,,Cortical dysplasia,,Neoplasm,,,Cortical Dysplasia,,Mono
0,480,TSC2,,Either,Kidney Cancer,Renal Cell Carcinoma,,Cancer,Kidney,,,,,,,,,,,,,,,,,,,,,1,Low,,,riñón,肾,Masculino,男性,0,0,,,,Kidney cancer,renal cell carcinoma,Cancer,,,Kidney Cancer,,Mono
0,481,VHL,,Either,Neuroendocrine,Pancreatic Neuroendocrine Tumor,,Neoplasm,Pancreas,1,ClinGenis definitive or moderate while NCCN is mute.,,,Mentioned,1,,,,,,,,,,,,,,,1,Low,,1,,,Masculino,男性,0,0,,252,,Pancreatic Neuroendocrine Tumor,,Cancer,,,Neuroendocrine,,Mono
0,487,BMPR1A,,Either,Duodenum Cancer,,,Cancer,Duodenum,1,Clingen:The risk of gastric and duodenal cancer in JPS is around 15-21%,,,Mentioned,1,,,,,,,1,1,,,,,,,,,,,duodenal,十二指肠,Masculino,男性,0,0,,255,,Duodenal cancer,,Cancer,,1,Duodenum Cancer,,Mono
1,489,SDHB,,Female,Breast Cancer,,,Cancer,Breast,0,,,,,,,,,1,,,,1,,,,,,,,,,,mama,乳腺,Femenino,女性,0,0,,256,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
0,492,BAP1,,Either,Brain Tumor,Meningioma,,Neoplasm,Brain,9,"inconsistent, evidence for their inclusion in the spectrum of BAP1-TPDS malignancies",,,Mentioned,9,,,,,,1,,1,,,,,,,,,,1,leucemia,白血病,Masculino,男性,0,0,,258,,Meningioma,,Cancer,,,Brain Tumor,,Mono
1,496,BRCA1,,Male,Prostate Cancer,,,Cancer,Prostate,1,NCCN prevelance of 0.9,,,Mentioned,1,1,1,1,1,,,,1,,,,,,,1,Low,,1,próstata,前列腺,Masculino,男性,0,0,,260,,Prostate cancer,,Cancer,1,,Prostate Cancer,,Mono
0,498,ATM,,Either,Leukemia,T cell prolymphocytic leukemia,,Cancer,Blood,0,"Biallelic? 11208881, 9463314",,,,,,,,,2,1,,1,,,,,,,1,Mod,,2,leucemia,白血病,Masculino,男性,0,0,,261,,Leukemia,T cell prolymphocytic leukemia,Cancer,1,1,Leukemia,,Biallellic
0,499,WT1,,Either,Wilms Tumor,Nephroblastoma,,Cancer,Kidney,1,,,,Definitive,1,,,,1,1,1,1,1,,,,,,1,1,High,,,riñón,肾,Masculino,男性,0,0,,,,Wilm's tumor,,Cancer,,,Wilms Tumor,,Mono
0,502,BRCA2,,Either,Melanoma,,,Cancer,Skin,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,1,1,1,,,,1,,,,,,,1,Low,,1,melanoma,黑色素瘤,Masculino,男性,0,0,,263,,Melanoma,,Cancer,1,,Melanoma,,Mono
0,503,WT1,,Either,Leukemia,AML,,Cancer,Blood,9,,,,,,,,,1,,,,1,,,,,,,1,Low,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,AML,Cancer,,,Leukemia,,Mono
1,507,WT1,,Male,Prostate Cancer,,,Cancer,Prostate,9,,,,,,,,,1,,,,1,,,,,,,1,High,,,próstata,前列腺,Masculino,男性,0,0,,292,,Prostate cancer,,Cancer,,,Prostate Cancer,,Mono
0,508,CDH1,,Either,Colorectal Cancer,,,Cancer,Colorectal,0,,,,Limited,9,,,,,,,,1,,,,,,,1,Low,,1,colorrectal,结直肠,Masculino,男性,0,0,,266,,Colorectal cancer,,Cancer,1,,Colorectal Cancer,,Mono
0,509,XRCC2,,Either,Breast Cancer,,,Cancer,Breast,0,-1,,,Limited,9,,,,1,,,,,,,,,,1,1,Mod,,,mama,乳腺,Masculino,男性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
0,513,XRCC2,,Either,Leukemia,AML,,Cancer,Blood,,,,,,,,,,,,,,,,,,,,,1,Low,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,AML,Cancer,,,Leukemia,,Mono
1,517,XRCC2,,Female,Ovarian Cancer,,,Cancer,Ovary,0,-1,,,No Reported Evidence,0,,,,,,,,,,,,,,,,,,,mama,乳腺,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,,,Ovarian Cancer,,Mono
1,518,NBN,,Female,Ovarian Cancer,,,Cancer,Ovary,0,(No reported evidence by lee21018GenIn),,,,,,,,1,,,,1,,,,,,,,,,1,ovario,卵巢,Femenino,女性,0,0,,271,,Ovarian cancer,,Cancer,1,,Ovarian Cancer,,Mono
1,520,RAD50,,Female,Breast Cancer,,,Cancer,Breast,9,PMID: 27783279 ; 29726012,,,Limited,9,,,,,,1,,1,,,,,,1,1,Low,,1,mama,乳腺,Femenino,女性,0,0,,272,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
1,522,RAD50,,Female,Ovarian Cancer,,,Cancer,Ovary,9,PMID:30441849,,,Disputed,0,1,,1,1,,1,,1,,,,,,1,,,,1,ovario,卵巢,Femenino,女性,0,0,,273,,Ovarian cancer,,Cancer,,,Ovarian Cancer,,Mono
0,523,ACD,,Either,Skin (Benign),Dyskeratosis Congenita,,Benign,Skin,,,,,,,,,,1,1,1,1,,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Dyskeratosis congenitama,,Cancer,,,Dyskeratosis Congenita,,Mono
1,524,RAD51C,,Female,Breast Cancer,,,Cancer,Breast,9,NCCN 1 for triple negative Clingen disagrees,,,Disputed,0,1,1,,,1,1,1,1,,,,,,1,,,Unclear,1,mama,乳腺,Femenino,女性,0,0,,274,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
1,526,RAD51D,,Female,Breast Cancer,,,Cancer,Breast,9,NCCN 1 for triple negativeClingen disagrees,,,Limited,9,1,1,,,1,1,1,1,,,,,,1,,,Unclear,1,mama,乳腺,Femenino,女性,0,0,,275,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
0,527,ALK,,Either,Lung Cancer,,,Cancer,Lung,0,somatic,,,,,,,,2,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Lung cancer,,Cancer,,,Lung Cancer,,Mono
1,528,STK11,,Female,Endometrial Cancer,,,Cancer,Uterus,1,Clingen: Lifetime risk: 9% uterus,,,Mentioned,1,1,1,1,,1,,,1,,,,,,,,,,1,endometrio,子宫内膜,Femenino,女性,0,0,,276,,Endometrial cancer,,Cancer,1,1,Endometrial Cancer,,Mono
0,531,ALK,,Either,Lymphoma,Anaplastic Large Cell Lymphoma,,Cancer,Nodes,0,somatic,,,,,,,,2,,1,,1,,,,,,,,,,,linfoma,淋巴瘤,Masculino,男性,0,0,,,,Anaplastic large cell lymphoma,,Cancer,,,Lymphoma,,Mono
0,532,STK11,,Either,Small Intestine Cancer,,,Cancer,Small Bowel,1,Clingen RR=50.5 for gastrointestinal cancer ; Lifetime risk:  13% small intestine,,,Mentioned,1,1,1,1,,,,,1,,,,,,,1,Mod,,,intestino delgado,小肠,Masculino,男性,0,0,,278,,Small Instestine,,Cancer,1,1,Small Intestine Cancer,,Mono
0,536,TP53,,Either,Colorectal Cancer,,,Cancer,Colorectal,1,Clingen: tumor-specific relative risks and 95% confidence intervals colon: 2.8,,,Mentioned,1,1,1,,2,1,,1,1,,,,,,,1,Low,,1,colorrectal,结直肠,Masculino,男性,0,0,,280,,Colorectal cancer,,Cancer,1,1,Colorectal Cancer,,Mono
0,537,CDKN1B,,Either,Parathyroid Neoplasm,Parathyroid Adenoma,MEN4,Neoplasm,Parathyroid,1,,,,Mentioned,1,,,,1,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Parathyroid adenoma,,Cancer,,,Parathyroid Neoplasm,,Mono
1,540,TP53,,Female,Endometrial Cancer,,,Cancer,Uterus,0,,,,,,,,,,2,,,1,,,,,,,,,,,endometrio,子宫内膜,Femenino,女性,0,0,,282,,Endometrial cancer,,Cancer,1,1,Endometrial Cancer,,Mono
0,543,CDKN1B,,Either,Parathyroid (Benign),Hyperparathyroid,MEN4,Benign,Parathyroid,1,,,,,,,,,,,1,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Hyperparathyroid,,Cancer,,,Hyperparathyroid,,Mono
0,546,TP53,,Either,Adrenal Cortical Carcinoma,,,Cancer,Adrenal,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,2,1,1,1,1,,,,,,,1,High,,1,suprarrenal,肾上腺,Masculino,男性,0,0,,285,,Adrenocortical carcinoma,,Cancer,1,1,Adrenal Cortical Carcinoma,,Mono
0,549,CDKN1C,,Either,Developmental,Intrauterine Growth Restriction,,Benign,Developmental,1,,,,,,,,,1,1,1,1,1,,,,,,1,,,,1,,,Masculino,男性,0,0,,,,Intrauterine growth restriction,,Benign Disease,,,Intrauterine Growth Restriction,,Mono
0,550,TP53,,Either,Melanoma,,,Cancer,Skin,9,,,,,,,,,1,,,,1,,,,,,,1,Low,,1,melanoma,黑色素瘤,Masculino,男性,0,0,,287,,Melanoma,,Cancer,1,1,Melanoma,,Mono
0,553,CDKN1C,,Either,Bone (Benign),Metaphyseal Dysplasia,,Benign,Bone,1,,,,,,,,,1,1,1,1,1,,,,,,1,,,,,,,Masculino,男性,0,0,,,,Metaphyseal dysplasia,,Benign Disease,,,Metaphyseal Dysplasia,,Mono
1,554,TP53,,Female,Ovarian Cancer,,,Cancer,Ovary,9,-1,,,Limited,9,,,,2,,,,1,,,,,,,1,Low,,1,ovario,卵巢,Femenino,女性,0,0,,289,,Ovarian cancer,,Cancer,1,1,Ovarian Cancer,,Mono
0,556,TP53,,Either,Pancreatic Cancer,,,Cancer,Pancreas,1,Clingen: tumor-specific relative risks and 95% confidence intervals are: pancreas: 7.3,,,Mentioned,1,,,,,1,,1,1,,,,,,,1,Low,,1,páncreas,胰腺,Masculino,男性,0,0,,290,,Pancreatic cancer,,Cancer,1,1,Pancreatic Cancer,,Mono
0,557,CDKN1C,,Either,Adrenal Neoplasm,Adrenal Hypoplasia,,Neoplasm,Adrenal,1,,,,,,,,,1,1,1,1,1,,,,,,1,,,,,,,Masculino,男性,0,0,,,,Adrenal hypoplasia,,Benign Disease,,,Adrenal Hypoplasia,,Mono
1,560,TP53,,Male,Prostate Cancer,,,Cancer,Prostate,9,,,,,,,,,,1,,,1,,,,,,,,Low,,,próstata,前列腺,Masculino,男性,0,0,,292,,Prostate cancer,,Cancer,1,1,Prostate Cancer,,Mono
0,564,MUTYH-Biallelic/G396D,G396D,Either,Colorectal Cancer,,,Cancer,Colorectal,9,NO source,,,,,,,,,,,,1,1,,,1,,,1,High,,,colorrectal,结直肠,Masculino,男性,0,0,Ask2Me,294,,Colorectal cancer,,Cancer,,,Colorectal Cancer,,Biallelic
0,569,EGFR,,Either,Gastrointestinal (Benign),Inflammatory Bowel Disease,,Benign,GI,0,,,,,,,,,,1,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Inflammatory skin and bowel disease,,Benign Disease,,,Inflammatory Skin And Bowel Disease,,Mono
0,572,STK11,,Either,Pancreatic Cancer,,,Cancer,Pancreas,1,Clingen Lifetime risk: 11-36% pancreas,,,Mentioned,1,1,1,1,2,2,1,1,1,,,,,,,1,Mod,,1,páncreas,胰腺,Masculino,男性,0,0,,298,,Pancreatic cancer,,Cancer,1,1,Pancreatic Cancer,,Mono
0,579,MET,,Either,Bone (Benign),Osteofibrous Dysplasia,,Benign,Bone,,,,,,,,,,,1,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Osteofibrous dysplasia,,Cancer,,,Osteofibrous Dysplasia,,Mono
0,580,BMPR1A,,Either,Colorectal Cancer,,,Cancer,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,,1,,,1,,,,,,,1,Mod,,1,colorrectal,结直肠,Masculino,男性,0,0,,302,,Colorectal cancer,,Cancer,,1,Colorectal Cancer,,Mono
0,582,BMPR1A,,Either,Pancreatic Cancer,,,Cancer,Pancreas,1,NCCN-lifetime risk 11-36% (famillial risk for colorectal cance),,,,,1,,1,,,,1,1,,,,,,,,,,1,páncreas,胰腺,Masculino,男性,0,0,,303,,Pancreatic cancer,,Cancer,,1,Pancreatic Cancer,,Mono
0,583,MET,,Either,Hepatobiliary Cancer,Hepatocellular Cancer,,Cancer,Liver,,,,,,,,,,,2,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Hepatocellular carcinoma,,Cancer,,,Hepatocellular Cancer,,Mono
0,583,IGF2R,,Either,Hepatobiliary Cancer,Hepatocellular Cancer,,Cancer,Liver,,,,,,,,,,,2,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Hepatocellular carcinoma,,Cancer,,,Hepatocellular Cancer,,Mono
0,583,FAT4,,Either,Hepatobiliary Cancer,Hepatocellular Cancer,,Cancer,Liver,,,,,,,,,,,2,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Hepatocellular carcinoma,,Cancer,,,Hepatocellular Cancer,,Mono
0,583,NTRK,,Either,Hepatobiliary Cancer,Hepatocellular Cancer,,Cancer,Liver,,,,,,,,,,,2,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Hepatocellular carcinoma,,Cancer,,,Hepatocellular Cancer,,Mono
0,584,BMPR1A,,Either,Gastric Cancer,,,Cancer,Gastric,1,Clingen:The risk of gastric and duodenal cancer in JPS is around 15-21%,,,Mentioned,1,1,1,,,,,1,1,,,,,,,1,Low,,,gástrico,胃,Masculino,男性,0,0,,304,,Gastric cancer,,Cancer,,1,Gastric Cancer,,Mono
0,586,BMPR1A,,Either,Small Intestine Cancer,,,Cancer,Small Bowel,1,NCCN-lifetime risk 13% (famillial risk for colorectal cance),,,,,1,,1,,,,1,1,,,,,,,1,,,,intestino delgado,小肠,Masculino,男性,0,0,,305,,Small Instestine,,Cancer,,1,Small Intestine Cancer,,Mono
0,587,MET,,Either,Lung Cancer,,,Cancer,Lung,,,,,,,,,,1,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Lung,,Cancer,,,Lung Cancer,,Mono
0,592,CDKN2A,p14,Either,Melanoma,,,Cancer,Skin,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,,1,1,1,1,,,,,,1,1,Mod,,1,melanoma,黑色素瘤,Masculino,男性,0,0,,308,,Melanoma,,Cancer,,,Melanoma,,Mono
0,594,CDKN2A,p14,Either,Pancreatic Cancer,,,Cancer,Pancreas,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,,1,1,,,,,,1,1,Low,,1,páncreas,胰腺,Masculino,男性,0,0,,309,,Pancreatic cancer,,Cancer,,,Pancreatic Cancer,,Mono
0,596,GREM1,,Either,Colorectal Cancer,,,Cancer,Colorectal,1,ClinGen and NCCN,,,Strong,1,1,1,1,1,,1,,1,,,,,,,1,Mod,,1,colorrectal,结直肠,Masculino,男性,0,0,,310,,Colorectal cancer,,Cancer,,1,Colorectal Cancer,,Mono
0,597,MITF,,Either,Skin (Benign),Albinism,,Benign,Skin,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,,1,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Albinism,,Benign Disease,,,Albinism,,Mono
0,600,POLD1,,Either,Colorectal Cancer,,,Cancer,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,1,,,1,,1,1,High,,1,colorrectal,结直肠,Masculino,男性,0,0,Ask2Me,312,,Colorectal cancer,,Cancer,,1,Colorectal Cancer,,Mono
0,601,MITF,,Either,Ear (Benign),Hearing Loss,,Benign,Head and neck,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Deafness,,Benign Disease,,,Deafness,,Mono
0,604,POLE,,Either,Colorectal Cancer,,,Cancer,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,,1,1,1,,,1,,1,1,High,,,colorrectal,结直肠,Masculino,男性,0,0,Ask2Me,314,,Colorectal cancer,,Cancer,,1,Colorectal Cancer,,Mono
0,605,MITF,,Either,Eye (Benign),Coloboma,,Benign,Eye,0,Biallelic,,,,,,,,,1,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Coloboma,,Benign Disease,,,Coloboma,,Biallelic
0,608,SMAD4,,Either,Colorectal Cancer,,,Cancer,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Mentioned,1,1,1,1,2,1,1,1,1,,,,,,,1,High,,,colorrectal,结直肠,Masculino,男性,0,0,,316,,Colorectal cancer,,Cancer,,1,Colorectal Cancer,,Mono
0,609,MITF,,Either,Bone (Benign),Osteopetrosis,,Benign,Bone,0,Biallelic,,,,,,,,,1,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Osteopetrosis,,Benign Disease,,,Osteopetrosis,,Biallelic
0,612,SMAD4,,Either,Gastric Cancer,,,Cancer,Gastric,1,Clingen:  risk of gastric and duodenal cancer in JPS is around 15-21%,,,Mentioned,1,1,1,1,,,,1,1,,,,,,,1,Low,,,gástrico,胃,Masculino,男性,0,0,,318,,Gastric cancer,,Cancer,,1,Gastric Cancer,,Mono
0,613,MITF,,Either,Eye (Benign),Microphthalmia,,Benign,Eye,0,Biallelic,,,,,,,,,1,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Microphthalmia,,Benign Disease,,,Microphthalmia,,Biallelic
0,616,SMAD4,,Either,Pancreatic Cancer,,,Cancer,Pancreas,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,1,2,1,1,1,,,,,,,1,High,,1,páncreas,胰腺,Masculino,男性,0,0,,320,,Pancreatic cancer,,Cancer,,1,Pancreatic Cancer,,Mono
0,617,MITF,,Either,Dysmorphic Feature,Macrocephaly,,Benign,Head and neck,0,Biallelic,,,,,,,,,1,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Macrocephaly,,Benign Disease,,,Macrocephaly,,Biallelic
0,620,SMAD4,,Either,Small Intestine Cancer,,,Cancer,Small Bowel,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,,,,1,1,,,,,,,1,Low,,,intestino delgado,小肠,Masculino,男性,0,0,,322,,Small Instestine,,Cancer,,1,Small Intestine Cancer,,Mono
0,623,PARK2,,Either,Central Nervous System (Benign),Parkinsons,,Benign,CNS,,,,,,,,,,,1,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,"Parkinson disease, juvenile, type 2",,Benign Disease,,,Parkinsons,,Mono
0,627,PDGFRA,,Either,Hypereosinophilic Syndrome,,,Benign,Blood,,,,,,,,,,,1,1,1,,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,,,Hypereosinophilic syndrome,,Benign disease,,,Hypereosinophilic Syndrome,,Mono
0,628,NF1,,Either,Sarcoma,Rhabdomyosarcoma,,Cancer,Soft tissue,1,"PMID: 30287926 , 31328317 , 26283846 , 23244495, 28620004 , 30563612",,,,,,,,,1,,,1,,,,,,,,,,,sarcoma,肉瘤,Masculino,男性,0,0,,328,,Sarcoma,rhabdomyosarcoma,Cancer,1,,Sarcoma,,Mono
0,631,PHOX2B,,Either,Central Nervous System (Benign),Central Hypoventilation,,Benign,CNS,,,,,,,,,,1,1,1,1,,,,,,,1,,,,,,,Masculino,男性,0,0,,,,Central hypoventilation,,Benign Disease,,,Central Hypoventilation,,Mono
1,632,PALB2,,Female,Ovarian Cancer,,,Cancer,Ovary,1,,,,Moderate,1,1,,1,,,,,1,,,,,,1,1,,,1,ovario,卵巢,Femenino,女性,0,0,,330,,Ovarian Cancer,,Cancer,1,,Ovarian Cancer,,Mono
1,634,PALB2,,Male,Prostate Cancer,,,Cancer,Prostate,1,NCCN prevelance of 0.4,,,,,1,,1,,,,,1,,,,,,,,,,1,próstata,前列腺,Masculino,男性,0,0,,331,,Prostate cancer,,Cancer,1,,Prostate Cancer,,Mono
0,635,PHOX2B,,Either,Gastrointestinal (Benign),Hirschsprung Disease,,Benign,Colorectal,,,,,,,,,,1,1,1,,,,,,,,1,,,,,,,Masculino,男性,0,0,,,,Hirschsprung disease,,Benign Disease,,,Hirschsprung Disease,,Mono
1,638,MLH1,,Male,Prostate Cancer,,,Cancer,Prostate,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,1,1,,,,,1,,,,,,,,,,1,próstata,前列腺,Masculino,男性,0,0,,333,,Prostate cancer,,Cancer,,1,Prostate Cancer,,Mono
1,639,MRE11A,,Male,Prostate Cancer,,,Cancer,Prostate,9,27433846,,,,,9,,9,,,,,1,,,,,,,,,,,próstata,前列腺,Masculino,男性,0,0,,,,Prostate cancer,,Cancer,,,Prostate Cancer,,Mono
1,640,MSH2,,Male,Prostate Cancer,,,Cancer,Prostate,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,1,1,,,,,1,,,,,,,,,,1,próstata,前列腺,Masculino,男性,0,0,,334,,Prostate cancer,,Cancer,,1,Prostate Cancer,,Mono
1,641,ABRAXAS1,,Male,Prostate Cancer,,,Cancer,Prostate,9,27433846,,,,,9,,9,,,,,1,,,,,,,,,,,próstata,前列腺,Masculino,男性,0,0,,,,Prostate cancer,,Cancer,,,Prostate Cancer,,Mono
0,642,CDH1,,Either,Gastric Cancer,,,Cancer,Gastric,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,1,,,1,,1,1,High,,1,gástrico,胃,Masculino,男性,0,0,Ask2Me,335,,Gastric cancer,"Diffuse gastric cancer, signet ring cell",Cancer,1,,Gastric Cancer,,Mono
1,643,GEN1,,Male,Prostate Cancer,,,Cancer,Prostate,9,27433846,,,,,9,,9,,,,,1,,,,,,,,,,,próstata,前列腺,Masculino,男性,0,0,,,,Prostate cancer,,Cancer,,,Prostate Cancer,,Mono
0,645,PRKAR1A,,Either,Dysmorphic Feature,Acrodysostosis,,Benign,Bone,9,,,,,,,,,,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Acrodysostosis 1,,Benign Disease,,,Acrodysostosis,,Mono
0,646,CDK4,,Either,Melanoma,,,Cancer,Skin,1,,,,,,1,,1,1,1,1,1,1,1,,,1,,1,1,Low,,1,melanoma,黑色素瘤,Masculino,男性,0,0,Ask2Me,337,,Melanoma,,Cancer,,,Melanoma,,Mono
0,649,PRKAR1A,,Either,Pheochromocytoma/Paraganglioma,Pheochromocytoma,,Neoplasm,Adrenal,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Adrenocortical carcinoma,,Cancer,,,Neuroendocrine,,Mono
0,649,PRKAR1A,,Either,Hepatobiliary Cancer,Hepatocellular Cancer,,Cancer,Liver,,"PMID:30428497 only 1 patient ClinGen:prkar1a +/− mice exhibited extracardiac tumorigenesis, developed sarcomas and hepatocellular carcinomas as well as thyroid, adrenocortical and mesenchymal tumors, which sharing similar phenotypes to CNC patients",,,Mentioned,1,,,,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Adrenocortical carcinoma,,Cancer,,,Hepatocellular carcinoma,,Mono
0,649,PRKAR1A,,Either,Adrenal Cortical Carcinoma,,,Cancer,Adrenal,9,"PMID:30428497 , 22312093 Only 2 cases of adrenocortical carcinoma in CNC patients with PPNAD and PRKAR1A mutation ClinGen:prkar1a +/− mice exhibited extracardiac tumorigenesis, adrenocortical , which sharing similar phenotypes to CNC patients",,,Mentioned,1,,,,,2,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Adrenocortical carcinoma,,Cancer,,,Adrenal Cortical Carcinoma,,Mono
0,650,CDKN2A,p16,Either,Melanoma,,,Cancer,Skin,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,1,1,,,1,,1,1,Mod,,1,melanoma,黑色素瘤,Masculino,男性,0,0,Ask2Me,339,,Melanoma,,Cancer,,,Melanoma,,Mono
0,653,PRKAR1A,,Either,Skin Neoplasm,Cutaneous Myxoma,,Neoplasm,Skin,1,"PMID:30428497 ClinGen:prkar1a +/− mice exhibited extracardiac tumorigenesis, developed sarcomas and hepatocellular carcinomas as well as thyroid, adrenocortical and mesenchymal tumors, which sharing similar phenotypes to CNC patients",,,Mentioned,1,,,,,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Intracardiac Myxoma,,Cancer,,,Cutaneous Myxoma,,Mono
0,653,SRGAP1,,Either,Endocrine Abnormalities,,,Benign,Endocrine,9,,,,,,,,,,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Intracardiac Myxoma,,Cancer,,,Endocrine Abnormalities,,Mono
0,653,PRKAR1A,,Either,Cardiovascular Neoplasm,Cardiac Myxoma,,Neoplasm,Heart,1,"PMID:30428497 ClinGen:prkar1a +/− mice exhibited extracardiac tumorigenesis, developed sarcomas and hepatocellular carcinomas as well as thyroid, adrenocortical and mesenchymal tumors, which sharing similar phenotypes to CNC patients",,,Mentioned,1,,,,,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Intracardiac Myxoma,,Cancer,,,Intracardiac Myxoma,,Mono
0,653,SRGAP1,,Either,Cardiovascular Neoplasm,Cardiac Myxoma,,Neoplasm,Heart,9,,,,,,,,,,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Intracardiac Myxoma,,Cancer,,,Cardiac Myxoma,,Mono
0,653,SRGAP1,,Either,Skin Neoplasm,Mucocutaneous myoma,,Neoplasm,Skin,9,,,,,,,,,,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Intracardiac Myxoma,,Cancer,,,Mucocutaneous myoma,,Mono
0,654,CDKN2A,p16,Either,Pancreatic Cancer,,,Cancer,Pancreas,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,,1,1,1,,,1,,1,1,Low,,1,páncreas,胰腺,Masculino,男性,0,0,Ask2Me,341,,Pancreatic cancer,,Cancer,,,Pancreatic Cancer,,Mono
0,657,PRKAR1A,,Either,Adrenal Cortical (Benign),Pigmented Nodular Adrenocortical Disease,,Benign,Adrenal,1,PMID:30428497,,,,,,,,,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Pigmented nodular adrenocortical disease,,Benign Disease,,,Adrenocortical Disease,,Mono
0,661,NKX2-1,,Either,Developmental,"Global developmental delay
- Difficulty walking in childhood
- Choreoathetosis
- Hypotonia
- Ataxia
- Dysarthria
- Dystonia
- Symptoms of hypothalamic disturbances",,Benign,Developmental,9,,,,,,,,,,1,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Holoprosencephaly,,Benign Disease,,,Central Nervous System (Benign),,Mono
0,661,PTCH1,,Either,Central Nervous System (Benign),Holoprosencephaly,,Benign,Brain,1,,,,,,,,,1,1,1,1,1,,,,,,1,,,,1,,,Masculino,男性,0,0,,,,Holoprosencephaly,,Benign Disease,,,Holoprosencephaly,,Mono
0,665,PTCH1,,Either,Eye (Benign),Coloboma,,Benign,Eye,1,,,,,,,,,1,1,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Coloboma,,Benign Disease,,,Coloboma,,Mono
0,669,PTCH1,,Either,Breast Cancer,,,Cancer,Breast,0,,,,,,,,,2,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
0,670,EPCAM,,Either,Colorectal Cancer,,Lynch Syndrome,Cancer,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,1,,,1,,,1,High,,1,colorrectal,结直肠,Masculino,男性,0,0,Ask2Me,349,,Colorectal cancer,,Cancer,,1,Colorectal Cancer,,Mono
0,673,PTCH1,,Either,Colorectal Cancer,,,Cancer,Colorectal,0,,,,,,,,,2,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Colon cancer,,Benign Disease,,,Colorectal Cancer,,Mono
0,674,MLH1,,Either,Colorectal Cancer,,Lynch Syndrome,Cancer,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,,1,1,,,1,,,1,High,,1,colorrectal,结直肠,Masculino,男性,1,0,Ask2Me,351,,Colorectal cancer,,Cancer,,1,Colorectal Cancer,,Mono
1,676,MLH1,,Female,Endometrial Cancer,,Lynch Syndrome,Cancer,Uterus,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,,,,1,1,,,1,,,1,Mod,,1,endometrio,子宫内膜,Femenino,女性,0,0,Ask2Me,352,,Endometrial cancer,,Cancer,,1,Endometrial Cancer,,Mono
0,677,PTCH1,,Either,Bone Neoplasm,Keratocystic Odontogenic Tumor,,Neoplasm,Bone,9,,,,,,,,,2,1,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Jaw Keratocyst,,Mono
0,680,MLH1,,Either,Gastric Cancer,,Lynch Syndrome,Cancer,Gastric,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,,1,1,,,,1,1,,,1,,,1,Low,,1,gástrico,胃,Masculino,男性,0,0,Ask2Me,354,,Gastric cancer,,Cancer,,1,Gastric Cancer,,Mono
0,681,PTCH1,,Either,Skin (Benign),Nevi,,Benign,Skin,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Skin (Benign),Nevus,Benign Disease,,,Skin (Benign),,Mono
1,682,MLH1,,Female,Ovarian Cancer,,Lynch Syndrome,Cancer,Ovary,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,,,,1,1,,,1,,,1,Low,,1,ovario,卵巢,Femenino,女性,0,0,Ask2Me,355,,Ovarian cancer,,Cancer,,1,Ovarian Cancer,,Mono
0,686,MLH1,,Either,Pancreatic Cancer,,,Cancer,Pancreas,1,Clingen:The risk of cancer in LS by age 70:  pancreas=1-4%,,,Mentioned,1,1,1,1,,,,,1,1,,,1,,,1,Low,,,páncreas,胰腺,Masculino,男性,0,0,Ask2Me,357,,Pancreatic cancer,,Cancer,,1,Pancreatic Cancer,,Mono
0,690,MSH2,,Either,Colorectal Cancer,,Lynch Syndrome,Cancer,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,,,1,1,,,1,,,1,High,,1,colorrectal,结直肠,Masculino,男性,0,0,Ask2Me,359,,Colorectal cancer,,Cancer,,1,Colorectal Cancer,,Mono
0,690,MSH3,,Either,Colorectal Cancer,,,Cancer,Colorectal,1,,,,Limited,1,,,,,,,,1,,,,,,,,,,,colorrectal,结直肠,Masculino,男性,0,0,Ask2Me,359,,Colorectal cancer,,Cancer,,1,Colorectal Cancer,,Mono
0,691,RET,,Either,Pheochromocytoma/Paraganglioma,Pheochromocytoma,MEN2A/MEN2B,Neoplasm,Adrenal,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,1,1,1,1,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Pheochromocytoma,,Neoplasm,,,Neuroendocrine,,Mono
1,692,MSH2,,Female,Endometrial Cancer,,Lynch Syndrome,Cancer,Uterus,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,,,,1,1,,,1,,,1,High,,1,endometrio,子宫内膜,Femenino,女性,0,0,Ask2Me,360,,Endometrial cancer,,Cancer,,1,Endometrial Cancer,,Mono
0,695,RET,,Either,Gastrointestinal (Benign),Megacolon,,Benign,Colorectal,1,NCCN:2-5% in MEN2A,,,,,1,,1,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Hirschsprung disease,,Benign Disease,,,megacolon,,Mono
0,695,RET,,Either,Peripheral Nervous System Neoplasm,Mucosal Neuromas,,Neoplasm,PNS,1,often located on the lips and tongue,,,,,1,,1,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Hirschsprung disease,,Benign Disease,,,mucosal neuromas,,Mono
0,695,RET,,Either,Dysmorphic Feature,Marfanoid Body Habitus,,Benign,Connective tissue,1,,,,,,1,,1,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Hirschsprung disease,,Benign Disease,,,Marfanoid body habitus,,Mono
0,695,RET,,Either,GI Neoplasm,Intestinal Ganglioneuroma,,Neoplasm,GI,1,NCCN:95% in MEN2B,,,,,1,,1,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Hirschsprung disease,,Benign Disease,,,Intestinal Ganglioneuroma,,Mono
0,695,RET,,Either,Eye (Benign),Medullated corneal nerve fibers,,Benign,Eye,1,,,,,,1,,1,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Hirschsprung disease,,Benign Disease,,,Medullated corneal nerve fibers,,Mono
0,695,RET,,Either,Eye (Benign),Ectopic Lenses,,Benign,Eye,1,,,,,,1,,1,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Hirschsprung disease,,Benign Disease,,,Ectopic Lenses,,Mono
0,695,RET,,Either,Gastrointestinal (Benign),Hirschsprung Disease,,Benign,Colorectal,1,Clingen:Hirschsprung manifestations and renal malformations have also been reported,,,Mentioned,1,1,,1,1,1,1,1,1,,,,,,1,,,,,,,Masculino,男性,0,0,,,,Hirschsprung disease,,Benign Disease,,,Hirschsprung Disease,,Mono
1,696,MSH2,,Female,Ovarian Cancer,,Lynch Syndrome,Cancer,Ovary,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,,,,1,1,,,1,,,1,Low,,1,ovario,卵巢,Femenino,女性,0,0,Ask2Me,362,,Ovarian cancer,,Cancer,,1,Ovarian Cancer,,Mono
0,699,RET,,Either,Lung Cancer,,,Cancer,Lung,0,,,,,,,,,1,,,,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,,,Lung cancer,,Cancer,,,Lung Cancer,,Mono
0,700,MSH2,,Either,Pancreatic Cancer,,,Cancer,Pancreas,9,NCCN : Not well established? Clingen:The risk of cancer in LS by age 70:  pancreas=1-4%,,,Mentioned,1,9,9,1,,,,,1,1,,,1,,,1,Low,,1,páncreas,胰腺,Masculino,男性,0,0,Ask2Me,364,,Pancreatic cancer,,Cancer,,1,Pancreatic Cancer,,Mono
0,703,RET,,Either,Central Nervous System (Benign),Central Hypoventilation,,Benign,CNS,1,,,,,,,,,,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Central hypoventilation,,Benign Disease,,,Central Hypoventilation,,Mono
0,704,MSH6,,Either,Colorectal Cancer,,Lynch Syndrome,Cancer,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,1,,,1,,,1,Mod,,1,colorrectal,结直肠,Masculino,男性,0,0,Ask2Me,366,,Colorectal cancer,,Cancer,,1,Colorectal Cancer,,Mono
1,706,MSH6,,Female,Endometrial Cancer,,Lynch Syndrome,Cancer,Uterus,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,1,,,1,,,1,High,,1,endometrio,子宫内膜,Femenino,女性,0,0,Ask2Me,367,,Endometrial cancer,,Cancer,,1,Endometrial Cancer,,Mono
0,707,ETV6,,Either,Sarcoma,,,Cancer,Bone,,,,,,,,,,,,1,,,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,,,Fibrosarcoma,,Cancer,,,Sarcoma,,Mono
0,710,MSH6,,Either,Gastric Cancer,,Lynch Syndrome,Cancer,Gastric,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,,1,1,,,,1,1,,,1,,,1,Low,,,gástrico,胃,Masculino,男性,0,0,Ask2Me,369,,Gastric cancer,,Cancer,,1,Gastric Cancer,,Mono
1,712,MSH6,,Female,Ovarian Cancer,,Lynch Syndrome,Cancer,Ovary,1,Clingen is definitive or moderate,,,Definitive,1,1,1,,1,,,,1,1,,,1,,,1,Mod,,1,ovario,卵巢,Femenino,女性,0,0,Ask2Me,370,,Ovarian cancer,,Cancer,,1,Ovarian Cancer,,Mono
0,715,FANCC,,Either,Gastrointestinal (Benign),Tracheoesophageal Fistula ,,Benign,Mediastinum,,,,,,,,,,,,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Tracheoesophageal fistula,,Benign Disease,,,Tracheoesophageal Fistula ,,Biallilic
0,716,MUTYH-Biallelic/Compound Heterozygous,Compound Heterozygous,Either,Colorectal Cancer,,,Cancer,Colorectal,9,NO source,,,,,,,,,,,,1,1,,,1,,,1,High,,,colorrectal,结直肠,Masculino,男性,1,1,Ask2Me,372,,Colorectal cancer,,Cancer,,,Colorectal Cancer,,Biallelic
0,716,"MUTYH-Biallelic/Compound Heterozygous
MUTYH-Biallelic/Compound Heterozygous",Compound Heterozygous,Either,Colorectal Cancer,,,Cancer,Colorectal,9,NO source,,,,,,,,,,,,1,1,,,1,,,1,High,,,colorrectal,结直肠,Masculino,男性,1,1,Ask2Me,372,,Colorectal cancer,,Cancer,,,Colorectal Cancer,,Biallelic
1,718,MUTYH,,Female,Ovarian Cancer,,,Cancer,Ovary,9,-MonoallelicAccording to clingen monoallelic (Limited by lee21018GenIn),,,Limited,9,,,,,,,,1,,,,,,,,,,1,ovario,卵巢,Femenino,女性,0,0,,373,,Ovarian cancer,,Cancer,,1,Ovarian Cancer,,Biallelic
0,719,FH,,Either,Fumarase Deficiency,,,Benign,Metabolic,,Biallelic,,,,,,,,1,,1,1,,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Fumarase deficiency,,Benign Disease,,,Fumarase Deficiency,,Biallilic
0,722,MUTYH-Biallelic,,Either,Bladder Cancer,,,Cancer,Urinary Bladder,9,Clingen: still not clear if the lifetime risk of these malignancies is increased.,,,Mentioned,9,,,,,,,,1,1,,,1,,,,,,,vejiga urinaria,膀胱,Masculino,男性,0,0,Ask2Me,375,,Urinary Bladder,,Cancer,,1,Bladder Cancer,,Biallelic
0,723,FH,,Either,Adrenal Neoplasm,Primary Macronodular Adrenal Hyperplasia,,Neoplasm,Adrenal,,,,,,,,,,1,1,1,,,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Primary macronodular adrenal hyperplasia,,Benign Disease,,,Adrenal Hyperplasia,,Mono
0,726,MUTYH,,Either,Colorectal Cancer,,,Cancer,Colorectal,1,Monoallelic,,,Moderate,1,,,,,,,,1,1,,,1,,,,,,,colorrectal,结直肠,Masculino,男性,1,0,Ask2Me,377,,Colorectal cancer,,Cancer,,1,Colorectal Cancer,,Mono
0,727,FLCN,,Either,Skin Cancer (Non-Melanoma),Basal Cell Carcinoma,,Cancer,Skin,,,,,,,,,,1,1,1,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Skin cancer,,Cancer,,,Skin Cancer (Non-Melanoma),,Mono
1,728,MUTYH,,Female,Endometrial Cancer,,,Cancer,Uterus,9,NO source,,,,,,,,,,,,1,1,,,1,,,,,,,endometrio,子宫内膜,Femenino,女性,0,0,Ask2Me,378,,Endometrial cancer,,Cancer,,1,Endometrial Cancer,,Mono
0,731,FLCN,,Either,Lung (Benign),Lung Cyst,,Benign,Lung,,Not plura,,,,,,,,1,1,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Lung cyst,,Cancer,,,Lung (Benign),,Mono
0,732,MUTYH,,Either,Gastric Cancer,,,Cancer,Gastric,9,Somatic mutation,,,,,,,,,2,2,2,1,1,,,1,,,1,Low,,1,gástrico,胃,Masculino,男性,0,0,Ask2Me,380,,Gastric cancer,,Cancer,,1,Gastric Cancer,,Mono
0,735,FLCN,,Either,Lung (Benign),Primary Spontaneous Pneumothorax,,Benign,Lung,,,,,,,,,,1,1,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Primary spontaneous pneumothorax,,Benign Disease,,,Pneumothorax,,Mono
0,736,MUTYH,,Either,Hepatobiliary Cancer,,,Cancer,Liver,9,NO source,,,,,,,,,,,,1,1,,,1,,,,,,,hepatobiliar,肝,Masculino,男性,0,0,Ask2Me,382,,Hepatobiliary,,Cancer,,1,Hepatobiliary Cancer,,Mono
1,738,NBN,657del5,Female,Breast Cancer,,,Cancer,Breast,9,ClinGen and NCCN disagree NCCN 1 only for 657del5 varient,,,Limited,9,9,9,9,1,,,,1,1,,,1,,1,1,Low,,1,mama,乳腺,Femenino,女性,1,1,Ask2Me,383,,Breast cancer,,Cancer,1,,Breast Cancer,,Mono
0,739,FLCN,,Either,Skin (Benign),"trichodiscomas, and acrochordons",,Benign,Skin,,MedNeon(Kelly),,,,,,,,,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Fibrofolliculomas,,Cancer,,,Skin (Benign),,Mono
0,739,FLCN,,Either,Skin (Benign),Fibrofolliculoma,,Benign,Skin,,,,,,,,,,,,,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Fibrofolliculomas,,Cancer,,,Skin (Benign),,Mono
1,740,NBN,657del5,Male,Prostate Cancer,,,Cancer,Prostate,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,1,,,,1,,,,1,,,,,,1,próstata,前列腺,Masculino,男性,0,0,Ask2Me,384,,Prostate cancer,,Cancer,1,,Prostate Cancer,,Mono
0,743,GATA2,,Either,Blood (Benign),Myelodysplasia,,Benign,Blood,,,,,,,,,,1,1,1,1,,,,,,,1,,,,,leucemia,白血病,Masculino,男性,0,0,,,,Myelodysplasia,,Benign Disease,,,Myelodysplasia,,Mono
0,746,PALB2,,Either,Pancreatic Cancer,,,Cancer,Pancreas,1,,,,,,1,,1,,1,1,1,1,1,,,1,,1,1,Low,,1,páncreas,胰腺,Masculino,男性,0,0,Ask2Me,387,,Pancreatic Cancer,,Cancer,1,,Pancreatic Cancer,,Mono
0,747,GATA2,,Either,Lymphedema,,,Benign,Nodes,,,,,,,,,,1,,1,1,,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,,,Lymphedema,,Benign Disease,,,Lymphedema,,Mono
0,750,PMS2,,Either,Colorectal Cancer,,Lynch Syndrome,Cancer,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,1,,,1,,,1,Low,,1,colorrectal,结直肠,Masculino,男性,0,0,Ask2Me,,,Colorectal cancer,,Cancer,,1,Colorectal Cancer,,Mono
1,752,PMS2,,Female,Endometrial Cancer,,Lynch Syndrome,Cancer,Uterus,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,,,,1,1,,,1,,,1,Low,,1,endometrio,子宫内膜,Femenino,女性,0,0,Ask2Me,,,Endometrial cancer,,Cancer,,1,Endometrial Cancer,,Mono
1,754,PMS2,,Female,Ovarian Cancer,,Lynch Syndrome,Cancer,Ovary,9,Clingen and NCCN disagree Clingen is definitive or moderate PMID :23091106,,,Definitive,1,9,9,,1,,,,1,1,,,1,,,1,Low,,1,ovario,卵巢,Femenino,女性,0,0,Ask2Me,,,Ovarian cancer,,Cancer,,1,Ovarian Cancer,,Mono
1,756,PTEN,,Female,Breast Cancer,,,Cancer,Breast,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,1,1,1,1,,,1,1,,,1,,,1,High,High,,mama,乳腺,Femenino,女性,0,0,Ask2Me,392,,Breast cancer,,Cancer,1,1,Breast Cancer,,Mono
0,760,PTEN,,Either,Colorectal Cancer,,,Cancer,Colorectal,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,1,1,,,,,1,1,,,1,,,1,Low,,,colorrectal,结直肠,Masculino,男性,0,0,Ask2Me,394,,Colorectal cancer,,Cancer,1,1,Colorectal Cancer,,Mono
0,766,PTEN,,Either,Kidney Cancer,Renal Cell Carcinoma,,Cancer,Kidney,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,1,1,,,,,1,1,,,1,,,1,Mod,,,riñón,肾,Masculino,男性,0,0,Ask2Me,397,,Kidney,renal cell carcinoma,Cancer,1,1,Kidney Cancer,,Mono
0,769,KIT,,Either,Skin (Benign),Piebaldism,,Benign,Hair,,,,,,,,,,1,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Piebaldism,,Benign Disease,,,Piebaldism,,Mono
0,770,PTEN,,Either,Melanoma,,,Cancer,Skin,1,,,,Mentioned,1,,,,2,,,,1,1,,,1,,,1,Low,,1,melanoma,黑色素瘤,Masculino,男性,0,0,Ask2Me,399,,Melanoma,,Cancer,1,1,Melanoma,,Mono
0,774,WRN,,Either,Thyroid Cancer,,,Cancer,Thyroid,,MedNeon(Kelly) Biallelic,,,,,,,,,,,,,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,Ask2Me,401,,Thyroid cancer,,Cancer,1,1,Thyroid Cancer,,Mono
0,774,PTEN,,Either,Bladder Cancer,,,Cancer,Urinary Bladder,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,Ask2Me,401,,Thyroid cancer,,Cancer,1,1,Bladder Cancer,,Mono
0,774,PTEN,,Either,Thyroid Cancer,,,Cancer,Thyroid,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,1,1,,1,,,1,1,,,1,,,1,Mod,,2,tiroides,甲状腺,Masculino,男性,0,0,Ask2Me,401,,Thyroid cancer,,Cancer,1,1,Thyroid Cancer,,Mono
0,775,KIT,,Either,Leukemia,AML,,Cancer,Blood,,,,,,,,,,1,,,,,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,AML,Cancer,,,Leukemia,,Mono
1,776,RAD51C,,Female,Ovarian Cancer,,,Cancer,Ovary,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,,1,1,1,1,1,,,1,,1,1,Low,,1,ovario,卵巢,Femenino,女性,0,0,Ask2Me,402,,Ovarian cancer,,Cancer,,,Ovarian Cancer,,Mono
0,777,KIT,,Either,Blood (Benign),Systemic Mastocytosis,,Benign,Blood,,,,,,,,,,1,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Systemic mastocytosis,,Benign Disease,,,Systemic Mastocytosis,,Mono
1,778,RAD51D,,Female,Ovarian Cancer,,,Cancer,Ovary,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,,1,1,1,1,1,,,1,,1,1,Low,,1,ovario,卵巢,Femenino,女性,0,0,Ask2Me,403,,Ovarian cancer,,Cancer,,,Ovarian Cancer,,Mono
1,780,STK11,,Female,Breast Cancer,,,Cancer,Breast,1,Clingen : RR=20.3 for gynecological/breast cancer ; Lifetime risk: 45-50% breast,,,Mentioned,1,1,1,1,1,1,,,1,1,,,1,,,1,High,High,1,mama,乳腺,Femenino,女性,0,0,Ask2Me,404,,Breast cancer,,Cancer,1,1,Breast Cancer,,Mono
1,781,KIT,,Male,Testicular Cancer,,,Cancer,Testes,,,,,,,,,,1,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Testicular cancer,,Cancer,,,Testicular Cancer,,Mono
0,784,STK11,,Either,Colorectal Cancer,,,Cancer,Colorectal,1,Clingen: Lifetime risk: 39% colon,,,Mentioned,1,1,1,1,2,,,,1,1,,,1,,,1,Mod,,1,colorrectal,结直肠,Masculino,男性,0,0,Ask2Me,406,,Colorectal cancer,,Cancer,1,1,Colorectal Cancer,,Mono
1,787,MSH3,,Female,Endometrial Cancer,,,Cancer,Uterus,9,,,,,,,,,1,1,1,1,1,,,,,,,,,,,,,Femenino,女性,0,0,,,,Endometrial Cancer,,Cancer,,,Endometrial Cancer,,Mono
0,788,STK11,,Either,Gastric Cancer,,,Cancer,Gastric,1,Clingen Lifetime risk: 29% stomach,,,Mentioned,1,1,1,1,,1,,,1,1,,,1,,,1,Low,,,gástrico,胃,Masculino,男性,0,0,Ask2Me,408,,Gastric cancer,,Cancer,1,1,Gastric Cancer,,Mono
1,790,TP53,,Female,Breast Cancer,,,Cancer,Breast,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,1,1,1,2,1,1,1,1,,,1,,,1,High,High,1,mama,乳腺,Femenino,女性,0,0,Ask2Me,409,,Breast cancer,,Cancer,1,1,Breast Cancer,,Mono
0,791,MSH3,,Either,Gastric Neoplasm,Gastric Leiomyoma,,Neoplasm,Gastric,0,,,,,,,,,,,1,,1,,,,,,,,,,,gástrico,胃,Masculino,男性,0,0,,165,,Gastric leiomyoma,,Cancer,,,Gastric Neoplasm,,Mono
0,794,TP53,,Either,Brain Tumor,Glioma,,Cancer,Brain,1,,,,,,,,,1,1,,1,1,,,,,,,1,High,,1,cerebro,脑,Masculino,男性,0,0,Ask2Me,411,,Brain Tumor,,Cancer,1,1,Brain Tumor,,Mono
0,798,TP53,,Either,Leukemia,,,Cancer,Blood,9,Ambry Only,,,,,,,,,,1,,1,1,,,1,,,1,Low,,1,leucemia,白血病,Masculino,男性,0,0,Ask2Me,413,,Leukemia,,Cancer,1,1,Leukemia,,Mono
0,802,TP53,,Either,Sarcoma,Osteosarcoma,,Cancer,Bone,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,1,1,1,1,1,1,,,1,,,1,,,1,osteosarcoma,骨肉瘤,Masculino,男性,0,0,Ask2Me,415,,Osteosarcoma,,Cancer,1,1,Sarcoma (Bone),,Mono
0,806,TP53,,Either,Sarcoma,Soft Tissue Sarcoma,,Cancer,Soft Tissue,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,1,1,1,,1,1,,,1,,,1,High,,1,sarcoma de tejidos blandos,软组织肉瘤,Masculino,男性,0,0,Ask2Me,417,,Soft Tissue Sarcoma,,Cancer,1,1,Sarcoma,,Mono
0,807,NTHL1,,Either,Pancreatic Neoplasm,Periampullary Adenoma,,Neoplasm,Pancreas,,,,,,,,,,,,,,,,,,,,,,,,,colorrectal,结直肠,Masculino,男性,0,0,,,,Periampullary adenoma,,Benign Disease,,,Pancreatic Neoplasm,,Mono
1,808,MSH6,,Male,Prostate Cancer,,,Cancer,Prostate,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,1,1,,,,,1,,,,,,,,,,1,próstata,前列腺,Masculino,男性,0,0,,418,,Prostate cancer,,Cancer,,1,Prostate Cancer,,Mono
1,810,PMS2,,Male,Prostate Cancer,,,Cancer,Prostate,9,NCCN: Not well established NCCN : very low no of mutation carriers,,,Mentioned,1,9,,9,,,,,1,,,,,,,,,,1,próstata,前列腺,Masculino,男性,0,0,,,,Prostate cancer,,Cancer,,1,Prostate Cancer,,Mono
0,812,MLH1,,Either,Sebaceous Cancer,,,Cancer,Skin,1,,,,,,1,,1,1,1,,,1,,,,,,,1,Low,,1,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,420,,Sebaceous carcinoma,,Cancer,,1,Sebaceous Cancer,,Mono
0,814,PMS2,,Either,Gastric Cancer,,Lynch Syndrome,Cancer,Gastric,9,NCCN: Gastric paper  Clingen is definitive or moderate AND NCCN management and/or ID present,,,Mentioned,1,9,,9,1,,,1,1,,,,,,,1,Low,,,gástrico,胃,Masculino,男性,0,0,,,,Gastric cancer,,Cancer,,1,Gastric Cancer,,Mono
0,815,MAX,,Either,Pheochromocytoma/Paraganglioma,Pheochromocytoma,,Neoplasm,Adrenal,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,,,,,,,1,,,,,,,Masculino,男性,0,0,,,,Pheochromocytoma,,Benign Disease,,,Neuroendocrine,,Mono
0,818,MSH6,,Either,Pancreatic Cancer,,,Cancer,Pancreas,9,NCCN : Not well established? Clingen:The risk of cancer in LS by age 70:  pancreas=1-4%,,,Mentioned,1,9,9,,,,,,1,,,,,,,1,Low,,1,páncreas,胰腺,Masculino,男性,0,0,,423,,Pancreatic cancer,,Cancer,,1,Pancreatic Cancer,,Mono
0,822,PMS2,,Either,Pancreatic Cancer,,,Cancer,Pancreas,9,NCCN : Not well established Clingen:The risk of cancer in LS by age 70:  pancreas=1-4%,,,Mentioned,1,9,9,,,,,,1,,,,,,,1,Low,,1,páncreas,胰腺,Masculino,男性,0,0,,,,Pancreatic cancer,,Cancer,,1,Pancreatic Cancer,,Mono
0,823,RUNX1,,Either,Bone (Benign),Rheumatoid Arthritis,,Benign,Bone,,,,,,,,,,1,,,,,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,,,Rheumatoid arthritis.,,Benign Disease,,,Rheumatoid Arthritis,,Mono
0,826,APC,,Either,Thyroid Cancer,,,Cancer,Thyroid,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Mentioned,1,1,1,1,,1,,,1,,,,,,,1,High,,1,colorrectal,结直肠,Masculino,男性,0,0,,427,,Colorectal cancer,,Cancer,,1,Colorectal Cancer,,Mono
0,826,APC,,Either,Colorectal Cancer,,,Cancer,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,,,,,,,1,High,,1,colorrectal,结直肠,Masculino,男性,0,0,,427,,Colorectal cancer,,Cancer,,1,Colorectal Cancer,,Mono
0,827,RUNX1,,Either,Blood (Benign),Systemic Mastocytosis,,Benign,Blood,,,,,,,,,,1,,,,,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,,,Systemic mastocytosis,,Benign Disease,,,Systemic Mastocytosis,,Mono
0,830,APC,,Either,Gastric Cancer,,,Cancer,Gastric,1,Clingen:The lifetime risk for gastric cancer in FAP in Western countries is estimated between 0.5 and 1%. Malignant progression of fundic gland polyps of the stomach is uncommon and surveillance is considered adequate for monitoring for gastric cancers.,,,Mentioned,1,1,1,1,2,1,1,1,1,,,,,,,1,Low,,1,gástrico,胃,Masculino,男性,0,0,,429,,Gastric cancer,,Cancer,,1,Gastric Cancer,,Mono
0,834,APC,,Either,Brain Tumor,Medulloblastoma,,Cancer,Brain,1,Clingen: absolute risk for CNS tumors is 1-2%,,,Mentioned,1,1,1,1,1,1,1,,1,,,,,,,1,Low,,1,cerebro,脑,Masculino,男性,0,0,,433,,Medulloblastoma,medulloblastoma,Cancer,,1,Brain Tumor,,Mono
0,838,BAP1,,Either,Melanoma,,,Cancer,Skin,1,Clingen: prevalence of germline mutations in individuals with BAP1 associated cancers include: cutaneous melanoma (0.6%),,,Mentioned,1,1,1,,1,1,,,1,,,,,,,1,Low,,1,,,Masculino,男性,0,0,,435,,Melanoma,,Cancer,,,Melanoma,,Mono
0,839,SDHA,,Either,Pheochromocytoma/Paraganglioma,Pheochromocytoma,,Neoplasm,Adrenal,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,,,,,,,,,,1,,,,,,,Masculino,男性,0,0,,,,Pheochromocytoma,,Neoplasm,,,Neuroendocrine,,Mono
0,842,BAP1,,Either,Kidney Cancer,Clear Cell Carcinoma,,Cancer,Kidney,1,Renal cell carcinoma: 18/174 (10%),,,Mentioned,1,,,,1,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,437,,Renal cell carcinoma,ClearCell Carcinoma,Cancer,,,Kidney Cancer,,Mono
0,843,SDHAF2,,Either,Pheochromocytoma/Paraganglioma,Pheochromocytoma,,Neoplasm,Adrenal,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,,1,,,,,,,,1,,,,,,,Masculino,男性,0,0,,,,Pheochromocytoma,,Neoplasm,,,Neuroendocrine,,Mono
0,846,MEN1,,Either,Neuroendocrine,Gastrinoma,,Neoplasm,Pancreas,1,Clingen: penetrance gastric NET (10%),,,Mentioned,1,1,1,1,2,1,,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,439,,Lung Cancer,lung carcinoid tumor,Cancer,,,Neuroendocrine,,Mono
0,846,MEN1,,Either,Neuroendocrine,Lung Carcinoid,,Neoplasm,Lung,1,Clingen: penetrance bronchopulmonary NET (2%)   1:4 male:female ratio for bronchial carcinoids.,,,Mentioned,1,1,1,1,2,1,,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,439,,Lung Cancer,lung carcinoid tumor,Cancer,,,Neuroendocrine,,Mono
0,846,MEN1,,Either,Neuroendocrine,Thymus Carcinoid,,Neoplasm,Thymus,1,Clingen; Riak different for male and female  20:1 male:female ratio for thymic carcinoids and a 1:4 male:female ratio for bronchial carcinoids.,,,Mentioned,1,1,1,1,2,1,,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,439,,Lung Cancer,lung carcinoid tumor,Cancer,,,Neuroendocrine,,Mono
0,850,MEN1,,Either,Neuroendocrine,Pancreatic Neuroendocrine Tumor,,Neoplasm,Pancreas,1,Clingen: penetrance enteropancreatic tumor (30–75%),,,Mentioned,1,1,1,1,2,1,1,1,1,,,,,,,1,Low,,1,,,Masculino,男性,0,0,,441,,Pancreatic neuroendocrine tumor,,Neoplasm,,,Neuroendocrine,,Mono
0,851,SDHAF2,,Either,Neuroendocrine,Neural crest tumor,,Neoplasm,Neuroendocrine,,,,,,,,,,,,1,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Neural crest tumor,,Benign Disease,,,Neoroendocrine,,Mono
0,855,MEN1,,Either,Parathyroid (Benign),Primary Hyperparathyroidism,,Benign,Parathyroid,1,Clingen: penetrance parathyroid adenoma or PHPT (90-98%),,,Mentioned,1,1,1,1,1,1,1,1,1,,,,,,1,,,,2,,,Masculino,男性,0,0,,443,,Parathyroid tumor,,Neoplasm,,,Parathyroid Neoplasm,,Mono
0,856,SMARCA4,,Either,Lung Cancer,,,Cancer,Lung,,,,,,,,,,1,,,,,,,,,,,,,,,colorrectal,结直肠,Masculino,男性,0,0,,,,Lung cancer,,Cancer,,,Lung Cancer,,Mono
0,859,VHL,,Either,Brain Tumor,CNS Hemangioblastoma,,Benign,Brain,1,CNS Hemangioblastoma-60-80%,,,Mentioned,1,,,,1,2,1,1,,,,,,,,,,,2,,,Masculino,男性,0,0,,445,,Hemangioblastoma,,Neoplasm,,,Brain/CNS/Eye Tumor,,Mono
0,860,SMARCA4,,Either,Sarcoma,Thoracic Sarcomas,,Cancer,Soft Tissue,,,,,,,,,,1,,1,,,,,,,,,,,,,colorrectal,结直肠,Masculino,男性,0,0,,,,Thoracic sarcomas,,Cancer,,,Sarcoma,,Mono
0,863,SDHB,,Either,GIST,,,Neoplasm,Small Bowel,1,,,,Mentioned,1,,,,1,2,1,1,1,,,,,,1,1,Low,,1,,,Masculino,男性,0,0,,447,,Gastrointestinal Stromal Tumor,,Cancer,,,GIST,,Mono
0,864,SMARCA4,,Either,Developmental,Intellectual Disability,,Benign,CNS,,,,,,,,,,,,,1,,,,,,,,,,,,colorrectal,结直肠,Masculino,男性,0,0,,,,Intellectual disability,,Benign Disease,,,Intellectual Disability,,Mono
0,867,SDHC,,Either,GIST,,,Neoplasm,Small Bowel,1,,,,Mentioned,1,,,,1,1,1,1,,,,,,,1,1,Low,,1,,,Masculino,男性,0,0,,449,,Gastrointestinal Stromal Tumor,,Cancer,,,GIST,,Mono
0,868,SMARCB1,,Either,Peripheral Nervous System Neoplasm,Schwannoma,,Neoplasm,PNS,,,,,,,,,,1,1,1,1,,,,,,,1,,,,,,,Masculino,男性,0,0,,,,Schwannomatosis,,Cancer,,,Peripheral Nervous System Neoplasm,,Mono
0,871,SDHD,,Either,GIST,,,Neoplasm,Small Bowel,1,,,,Mentioned,1,,,,1,2,1,,1,,,,,,1,1,Low,,,,,Masculino,男性,0,0,,451,,Gastrointestinal Stromal Tumor,,Cancer,,,GIST,,Mono
0,872,SMARCB1,,Either,Developmental,Intellectual Disability,,Benign,CNS,,,,,,,,,,,,,1,,,,,,,,,,,,colorrectal,结直肠,Masculino,男性,0,0,,,,Intellectual disability,,Benign Disease,,,Intellectual Disability,,Mono
0,875,SUFU,,Either,Skin (Benign),Nevi,,Benign,Skin,1,,,,,,,,,,1,1,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Nevus,,Benign Disease,,,Skin (Benign),,Mono
0,877,SDHC,,Either,Kidney Cancer,Renal Cell Carcinoma,,Cancer,Kidney,0,,,,,,,,,,,,,,,,,,,,,,,1,,,Masculino,男性,0,0,,455,,Kidney,renal cell carcinoma,Cancer,,,Kidney Cancer,,Mono
0,880,TERC,,Either,Oropharynx (Benign),Leukoplakia,,Benign,Oropharynx,,,,,,,,,,1,,,,,,,,,,,,,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,Oral leukoplakia,,Benign Disease,,,Leukoplakia,,Mono
0,881,SDHD,,Either,Kidney Cancer,Renal Cell Carcinoma,,Cancer,Kidney,9,,,,,,,,,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,457,,Kidney,renal cell carcinoma,Cancer,,,Kidney Cancer,,Mono
0,884,TERC,,Either,Skin (Benign),Dyskeratosis Congenita,,Benign,Skin,,,,,,,,,,1,1,1,1,,,,,,,,,,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,Dyskeratosis congenita,,Benign Disease,,,Dyskeratosis Congenita,,Mono
0,885,BRIP1,,Either,Leukemia,,,Cancer,Blood,0,,,,,,,,,,,,,1,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,,Cancer,,,Leukemia,,Mono
1,888,HOXB13,,Male,Prostate Cancer,,,Cancer,Prostate,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,1,1,1,1,1,,,,1,,1,1,Mod,,1,próstata,前列腺,Masculino,男性,0,0,Ask2Me,,,Prostate cancer,,Cancer,,,Prostate Cancer,,Mono
0,889,TERC,,Either,Blood (Benign),Aplastic Anemia,,Benign,Blood,,,,,,,,,,1,1,,,,,,,,,,,,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,Aplastic anemia,,Benign Disease,,,Aplastic Anemia,,Mono
0,893,TERC,,Either,Lung (Benign),Pulmonary Fibrosis,,Benign,Lung,,,,,,,,,,1,1,1,1,,,,,,,,,,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,Pulmonary fibrosis,,Benign Disease,,,Pulmonary Fibrosis,,Mono
1,894,PTEN,,Male,Breast (Benign),Gynecomastia,,Benign,Breast,9,,,,,,,,,,1,,,1,,,,,,,,,,,enfermedad fibroquística de la mama,纤维囊性乳房疾病,Femenino,女性,,,,,,Fibrocystic breast disease,,Neoplasm,1,1,Breast (Benign),,Mono
1,894,PTEN,,Female,Breast (Benign),"Virginal hyperplasia
- Fibrocystic breast disease
- Breast fibroadenomas",,Benign,Breast,9,,,,,,,,,,1,,,1,,,,,,,,,,,enfermedad fibroquística de la mama,纤维囊性乳房疾病,Femenino,女性,,,,,,Fibrocystic breast disease,,Neoplasm,1,1,Breast (Benign),,Mono
1,896,SEC23B,,Female,Uterus (Benign),Uterine Fibroids,,Benign,Uterus,9,,,,,,,,,,1,,,1,,,,,,,,,,,fibroides uterinos,子宫平滑肌瘤,Femenino,女性,,,,,,,,Neoplasm,,,Uterine Corpus (Benign),,Mono
1,896,PTEN,,Female,Uterus (Benign),Uterine Fibroids,,Benign,Uterus,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,2,1,,,1,,,,,,,,,,,fibroides uterinos,子宫平滑肌瘤,Femenino,女性,,,,,,Uterine fibroids,,Neoplasm,1,1,Uterine Corpus (Benign),,Mono
0,897,TERT,,Either,Skin (Benign),Dyskeratosis Congenita,,Benign,Skin,,,,,,,,,,1,1,1,1,,,,,,,,,,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,Dyskeratosis congenita,,Benign Disease,,,Dyskeratosis Congenita,,Mono
0,900,PTEN,,Either,Dysmorphic Feature,"Abnormal Facies, Birdlike' facies, Short nose 
- Depressed nasal bridge 
- Hypoplastic mandible (uncommon)
- Hypoplastic maxilla (uncommon)
- Broad forehead 
- Square outline
- Frontal bossing 
- 'Dished out' midface
- Long philtrum",,Benign,Face,9,,,,,,,,,,1,,,1,,,,,,,,,,1,,,Masculino,男性,,,,,,Cerebrovascular malformations,,Benign Disease,1,1,Abnormal Facies,,Mono
0,900,PTEN,,Either,Ear (Benign),Hearing Loss,,Benign,Head and neck,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,,,,,,Cerebrovascular malformations,,Benign Disease,1,1,Hearing Loss,,Mono
0,900,PTEN,,Either,Eye (Benign),"Cataract
- Angioid streaks
- Myopia",,Benign,Eye,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,,,,,,Cerebrovascular malformations,,Benign Disease,1,1,Eye (Benign),,Mono
0,900,PTEN,,Either,Oropharynx (Benign),"Microstomia 
- High-arched palate
- Scrotal tongue 
- Oral papillomas",,Benign,Oropharynx,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,,,,,,Cerebrovascular malformations,,Benign Disease,1,1,Oral (Benign),,Mono
0,900,PTEN,,Either,Liver (Benign),Hepatomegaly,,Benign,Liver,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,,,,,,Cerebrovascular malformations,,Benign Disease,1,1,Hepatomegaly,,Mono
0,900,PTEN,,Either,Spleen (Benign),Splenomegaly,,Benign,Spleen,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,,,,,,Cerebrovascular malformations,,Benign Disease,1,1,Splenomegaly,,Mono
0,900,STK11,,Either,Nose (Benign),Nasal Polyps,,Benign,Head and neck,9,OMIM only,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,,,,,,Cerebrovascular malformations,,Benign Disease,1,1,Nose (Benign),,Mono
0,900,STK11,,Either,Lung (Benign),Bronchial Polyps,,Benign,Lung,9,OMIM only,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,,,,,,Cerebrovascular malformations,,Benign Disease,1,1,Respiratory (Benign),,Mono
0,900,STK11,,Either,Bladder (Benign),Bladder Polyps,,Benign,Urinary Bladder,9,OMIM only,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,,,,,,Cerebrovascular malformations,,Benign Disease,1,1,Bladder (Benign),,Mono
0,900,PTEN,,Either,Central Nervous System (Benign),Cerebrovascular Malformations,,Benign,Brain,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,,1,1,1,,,1,,,,,,,,,,1,malformaciones vasculares cerebrales,脑血管畸形,Masculino,男性,,,,,,Cerebrovascular malformations,,Benign Disease,1,1,Cerebrovascular Malformations,,Mono
0,901,TERT,,Either,Lung (Benign),Pulmonary Fibrosis,,Benign,Lung,,,,,,,,,,1,1,1,1,,,,,,,,,,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,Pulmonary fibrosis,,Benign Disease,,,Pulmonary Fibrosis,,Mono
0,902,PTEN,,Either,Brain Tumor,Cerebellar Gangliocytoma,,Cancer,Brain,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,,1,,,1,,,,,,,,,,1,enfermedad de Lhermitte-Duclos ,Lhermitte-Duclos病,Masculino,男性,,,,,,Lhermitte-Duclos disease,,Benign Disease,1,1,Brain Tumor,,Mono
0,905,TERT,,Either,Breast Cancer,,,Cancer,Breast,,,,,,,,,,1,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
0,906,STK11,,Either,Skin (Benign),Perioral Freckling,,Benign,Skin,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Mentioned,1,1,,1,,1,1,,1,,,,,,,,,,,pecas periorales,口周雀斑,Masculino,男性,,,,,,Perioral freckling,,Benign Disease,1,1,Skin (Benign),,
0,909,TERT,,Either,Hepatobiliary Cancer,Gallbladder Cancer,,Cancer,Gallbladder,,,,,,,,,,1,,,,,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,,,Cholangiocarcinoma,,Cancer,,,Hepatobiliary Cancer,,Mono
0,910,PTEN,,Either,Dysmorphic Feature,Macrocephaly,,Benign,Head and neck,1,80-100% of individuals with CS have macrocephaly.,,,Mentioned,1,1,1,1,,1,1,1,1,,,,,,,,,,1,macrocefalia,大头畸形,Masculino,男性,,,,,,Macrocephaly,,Benign Disease,1,1,Macrocephaly,,
0,913,TERT,,Either,Blood (Benign),Aplastic Anemia,,Benign,Blood,,,,,,,,,,1,1,1,1,,,,,,,,,,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,Aplastic anemia,,Benign Disease,,,Aplastic Anemia,,Mono
0,914,PTEN,,Either,Lipoma,,,Benign,Lipid,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,,1,,1,,,1,,,,,,,,,,,lipoma,脂肪瘤,Masculino,男性,,,,,,Lipoma,,Neoplasm,1,1,Lipoma,,Mono
0,921,TMEM127,,Either,Pheochromocytoma/Paraganglioma,Pheochromocytoma,,Neoplasm,Adrenal,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,,,,,,,1,,,,,,,Masculino,男性,0,0,,,,Pheochromocytoma,,Neoplasm,,,Neuroendocrine,,Mono
0,922,PTEN,,Either,Thyroid (Benign),,,Benign,Thyroid,1,,,,,,1,,1,,1,,,1,,,,,,,,,,,,良性甲状腺疾病,Masculino,男性,,,,,,Benign thyroid disease,,Benign Disease,1,1,Thyroid (Benign),,
0,923,TMEM127,,Either,Lymphadenopathy,Generalized,,Benign,Nodes,,,,,,,,,,,,1,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Generalized lymphadenopathy,,Benign Disease,,,Lymphadenopathy,,Mono
0,926,STK11,,Either,Oropharynx (Benign),Orofacial Cleft,,Benign,Oropharynx,0,Ambry Only - Not included in paper,,,,,,,,,,,,1,,,,,,,,,,1,hendidura orofacial,口面裂,Masculino,男性,,,,,,Orofacial clefting,,Benign Disease,1,1,Orofacial Cleft,,
0,927,TMEM127,,Either,Cardiovascular (Benign),Tricuspid Atresia,,Benign,Heart,,,,,,,,,,,,1,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Tricuspid atresia,,Benign Disease,,,Tricuspid Atresia,,Mono
0,928,NF1,,Either,Sarcoma,Malignant Peripheral Nerve Sheath Tumor,,Cancer,Soft Tissue,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,1,1,,1,,,1,1,,,1,,,,,,1,Tumor maligno de la vaina del nervio periférico,恶性外周神经鞘瘤,Masculino,男性,0,0,Ask2Me,,,Malignant peripheral nerve sheath tumor,,Cancer,1,,Malignant Peripheral Nerve Sheath Tumor,,Mono
0,931,TSC1,,Either,Lung (Benign),Lymphangiomyomatosis,,Benign,Lung,,,,,,,,,,1,1,1,1,,,,,,,,,,,,cerebro,脑,Masculino,男性,0,0,,,,Lymphangioleiomyomatosis,,Benign Disease,,,Lymphangiomyomatosis,,Mono
0,934,MLH1,,Either,Bladder Cancer,,,Cancer,Urinary Bladder,1,Clingen:The risk of cancer in LS by age 70:  bladder =2-16%,,,Mentioned,1,,,,,,,,1,1,,,1,,,1,Low,,1,Vejiga urinaria,膀胱,Masculino,男性,0,0,Ask2Me,,,Urinary Bladder,,Cancer,,1,Bladder Cancer,,Mono
0,938,MSH2,,Either,Bladder Cancer,,,Cancer,Urinary Bladder,1,Clingen:The risk of cancer in LS by age 70:  bladder =2-16%,,,Mentioned,1,1,,1,,,,,1,1,,,1,,,1,Mod,,,Vejiga urinaria,膀胱,Masculino,男性,0,0,Ask2Me,,,Urinary Bladder,,Cancer,,1,Bladder Cancer,,Mono
0,939,TSC1,,Either,Bladder Cancer,,,Cancer,Urinary bladder,,,,,,,,,,2,,,,,,,,,,,,,,,cerebro,脑,Masculino,男性,0,0,,,,Bladder cancer,,Cancer,,,Bladder Cancer,,Mono
0,942,MSH6,,Either,Bladder Cancer,,,Cancer,Urinary Bladder,1,Clingen:The risk of cancer in LS by age 70:  bladder =2-16%,,,Mentioned,1,,,,,,,,1,1,,,1,,,1,Low,,,Vejiga urinaria,膀胱,Masculino,男性,0,0,Ask2Me,,,Urinary Bladder,,Cancer,,1,Bladder Cancer,,Mono
0,943,TSC1,,Either,Cardiovascular (Benign),,,Benign,Heart,,,,,,,,,,,,1,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Congenital heart defects,,Benign Disease,,,Congenital Heart Defects,,Mono
0,946,MLH1,,Either,Upper Urinary Tract Cancer,,,Cancer,Upper Urinary Tract,1,Clingen:The risk of cancer in LS by age 70: upper urinary tract=6%,,,Mentioned,1,1,,1,1,,,,1,1,,,1,,,1,Low,,1,tracto urinario superior,上尿路,Masculino,男性,0,0,Ask2Me,,,Upper Urinary Tract,,Cancer,,1,Upper Urinary Tract Cancer,,Mono
0,947,TSC1,,Either,Oropharynx (Benign),Hamartomas Of Tongue,,Benign,Oropharynx,,,,,,,,,,,,1,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Hamartomas of tongue,,Benign Disease,,,Hamartoma,,Mono
0,950,MSH2,,Either,Upper Urinary Tract Cancer,,,Cancer,Upper Urinary Tract,1,Clingen:The risk of cancer in LS by age 70: upper urinary tract=6%,,,Mentioned,1,1,1,1,1,,,,1,1,,,1,,,1,Mod,,,tracto urinario superior,上尿路,Masculino,男性,0,0,Ask2Me,,,Upper Urinary Tract,,Cancer,,1,Upper Urinary Tract Cancer,,Mono
0,951,TSC1,,Either,Bone (Benign),Polysyndactyly,,Benign,Hand,,,,,,,,,,,,1,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Polysyndactyly,,Benign Disease,,,Polysyndactyly,,Mono
0,954,MSH6,,Either,Upper Urinary Tract Cancer,,,Cancer,Upper Urinary Tract,1,Clingen:The risk of cancer in LS by age 70: upper urinary tract=6%,,,Mentioned,1,1,,1,1,,,,1,1,,,1,,,1,Low,,,tracto urinario superior,上尿路,Masculino,男性,0,0,Ask2Me,,,Upper Urinary Tract,,Cancer,,1,Upper Urinary Tract Cancer,,Mono
0,955,TSC2,,Either,Lung (Benign),Lymphangiomyomatosis,,Benign,Lung,,,,,,,,,,1,1,1,1,,,,,,,,,,,,cerebro,脑,Masculino,男性,0,0,,,,Lymphangioleiomyomatosis,done,Benign Disease,,,Lymphangiomyomatosis,,Mono
0,956,AXIN2,,Female,Breast Cancer,,,Cancer,Breast,0,polymorphism papers and case reports,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,Colorectal cancer,,Cancer,,,,,
0,956,AXIN2,,Either,Colorectal Cancer,,oligodontia-cancer predisposition syndrome,Cancer,Colorectal,1,NCCN says uncertain,,,,,9,,9,1,1,1,1,1,,,,,,1,1,High,,2,,,,,,,,,,Colorectal cancer,,Cancer,,,Colorectal Cancer,,
0,960,BRCA2,,Either,Melanoma,Uveal Melanoma,,Cancer,Eye,1,NCCN management or identification is present.  ClinGenSilent. PMID:12385017,,,,,1,,1,1,,,,1,,,,,,,,,,1,,,,,,,,,,Ocular Melanoma,,Cancer,1,,Melanoma,,
0,964,PTEN,,Either,Psychiatric,Autism,,Benign,CNS,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,1,1,1,1,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Autism spectrum disorder,,Benign Disease,1,1,Autism,,Mono
0,967,WT1,,Either,Kidney (Benign),Nephrotic Syndrome,,Benign,Kidney,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,,riñón,肾,Masculino,男性,0,0,,,,Congenital nephrotic syndrome,,Benign Disease,,,Congenital Nephrotic Syndrome,,Mono
0,968,PTEN,,Either,GI Neoplasm,Hamartomatous Polyps,,Neoplasm,GI,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,,1,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,GI hamartoma,,Neoplasm,1,1,GI Hamartoma,,Mono
0,972,PTEN,,Either,Skin (Benign),"Palmoplantar Keratoses - Multiple facial papules
- Acral keratoses
- Multiple skin tags
- Facial trichilemmomas
- Subcutaneous lipomas",,Benign,Skin,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Palmoplantar keratoses,,Benign Disease,1,1,Palmoplantar Keratoses,,Mono
0,975,WT1,,Either,Eye (Benign),Anirida,,Benign,Eye,1,,,,Mentioned,1,,,,1,1,1,1,1,,,,,,,,,,,cerebro,脑,Masculino,男性,0,0,,,,Anirida,,Benign Disease,,,Anirida,,Mono
0,976,PTEN,,Either,Facial Papules,,,Benign,Skin,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,,1,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Facial papules,,Benign Disease,1,1,Facial Papules,,Mono
0,979,CFTR,,Male,Genitourinary (Benign),Congenital bilateral absence of the vas deferens,,Benign,Genitals,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Genitourinary anomalies,,Benign Disease,,,Genitourinary Anomalies,,Mono
0,979,WT1,,Female,Genitourinary (Benign),"streak ovaries, hypoplastic uterus",,Benign,Genitals,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Genitourinary anomalies,,Benign Disease,,,Genitourinary Anomalies,,Mono
0,979,WT1,,Male,Genitourinary (Benign),"Cryptorchidism, ectopic ureter",,Benign,Genitals,1,Male more common,,,Mentioned,1,,,,1,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Genitourinary anomalies,,Benign Disease,,,Genitourinary Anomalies,,Mono
0,980,PTEN,,Either,Oropharynx (Benign),Oral Mucosal Papillomatosis,,Benign,Oropharynx,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Oral mucosal papillomatosis,,Cancer,1,1,Oral Mucosal Papillomatosis,,Mono
0,983,WT1,,Either,Gastrointestinal (Benign),Diaphragmatic Hernia,,Benign,Diaphragm,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,,cerebro,脑,Masculino,男性,0,0,,,,Diaphragmatic hernia,,Benign Disease,,,Diaphragmatic Hernia,,Mono
0,984,PTEN,,Either,Skin (Benign),Trichilemmoma,,Benign,Skin,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,1,1,,1,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Trichilemmoma,,Neoplasm,1,1,Skin (Benign),,Mono
0,987,WT1,,Either,Mesothelioma,Pleura,,Cancer,Mesothelium,0,,,,,,,,,,2,1,,1,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,,,Mesothelioma,,Cancer,,,Mesothelioma,,Mono
0,988,PTEN,,Either,Skin (Benign),Acral Keratoses,,Benign,Skin,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,1,1,,1,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Skin (Benign),Acral keratoses,Benign Disease,1,1,Skin (Benign),,Mono
0,991,WT1,,Either,Developmental,Hemihyperplasia,,Benign,Bone,1,,,,Mentioned,1,,,,1,1,1,1,1,,,,,,,,,,,cerebro,脑,Masculino,男性,0,0,,,,Intellectual disability,,Benign Disease,,,Hemihyperplasia,,Mono
0,991,WT1,,Either,Developmental,Intellectual Disability,,Benign,CNS,1,,,,Mentioned,1,,,,1,1,1,1,1,,,,,,,,,,,cerebro,脑,Masculino,男性,0,0,,,,Intellectual disability,,Benign Disease,,,Intellectual Disability,,Mono
0,997,BARD1,,Either,Colorectal Cancer,,,Cancer,Colorectal,0,-1,,,Limited,9,,,,,,,,1,,,,,,,,,,1,colorrectal,结直肠,Masculino,男性,0,0,,302,,Colorectal cancer,,Cancer,1,,Colorectal Cancer,,Mono
1,999,RAD51C,,Male,Prostate Cancer,,,Cancer,Prostate,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,,,,,1,,,,,,,,,,,próstata,前列腺,Masculino,男性,0,0,,,,Prostate cancer,,Cancer,,,Prostate Cancer,,Mono
0,1000,MSH6,,Either,Adrenal Cortical Carcinoma,,,Cancer,Adrenal,1,"PMID: 30963136, PMID: 23752102,PMID: 27144940",,,,,,,,,,,,1,,,,,,,1,Low,,,suprarrenal,肾上腺,Masculino,男性,0,0,,,,Adrenocortical carcinoma,,Cancer,,1,Adrenal Cortical Carcinoma,,Mono
0,1002,TP53,,Either,Esophageal Cancer,,,Cancer,Esophagus,0,,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Esophageal cancer,,Cancer,1,1,Esophageal Cancer,,Mono
0,1003,TP53,,Either,Skin Cancer (Non-Melanoma),Squamous Cell Carcinoma,,Cancer,Skin,9,Ambry Only,,,,,,,,,,,,1,,,,,,,1,Low,,1,,,Masculino,男性,0,0,,,,Squamous cell carcinoma,,Cancer,1,1,Skin Cancer,,Mono
0,1005,APC,,Either,Cardiovascular (Benign),Bicuspid Aortic Valve,,Benign,Heart,0,Ambry Only-Not in paper,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Bicuspid Aortic Valve,,Benign Disease,,1,Bicuspid Aortic Valve,,Mono
0,1007,APC,,Either,Facial Palsy,,,Benign,Nerve,0,Ambry Only-Not in paper,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Facial Palsy,,Benign Disease,,1,Facial Palsy,,Mono
0,1010,APC,,Either,Skin (Benign),Pilomatrixoma,,Benign,Skin,9,NLP-OMIM only,,,,,,,,,1,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Pilomatrixoma,,Neoplasm,,1,Skin (Benign),,Mono
0,1015,PTCSC2,,Either,Brain Tumor,Glioblastoma Multiforme,,Cancer,Brain,9,,,,,,,,,,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Brain Tumor,Malignant glioma,Cancer,,,Brain Tumor,,Mono
0,1015,PTCSC3,,Either,Brain Tumor,Glioma,,Cancer,Brain,9,,,,,,,,,,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Brain Tumor,Malignant glioma,Cancer,,,Brain Tumor,,Mono
0,1015,ATM,,Either,Brain Tumor,Glioblastoma Multiforme,,Cancer,Brain,0,,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Brain Tumor,Malignant glioma,Cancer,1,1,Brain Tumor,,Mono
0,1018,ATM,,Either,Lung Cancer,NSCLC,,Cancer,Lung,0,,,,,,,,,1,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Lung cancer,NSCLC,Cancer,1,1,Lung Cancer,,Mono
1,1020,ATM,,Female,Ovarian Cancer,,,Cancer,Ovary,1,"PMID: 33509806
NCCN :Evidence insufficient, (limited by lee21018GenIn), 30128536, 15928302, 28888541 ( over 2 times RR n referance paper)",,,Limited,9,9,9,9,1,,,,1,,,,,,,,,,1,,,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,1,1,Ovarian Cancer,,Mono
1,1021,ATM,,Female,Endometrial Cancer,,,Cancer,Uterus,0,"Ambry Only, 15928302, PMID:33509806",,,,,,,,,,,,1,,,,,,,,,,1,,,Femenino,女性,0,0,,,,Uterine Carcinoma,,Cancer,1,1,Endometrial Cancer,,Mono
0,1029,AXIN2,,Either,Teeth (Benign),Oligodontia,oligodontia-cancer predisposition syndrome,Benign,Head and neck,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Moderate,1,1,,1,1,1,1,1,1,,,,,,1,,,,1,,,Masculino,男性,0,0,,,,Oligodontia,,Benign Disease,,,Oligodontia,,Mono
0,1034,BAP1,,Either,Hepatobiliary Cancer,Cholangiocarcinoma,,Cancer,Bile Duct,9?,"inconsistent, evidence for their inclusion in the spectrum of BAP1-TPDS malignancies",,,Mentioned,9,,2,,1,2,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Cholangiocarcinoma,,Cancer,,,Hepatobiliary Cancer,,Mono
0,1036,BAP1,,Either,Neuroendocrine,,,Neoplasm,Neuroendocrine,9,"inconsistent, evidence for their inclusion in the spectrum of BAP1-TPDS malignancies",,,Mentioned,9,,,,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,,,Neuroendocrine,,Mono
0,1036,BAP1,,Either,Thyroid Cancer,,,Cancer,Thyroid,0,"inconsistent, evidence for their inclusion in the spectrum of BAP1-TPDS malignancies",,,Mentioned,9,,,,,,,,1,,,,,,,,,,1,tiroides,甲状腺,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,,,Thyroid Cancer,,Mono
0,1039,BAP1,,Either,Melanoma,Uveal Melanoma,,Cancer,Eye,1,Clingen: prevalence of germline mutations in individuals with BAP1 associated cancers include: uveal melanoma (1-3%),,,Mentioned,1,1,1,,1,1,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Uveal melanoma,,Cancer,,,Melanoma,,Mono
0,1043,BARD1,,Either,Lung Cancer,,,Cancer,Lung,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Lung cancer,,Cancer,1,,Lung Cancer,,Mono
0,1045,BARD1,,Either,Psychiatric,Schizophrenia,,Benign,CNS,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Schizophrenia,,Benign Disease,1,,Schizophrenia,,Mono
0,1046,BARD1,,Either,Cardiovascular (Benign),Tetralogy Of Fallot,,Benign,Heart,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Tetralogy of Fallot,,Benign Disease,1,,Tetralogy Of Fallot,,Mono
0,1048,BMPR1A,,Either,Cardiovascular (Benign),Atrioventricular Septum Defect,,Benign,Heart,0,Ambry Only-Not in paper,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Atrioventricular Septum Defect,,Benign Disease,,1,Atrioventricular Septum Defect,,Mono
0,1050,BMPR1A,,Either,Dysmorphic Feature,Facial Dysmorphism,,Benign,Face,0,Ambry Only-Not in paper,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Facial Dysmorphism,,Benign Disease,,1,Facial Dysmorphism,,Mono
0,1052,BMPR1A,,Either,Colorectal Neoplasia,Juvenile Polyps,,Neoplasm,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Juvenile polyps,,Neoplasm,,1,Juvenile Polyps,,Mono
0,1054,BMPR1A,,Either,Cardiovascular (Benign),Tetralogy Of Fallot,,Benign,Heart,0,Ambry Only-Not in paper,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Tetralogy of Fallot,,Benign Disease,,1,Tetralogy Of Fallot,,Mono
0,1056,BRCA1,,Either,Colorectal Cancer,,,Cancer,Colorectal,0,PMID: 30380096,,,,,,,,1,,,,1,,,,,,,,,,1,colorrectal,结直肠,Masculino,男性,0,0,,,,Colorectal cancer,,Cancer,1,,Colorectal Cancer,,Mono
0,1064,BRCA1,,Either,Gastric Cancer,,,Cancer,Gastric,9,NCCN says maybe PMID:12237282; 28024868,,,,,9,,9,,,,,1,,,,,,,,,,1,gástrico,胃,Masculino,男性,0,0,,,,Gastric cancer,,Cancer,1,,Gastric Cancer,,Mono
0,1065,BRCA1,,Either,Brain Tumor,Medulloblastoma,,Cancer,Brain,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Medulloblastoma,,Cancer,1,,Brain Tumor,,Mono
0,1068,BRCA1,,Either,Peripheral Nervous System Cancer,Neuroblastoma,,Cancer,PNS,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Neuroblastoma,,Cancer,1,,Neuroblastoma,,Mono
0,1069,BRCA1,,Either,Kidney Cancer,,,Cancer,Kidney,0,"Ambry Only PMID: 27306910, 21751003",,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Renal Cell Carcinoma,,Cancer,1,,Kidney Cancer,,Mono
0,1072,BRCA1,,Either,Thyroid Cancer,,,Cancer,Thyroid,0,"Ambry Only PMID: 27306910 , 23910109",,,,,,,,,,,,1,,,,,,,,,,1,tiroides,甲状腺,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,1,,Thyroid Cancer,,Mono
0,1075,BRCA2,,Either,Psychiatric,Autism,,Benign,CNS,0,Ambry Only PMID:26580448,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Autism,,Benign Disease,1,,Autism,,Biallelic
0,1076,BRCA2,,Either,Bladder Cancer,,,Cancer,Urinary Bladder,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Bladder cancer,,Cancer,1,,Bladder Cancer,,Mono
0,1078,BRCA2,,Either,Brain Tumor,Medulloblastoma,,Cancer,Brain,0,"PMID:29753700, 26740091, 22044372",,,,,,,,,1,,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Brain Tumor,,Cancer,1,,Brain Tumor,,Mono
0,1078,BRCA2,,Either,Brain Tumor,Glioma,,Cancer,Brain,0,"PMID:29753700, 26740091, 22044372",,,,,,,,1,1,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Brain Tumor,,Cancer,1,,Brain Tumor,,Mono
0,1080,BRCA2,,Either,Colorectal Cancer,,,Cancer,Colorectal,9,"Ambry Only PMID:25195694, 27978560, 28135145",,,,,,,,,,,,1,,,,,,,,,,1,colorrectal,结直肠,Masculino,男性,0,0,,,,Colorectal cancer,,Cancer,1,,Colorectal Cancer,,Mono
0,1082,BRCA2,,Either,Sarcoma,Ewing Sarcoma,,Cancer,Bone,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Ewing Sarcoma,,Cancer,1,,Sarcoma (Bone),,Mono
0,1089,BRCA2,,Either,Hepatobiliary Cancer,Hepatocellular Cancer,,Cancer,Liver,0,Ambry Only PMID:8840963,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Liver,,Cancer,1,,Hepatocellular Cancer,,Mono
0,1091,BRCA2,,Either,Esophageal Cancer,,,Cancer,Esophagus,9,"Ambry Only PMID:22126563, 19473207",,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Esophageal cancer,,Cancer,1,,Esophageal Cancer,,Mono
0,1093,BRCA2,,Either,Wilms Tumor,Nephroblastoma,,Cancer,Kidney,9,seems to be biallitic but papers are'nt clear PMID:20589654,,,,,,,,1,1,,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Wilms Tumor,,Cancer,1,,Wilms Tumor,,Mono
1,1094,BRIP1,,Female,Cervical Cancer,,,Cancer,Cervix,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Femenino,女性,0,0,,,,Cervical cancer,,Cancer,,,Cervical Cancer,,Mono
0,1097,BRIP1,,Either,Gastric Cancer,,,Cancer,Gastric,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,gástrico,胃,Masculino,男性,0,0,,,,Gastric cancer,,Cancer,,,Gastric Cancer,,Mono
1,1101,BRIP1,,Male,Prostate Cancer,,,Cancer,Prostate,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,,,,,1,,,,,,,,,,1,próstata,前列腺,Masculino,男性,0,0,,,,Prostate cancer,,Cancer,,,Prostate Cancer,,Mono
0,1103,CDH1,,Either,Bladder Cancer,,,Cancer,Urinary Bladder,0,Ambry Only-Not in paper,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Bladder cancer,,Cancer,1,,Bladder Cancer,,Mono
1,1104,CDH1,,Female,Endometrial Cancer,,,Cancer,Uterus,0,,,,,,,,,2,1,2,1,1,,,,,,,,,,1,,,Femenino,女性,0,0,,,,Endometrial cancer,,Cancer,1,,Endometrial Cancer,,Mono
0,1106,CDH1,,Either,Nasopharyngeal Cancer,,,Cancer,Head and neck,0,Ambry Only-Not in paper,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Nasopharyngeal Cancer,,Cancer,1,,Nasopharyngeal Cancer,,Mono
1,1107,CDH1,,Female,Ovarian Cancer,,,Cancer,Ovary,0,Clingen -No reported evidence,,,No Reported Evidence,0,,,,1,2,2,2,1,,,,,,,,,,1,ovario,卵巢,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,1,,Ovarian Cancer,,Mono
1,1108,CDH1,,Male,Prostate Cancer,,,Cancer,Prostate,0,Somatic,,,,,,,,2,2,2,1,1,,,,,,,,,,1,próstata,前列腺,Masculino,男性,0,0,,,,Prostate cancer,,Cancer,1,,Prostate Cancer,,Mono
0,1109,CDH1,,Either,Thyroid Cancer,,,Cancer,Thyroid,0,Ambry Only-Not in paper,,,,,,,,,,,,1,,,,,,,,,,1,tiroides,甲状腺,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,1,,Thyroid Cancer,,Mono
1,1111,CDK4,,Female,Breast Cancer,,,Cancer,Breast,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Femenino,女性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
0,1112,CDK4,,Either,Sarcoma,Liposarcoma,,Cancer,Skin,0,,,,,,,,,,,1,,1,,,,,,,,,,,melanoma,黑色素瘤,Masculino,男性,,,,,,Liposarcoma,,Cancer,,,Sarcoma,,Mono
0,1114,CDK4,,Either,Lung Cancer,,,Cancer,Lung,0,,,,,,,,,,,1,,1,,,,,,,,,,,melanoma,黑色素瘤,Masculino,男性,,,,,,Lung cancer,,Cancer,,,Lung Cancer,,Mono
1,1116,CDK4,,Female,Ovarian Cancer,,,Cancer,Ovary,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,ovario,卵巢,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,,,Ovarian Cancer,,Mono
0,1118,CDK4,,Either,Head And Neck Cancer,Squamous Cell Carcinoma,,Cancer,Skin,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Squamous cell carcinoma of the Head and Neck,,Cancer,,,Head And Neck Cancer,,Mono
0,1120,CDKN2A,,Either,Leukemia,ALL,,Cancer,Blood,0,,,,,,,,,,,,,1,,,,,,,,,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,ALL,Cancer,,,Leukemia,,Mono
0,1121,CDKN2A,,Either,Lung Cancer,,,Cancer,Lung,0,,,,,,,,,1,,,,1,,,,,,,1,Low,,,pulmonar,肺,Masculino,男性,0,0,,,,Lung cancer,,Cancer,,,Lung Cancer,,Mono
0,1123,CDKN2A,,Either,Esophageal Cancer,,,Cancer,Esophagus,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Esophageal cancer,,Cancer,,,Esophageal Cancer,,Mono
0,1125,CDKN2A,,Either,Orolaryngeal Carcinoma,,,Cancer,Head and neck,0,Ambry Only,,,,,,,,,1,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Orolaryngeal Carcinoma,,Cancer,,,Orolaryngeal Carcinoma,,Mono
0,1127,CDKN2A,,Either,Kidney Cancer,,,Cancer,Kidney,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Renal Carcinoma,,Cancer,,,Kidney Cancer,,Mono
0,1130,CDKN2A,,Either,Melanoma,,,Cancer,Skin,1,,,,,,1,,1,,1,,,1,,,,,,,1,Low,,1,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,Squamous cell carcinoma,,Cancer,,,Melanoma,,Mono
0,1130,CDKN2A,,Either,Pancreatic Cancer,Pancreatic Adenocarcinoma,,Cancer,Pancreas,1,,,,,,1,1,1,,1,,,1,,,,,,,1,Low,,,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,Squamous cell carcinoma,,Cancer,,,Pancreatic adenocarcinoma,,Mono
0,1130,CDKN2A,,Either,Skin Cancer (Non-Melanoma),Squamous Cell Carcinoma,,Cancer,Skin,9,,,,,,,,,,,,,1,,,,,,,1,Low,,1,carcinoma sebáceo,皮脂腺癌,Masculino,男性,0,0,,,,Squamous cell carcinoma,,Cancer,,,Squamous Cell Carcinoma,,Mono
1,1131,CDKN2A,p16,Female,Breast Cancer,,,Cancer,Breast,9,,,,,,,,,1,,,,1,,,,,,,,,,1,mama,乳腺,Femenino,女性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
0,1132,CDKN2A,p16,Either,Head And Neck Cancer,Squamous Cell Carcinoma,,Cancer,Skin,9,,,,,,,,,1,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Head and neck squamous cell carcinomas,,Cancer,,,Head And Neck Cancer,,Mono
0,1149,EPCAM,,Either,Adrenal Cortical Carcinoma,,,Cancer,Adrenal,9,PMID: 24423978 ( Paper doesnot  mention EPCAM),,,,,,,,,,,,1,,,,,,,1,Low,,,suprarrenal,肾上腺,Masculino,男性,0,0,,,,Adrenocortical carcinoma,,Cancer,,1,Adrenal Cortical Carcinoma,,Mono
1,1151,EPCAM,,Female,Breast Cancer,,,Cancer,Breast,0,,,,Disputed,0,,Insufficient,Insufficient,,,,,1,,,,,,,,,Unclear,1,,,Femenino,女性,0,0,,,,Breast cancer,,Cancer,,1,Breast Cancer,,Mono
1,1152,EPCAM,,Female,Cervical Cancer,,,Cancer,Cervix,0,Ambry only - not included in paper,,,,,,,,,,,,1,,,,,,,,,,1,,,Femenino,女性,0,0,,,,Cervical cancer,,Cancer,,1,Cervical Cancer,,Mono
0,1153,EPCAM,,Either,Gastrointestinal (Benign),Inflammatory Bowel Disease,,Benign,GI,0,Ambry only - not included in paper,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Inflammatory Bowel Disease,,Benign Disease,,1,Inflammatory Bowel Disease,,Mono
0,1156,EPCAM,,Either,Leukemia,ALL,,Cancer,Blood,0,Only Akras,,,,,,,,,,,,1,,,,,,,1,Mod,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,ALL/AML,Cancer,,1,Leukemia,,Mono
0,1157,EPCAM,,Either,Lymphoma,,,Cancer,Nodes,0,Ambry only - not included in paper,,,,,,,,,,,,1,,,,,,,1,Mod,,,linfoma,淋巴瘤,Masculino,男性,0,0,,,,Lymphoma,,Cancer,,1,Lymphoma,,Mono
0,1163,GREM1,,Either,Bone (Benign),Sclerosteosis,,Benign,Bone,,,,,,,,,,,,1,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Sclerosteosis,,Benign Disease,,1,Sclerosteosis,,Mono
0,1165,HOXB13,,Either,Bladder Cancer,,,Cancer,Urinary Bladder,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Bladder cancer,,Cancer,,,Bladder Cancer,,Mono
1,1167,HOXB13,,Female,Breast Cancer,,,Cancer,Breast,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Femenino,女性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
0,1168,HOXB13,,Either,Colorectal Cancer,,,Cancer,Colorectal,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,colorrectal,结直肠,Masculino,男性,0,0,,,,Colorectal cancer,,Cancer,,,Colorectal Cancer,,Mono
0,1170,HOXB13,,Either,Brain Tumor,Gioma,,Cancer,Brain,0,,,,,,,,,,,,,1,,,,,,,,,,,cerebro,脑,Masculino,男性,,0,,,,Spinal cord ependymoma,,Cancer,,,Brain Tumor,,Mono
0,1170,HOXB13,,Either,Brain Tumor,Ependymoma,,Cancer,Brain,9,,,,,,,,,,,1,,1,,,,,,,,,,,cerebro,脑,Masculino,男性,,0,,,,Spinal cord ependymoma,,Cancer,,,Brain Tumor,,Mono
0,1175,MEN1,,Either,Adrenal Cortical Carcinoma,,,Cancer,Adrenal,1,Clingen: penetrance adrenocortical tumor (40%),,,Mentioned,1,1,,1,,1,,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Adrenocortical carcinoma,,Cancer,,,Adrenal Cortical Carcinoma,,Mono
0,1176,MEN1,,Either,Nasopharyngeal Neoplasm,Angiofibroma,,Neoplasm,Head and neck,1,,,,Mentioned,1,1,,1,,1,,1,1,,,,,,,,,,2,,,Masculino,男性,0,0,,,,Angiofibroma,,Benign Disease,,,Angiofibroma,,Mono
0,1178,MEN1,,Either,Brain Tumor,Ependymoma,,Cancer,Brain,1,,,,Mentioned,1,,,,,,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Ependymoma,,Cancer,,,Brain Tumor,,Mono
0,1178,MEN1,,Either,Brain Tumor,Meningioma,,Neoplasm,Brain,1,,,,Mentioned,1,,,,,,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Ependymoma,,Cancer,,,Brain Tumor,,Mono
0,1184,MEN1,,Either,Lipoma,,,Benign,Lipid,1,,,,Mentioned,1,1,,1,,1,,1,1,,,,,,,,,,2,,,Masculino,男性,0,0,,,,Lipoma,,Neoplasm,,,Lipoma,,Mono
0,1189,MEN1,,Either,Pheochromocytoma/Paraganglioma,Pheochromocytoma,,Neoplasm,Adrenal,1,,,,Moderate,1,,,,,,,1,1,,,,,,,1,Low,,,,,Masculino,男性,0,0,,,,Paraganglioma,,Neoplasm,,,Neuroendocrine,,Mono
0,1189,MEN1,,Either,Pheochromocytoma/Paraganglioma,Paraganglioma,,Neoplasm,Nerve,1,,,,Moderate,1,,,,,,,,1,,,,,,,1,Low,,,,,Masculino,男性,0,0,,,,Paraganglioma,,Neoplasm,,,Neuroendocrine,,Mono
0,1193,MEN1,,Either,Thyroid Cancer,,,Cancer,Thyroid,0,,,,,,,,,,1,,1,1,,,,,,,,,,1,tiroides,甲状腺,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,,,Thyroid Cancer,,Mono
0,1194,MLH1,,Either,Adrenal Cortical Carcinoma,,,Cancer,Adrenal,1,"PMID: 30963136, PMID: 23752102",,,,,,,,,,,,1,,,,,,,1,Low,,,suprarrenal,肾上腺,Masculino,男性,0,0,,,,Adrenocortical carcinoma,,Cancer,,1,Adrenal Cortical Carcinoma,,Mono
1,1196,MLH1,,Female,Breast Cancer,,,Cancer,Breast,0,NCCN insignificant risk (Breast paper),,,Disputed,0,9,9,9,,1,,,1,,,,,,,,,Unclear,1,,,Femenino,女性,0,0,,,,Breast cancer,,Cancer,,1,Breast Cancer,,Mono
0,1201,MSH2,,Either,Adrenal Cortical Carcinoma,,,Cancer,Adrenal,1,"PMID: 30963136, PMID: 23752102,PMID: 27144940",,,,,,,,,,,,1,,,,,,,1,Low,,1,suprarrenal,肾上腺,Masculino,男性,0,0,,,,Adrenocortical carcinoma,,Cancer,,1,Adrenal Cortical Carcinoma,,Mono
1,1203,MSH2,,Female,Breast Cancer,,,Cancer,Breast,0,NCCN insignificant risk (Breast paper),,,Disputed,0,9,9,9,,1,,,1,,,,,,,,,Unclear,1,,,Femenino,女性,0,0,,,,Breast cancer,,Cancer,,1,Breast Cancer,,Mono
0,1205,MSH2-Biallelic,,Either,Leukemia,ALL,,Cancer,Blood,,,,,,,,,,,1,,,,,,,,,,1,,,1,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,ALL/AML,Cancer,,,Leukemia,,Mono
0,1209,MSH2,,Either,Thyroid Cancer,,,Cancer,Thyroid,0,Ambry Only- not incuded in paper,,,,,,,,,,,,1,,,,,,,,,,1,tiroides,甲状腺,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,,1,Thyroid Cancer,,Mono
1,1210,MSH6,,Female,Breast Cancer,,,Cancer,Breast,0,NCCN insignificant risk (Breast paper),,,Disputed,0,9,9,9,,,,,1,,,,,,,,,Unclear,1,,,Femenino,女性,0,0,,,,Breast cancer,,Cancer,,1,Breast Cancer,,Mono
0,1218,MSH6,,Either,Thyroid Cancer,,,Cancer,Thyroid,0,Ambry Only- not incuded in paper,,,,,,,,,,,,1,,,,,,,,,,1,tiroides,甲状腺,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,,1,Thyroid Cancer,,Mono
0,1229,MUTYH-Biallelic,,Either,Small Intestine Cancer,,,Cancer,Small Bowel,9,Akras only,,,,,,,,,,,,1,,,,,,,1,Low,,,intestino delgado,小肠,Masculino,男性,0,0,,,,Small Intestine,,Cancer,,1,Small Intestine Cancer,,Mono
0,1231,MUTYH-Biallelic,,Either,Thyroid Cancer,,,Cancer,Thyroid,9,Clingen:Annual thyroid screening by ultrasound should be recommended in all polyposis. An increased risk for thyroid cancer to individuals with MAP has not been demonstrated.,,,Mentioned,9,,,,,,,,1,,,,,,,1,Low,,,tiroides,甲状腺,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,,1,Thyroid Cancer,,Mono
0,1234,NBN,,Either,Bladder Cancer,,,Cancer,Urinary Bladder,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Bladder cancer,,Cancer,1,,Bladder Cancer,,Mono
0,1236,NBN,,Either,Hepatobiliary Cancer,Hepatocellular Cancer,,Cancer,Liver,9,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Hepatic Cancer,,Cancer,1,,Hepatocellular Cancer,,Mono
0,1239,NBN,,Either,Leukemia,ALL,,Cancer,Blood,9,PMID: 16810201,,,,,,,,,1,,1,1,,,,,,,1,Low,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,ALL,Cancer,1,,Leukemia,,Mono
0,1241,NBN,,Either,Lung Cancer,,,Cancer,Lung,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Lung Cancer,,Cancer,1,,Lung Cancer,,Mono
0,1243,NBN,,Either,Brain Tumor,Medulloblastoma,,Cancer,Brain,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Medulloblastoma,,Benign Disease,1,,Brain Tumor,,Mono
0,1245,NBN,,Either,Melanoma,,,Cancer,Skin,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Melanoma,,Benign Disease,1,,Melanoma,,Mono
0,1248,NBN,,Either,Nasopharyngeal Cancer,,,Cancer,Head and neck,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Nasopharyngeal Cancer,,Cancer,1,,Nasopharyngeal Cancer,,Mono
0,1250,NKX2-1,,Either,Developmental,Intellectual Disability,,Benign,CNS,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,Ask2Me,,,Autism,,Benign Disease,,,Learning Dysability,,Mono
0,1250,NF1,,Either,Developmental,Intellectual Disability,,Benign,CNS,1,,,,Mentioned,1,,,,,1,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,Ask2Me,,,Autism,,Benign Disease,1,,Learning Dysability,,Mono
0,1252,NF1,,Either,Skin (Benign),Cafe-Au-Lait Spots,,Benign,Skin,1,,,,Mentioned,1,,,,,1,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Cafe-Au-Lait Spots,,Benign Disease,1,,Cafe-Au-Lait Spots,,Mono
0,1255,NF1,,Either,Melanoma,,,Cancer,Skin,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Melanoma,,Benign Disease,1,,Melanoma,,Mono
0,1257,NKX2-1,,Either,Cardiovascular (Benign),Congenital septal defects,,Benign,Heart,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Ventricular Septal Defect,,Cancer,,,Congenital septal defects,,Mono
0,1257,NF1,,Either,Cardiovascular (Benign),Pulmonary Stenosis,,Benign,Heart,1,,,,,,,,,,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Ventricular Septal Defect,,Cancer,1,,Pulmonary Stenosis,,Mono
0,1258,PALB2,,Either,Colorectal Cancer,,,Cancer,Colorectal,9,,,,Limited,9,9,9,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Colorectal cancer,,Cancer,1,,Colorectal Cancer,,Mono
0,1262,PALB2,,Either,Melanoma,,,Cancer,Skin,0,,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Melanoma,,Cancer,1,,Melanoma,,Mono
0,1264,PALB2,,Either,Peripheral Nervous System Cancer,Neuroblastoma,,Cancer,PNS,0,,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Neuroblastoma,,Cancer,1,,Neuroblastoma,,Mono
0,1267,PALB2,,Either,Ovarian Cancer,,,Cancer,Ovary,0,,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Peritoneal Cancer,,Cancer,1,,Primary Peritoneal Cancer,,Mono
0,1269,PALB2,,Either,Lipoma,,,Benign,Lipid,0,,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Subcutaneous Lipomatosis,,Benign Disease,1,,Lipoma,,Mono
0,1270,PALB2,,Either,Gastrointestinal (Benign),Tracheoesophageal Fistula ,,Benign,Mediastinum,0,,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Tracheoesophageal fistula ,,Benign Disease,1,,Tracheoesophageal Fistula ,,Mono
1,1272,PALB2,,Female,Endometrial Cancer,,,Cancer,Uterus,0,,,,,,,,,,,,,1,,,,,,,,,,1,,,Femenino,女性,0,0,,,,Uterine Carcinoma,,Cancer,1,,Endometrial Cancer,,Mono
0,1274,PMS2,,Either,Adrenal Cortical Carcinoma,,,Cancer,Adrenal,9,NCCN: Not enough evidence  PMID: 30963136( Paper doesnot  mention PMS2),,,,,,,,,,,,1,,,,,,,1,Low,,,suprarrenal,肾上腺,Masculino,男性,0,0,,,,Adrenocortical carcinoma,,Cancer,,1,Adrenal Cortical Carcinoma,,Mono
0,1275,HABP2,,Either,Hair (Benign),Alopecia Mucinosa,,Benign,Hair,0,,,,,,,,,,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Alopecia areata,,Benign Disease,,,Alopecia Mucinosa,,Mono
0,1275,PMS2,,Either,Hair (Benign),Alopecia Areata,,Benign,Hair,0,GHR only we found no data,,,,,,,,1,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Alopecia areata,,Benign Disease,,1,Alopecia Areata,,Mono
1,1277,PMS2,,Female,Breast Cancer,,,Cancer,Breast,0,NCCN insignificant risk (Breast paper),,,Disputed,0,9,9,9,,,,,1,,,,,,,,,Unclear,1,,,Femenino,女性,0,0,,,,Breast cancer,,Cancer,,1,Breast Cancer,,Mono
0,1288,POLD1,,Either,Brain Tumor,Glioblastoma Multiforme,,Cancer,Brain,9,Clingen:Evidence on these associations is still limited,,,Mentioned,9,,,,,,,,1,,,,,,,1,Mod,,,,,Masculino,男性,0,0,,,,Brain Tumor,glioblastoma multiforme,Cancer,,1,Brain Tumor,,Mono
1,1290,POLD1,,Female,Breast Cancer,,,Cancer,Breast,0,,,,,,,,,,,1,,1,,,,,,,,,,,,,Femenino,女性,0,0,,,,Breast cancer,,Cancer,,1,Breast Cancer,,Mono
1,1293,POLD1,,Female,Endometrial Cancer,,,Cancer,Uterus,1,Clingen:Evidence on these associations is still limited,,,Mentioned,9,,,,,1,,,1,,,,,,1,,,,1,,,Femenino,女性,0,0,,,,Endometrial cancer,,Cancer,,1,Endometrial Cancer,,Mono
0,1296,POLD1,,Either,Pancreatic Cancer,,,Cancer,Pancreas,9,Clingen:Evidence on these associations is still limited,,,Mentioned,9,,,,,,,,1,,,,,,,1,Low,,1,páncreas,胰腺,Masculino,男性,0,0,,,,Pancreatic cancer,,Cancer,,1,Pancreatic Cancer,,Mono
1,1306,POLE,,Female,Breast Cancer,,,Cancer,Breast,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Femenino,女性,0,0,,,,Breast cancer,,Cancer,,1,Breast Cancer,,Mono
0,1313,POLE,,Either,Myopathy,Nemaline Myopathy ,,Benign,Muscle,0,,,,,,,,,,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Nemaline myopathy ,,Benign Disease,,1,Myopathy,,Mono
1,1315,POLE,,Female,Ovarian Cancer,,,Cancer,Ovary,9,,,,Mentioned,9,,,,,,,,1,,,,,,,,,,1,,,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,,1,Ovarian Cancer,,Mono
0,1318,PTEN,,Either,Brain Tumor,Meningioma,,Neoplasm,Brain,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Brain Tumor,Astrocytoma/Glioma,Cancer,1,1,Brain Tumor,,Mono
0,1318,PTEN,,Either,Brain Tumor,,,Cancer,Brain,1,,,,Mentioned,1,,,,2,,,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Brain Tumor,Astrocytoma/Glioma,Cancer,1,1,Brain Tumor,,Mono
0,1321,PTEN,,Either,Head And Neck Cancer,Squamous Cell Carcinoma,,Cancer,Skin,9,,,,,,,,,1,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Head and neck squamous cell carcinomas,,Cancer,1,1,Head And Neck Cancer,,Mono
0,1323,PTEN,,Either,Lung Cancer,,,Cancer,Lung,9,,,,,,,,,1,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Lung cancer,,Cancer,1,1,Lung Cancer,,Mono
1,1325,PTEN,,Male,Genitourinary (Benign),"Hydrocele
- Varicocele",,Benign,Genitals,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Pigmentation of glans penis,,Benign Disease,1,1,Genitourinary,,Mono
1,1325,PTEN,,Female,Genitourinary (Benign),"Vaginal cysts
- Vulvar cysts
- Ovarian cysts
- Leiomyomas",,Benign,Genitals,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Pigmentation of glans penis,,Benign Disease,1,1,Genitourinary,,Mono
1,1325,PTEN,,Male,Skin (Benign),Macular Pigmentation Of Glans Penis,,Benign,Genitals,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,,1,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Pigmentation of glans penis,,Benign Disease,1,1,Skin (Benign),,Mono
1,1326,PTEN,,Male,Prostate Cancer,,,Cancer,Prostate,9,,,,,,,,,1,2,,1,1,,,,,,,,,,,próstata,前列腺,Masculino,男性,0,0,,,,Prostate cancer,,Cancer,1,1,Prostate Cancer,,Mono
0,1328,PTEN,,Either,Skin Cancer (Non-Melanoma),Squamous Cell Carcinoma,,Cancer,Skin,9,,,,,,,,,,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Squamous cell carcinoma,,Cancer,1,1,Squamous Cell Carcinoma,,Mono
1,1329,RAD50,,Female,Ovarian (Benign),Polycystic Ovary Disease,,Benign,Ovary,9,,,,,,,,,1,,,,1,,,,,,,,,,,,,Femenino,女性,0,0,,,,Polycystic ovary disease,,Benign Disease,,,Polycystic Ovary Disease,,Mono
1,1330,RAD50,,Male,Prostate Cancer,,,Cancer,Prostate,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,próstata,前列腺,Masculino,男性,0,0,,,,Prostate cancer,,Cancer,,,Prostate Cancer,,Mono
0,1331,RAD51C,,Either,Colorectal Cancer,,,Cancer,Colorectal,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Colorectal cancer,,Cancer,,,Colorectal Cancer,,Mono
0,1335,RAD51C,,Either,Head And Neck Cancer,Squamous Cell Carcinoma,,Cancer,Skin,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Head and neck squamous cell carcinomas,,Cancer,,,Head And Neck Cancer,,Mono
0,1340,RAD51C,,Either,Gastrointestinal (Benign),Tracheoesophageal Fistula ,,Benign,Mediastinum,0,,,,,,,,,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Tracheoesophageal fistula ,,Benign Disease,,,Tracheoesophageal Fistula ,,Mono
0,1345,RB1,,Either,Head And Neck Cancer,,,Cancer,Head and neck,9,Ambry Only,,,,,,,,,,,,,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Head and Neck Cancer,,Cancer,,,Head And Neck Cancer,,Mono
0,1348,RB1,,Either,Sarcoma,Adamantinoma,,Cancer,Bone,,,,,,,,,,,,1,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Adamantinoma of long bones,,Cancer,,,Sarcoma (Bone),,Mono
0,1349,RB1,,Either,Bladder Cancer,,,Cancer,Urinary Bladder,,,,,,,,,,1,1,1,1,,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Bladder cancer,,Cancer,,,Bladder Cancer,,Mono
1,1351,RB1,,Female,Breast Cancer,,,Cancer,Breast,,,,,,,,,,1,,,,,,,,,,,,,,,,,Femenino,女性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
0,1353,RB1,,Either,Lung Cancer,,,Cancer,Lung,,,,,,,,,,1,1,1,1,,,,,,,,,,,2,,,Masculino,男性,0,0,,,,Lung cancer,,Cancer,,,Lung Cancer,,Mono
1,1354,RB1,,Female,Ovarian Cancer,,,Cancer,Ovary,9,Ambry Only,,,,,,,,,,,,,,,,,,,,,,1,,,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,,,Ovarian Cancer,,Mono
0,1356,SDHB,,Either,Adrenal Neoplasm,Adrenal Medulla Hyperplasia,,Neoplasm,Adrenal,0,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Bilateral Adrenal Medullary Hyperplasia,,Benign Disease,,,Adrenal Medulla Hyperplasia,,Mono
0,1361,SDHB,,Either,Kidney Cancer,Renal Cell Carcinoma,,Cancer,Kidney,9,,,,Mentioned,1,,,,1,1,,,1,,,,,,1,1,Low,,1,riñón,肾,Masculino,男性,0,0,,,,Renal Cell Carcinoma,renal cell carcinoma,Cancer,,,Kidney Cancer,,Mono
0,1365,SDHD,,Either,Skin Cancer (Non-Melanoma),Merkel Cell Carcinoma,,Cancer,Skin,0,,,,,,,,,,2,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Merkel Cell Carcinoma,,Cancer,,,Merkel Cell Carcinoma,,Mono
0,1370,SMAD4,,Either,Blood Vessel (Benign),Aortic Dilation,,Benign,Blood Vessel,1,"28874282, 25931195",,,,,,,,1,1,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Aortic dilation,,Benign Disease,,1,Aortic Dilation,,Mono
1,1371,SMAD4,,Female,Breast Cancer,,,Cancer,Breast,0,Ambry Only 21835029 - NOT included in paper,,,,,,,,,,,,1,,,,,,,,,,1,,,Femenino,女性,0,0,,,,Breast cancer,,Cancer,,1,Breast Cancer,,Mono
0,1372,SMAD4,,Either,Hepatobiliary Cancer,Cholangiocarcinoma,,Cancer,Bile Duct,9,Somatic mutation,,,,,,,,2,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Cholangiocarcinoma,,Cancer,,1,Hepatobiliary Cancer,,Mono
0,1377,SMAD4,,Either,Colorectal Neoplasia,Juvenile Polyps,,Neoplasm,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,,1,1,1,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Juvenile polyps,,Neoplasm,,1,Juvenile Polyps,,Mono
0,1378,SMAD4,,Either,Lung (Benign),Laryngotracheal Stenosis,,Benign,Lung,1,24424121,,,,,,,,,1,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Laryngotracheal Stenosis,,Benign Disease,,1,Laryngotracheal Stenosis,,Mono
0,1381,SMAD4,,Either,Psychiatric,Obsessive-Compulsive Disorder,,Benign,CNS,0,Ambry Only -Not included in paper,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Obsessive-Compulsive Disorder,,Benign Disease,,1,Obsessive-Compulsive Disorder,,Mono
0,1382,SMAD4,,Either,Bone (Benign),Prognathism,,Benign,Bone,1,24424121,,,,,,,,,1,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Prognathism,,Benign Disease,,1,Prognathism,,Mono
0,1385,SMAD4,,Either,Blood Vessel (Benign),Pulmonary Arterial Hypertension,,Benign,Blood Vessel,1,24442418,,,,,,,,,,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Pulmonary Arterial Hypertension,,Cancer,,1,Pulmonary Arterial Hypertension,,Mono
0,1386,TP53,,Either,Dysmorphic Feature,Short Stature,,Benign,Bone,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Short stature,,Benign Disease,1,1,Short Stature,,Mono
0,1386,SMAD4,,Either,Dysmorphic Feature,Short Stature,,Benign,Bone,1,24424121,,,,,,,,,1,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Short stature,,Benign Disease,,1,Short Stature,,Mono
0,1390,STK11,,Either,Melanoma,,,Cancer,Skin,0,Somatic,,,,,,,,2,2,1,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Melanoma,,Cancer,1,1,Melanoma,,Mono
0,1393,STK11,,Either,Kidney Cancer,Renal Cell Carcinoma,,Cancer,Kidney,0,Ambry Only - Not included in paper,,,,,,,,,,,,1,,,,,,,,,,1,riñón,肾,Masculino,男性,0,0,,,,Renal Cell Carcinoma,renal cell carcinoma,Cancer,1,1,Kidney Cancer,,Mono
1,1394,STK11,,Male,Testicular Neoplasm,Sertoli Cell Tumor,,Neoplasm,Testes,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,1,1,,2,1,1,1,,,,,,,1,Low,,1,,,Masculino,男性,0,0,,,,Testicular Tumor,,Cancer,1,1,Testicular Neoplasm,,Mono
0,1395,TP53,,Either,Skin Cancer (Non-Melanoma),Basal Cell Carcinoma,,Cancer,Skin,9,,,,,,,,,,1,,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Basal cell carcinoma,,Cancer,1,1,Skin Cancer (Non-Melanoma),,Mono
0,1397,TP53,,Either,Brain Tumor,Choroid Plexus Papilloma,,Cancer,Brain,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,,1,1,,1,1,,,1,,,,,,1,,,Masculino,男性,0,0,,,,Choroid Plexus Papilloma,,Cancer,1,1,Brain Tumor,,Mono
0,1401,TP53,,Either,Head And Neck Cancer,,,Cancer,Head and neck,0,,,,,,,,,1,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Head and neck cancer,,Cancer,1,1,Head And Neck Cancer,,Mono
0,1403,TP53,,Either,Hepatobiliary Cancer,Hepatocellular Cancer,,Cancer,Liver,1,Clingen: tumor-specific relative risks and 95% confidence intervals are:  liver: 18,,,Mentioned,1,,,,2,2,,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Hepatocellular Carcinoma,,Cancer,1,1,Hepatocellular Cancer,,Mono
0,1410,TP53,,Either,Brain Tumor,Medulloblastoma,,Cancer,Brain,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,,,,,1,,,,,,,1,Low,,,cerebro,脑,Masculino,男性,0,0,,,,Brain Tumor,Medulloblastoma,Cancer,1,1,Brain Tumor,,Mono
0,1412,TP53,,Either,Nasopharyngeal Cancer,,,Cancer,Head and neck,9,,,,,,,,,,2,,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Nasopharyngeal Cancer,,Cancer,1,1,Nasopharyngeal Cancer,,Mono
0,1415,TP53,,Either,Bladder Cancer,,,Cancer,Urinary Bladder,0,,,,,,,,,2,,,,1,,,,,,,1,Low,,,Vejiga urinaria,膀胱,Masculino,男性,0,0,,,,Urinary Bladder,,Cancer,1,1,Bladder Cancer,,Mono
1,1422,SDHB,,Female,Endometrial Cancer,,,Cancer,Uterus,0,,,,,,,,,1,,,,1,,,,,,,,,,,gástrico,胃,Femenino,女性,0,0,,256,,Endometrial cancer,,Cancer,,,Endometrial Cancer,,Mono
0,1424,TP53,,Either,Hepatobiliary Cancer,Cholangiocarcinoma,,Cancer,Bile Duct,0,,,,,,,,,2,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Cholangiocarcinoma,,Cancer,1,1,Bile Duct Cancer,,Mono
0,1426,CDC73,,Either,Wilms Tumor,Nephroblastoma,,Cancer,Kidney,1,,,,Mentioned,1,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Wilm's Tumor,,Cancer,1,1,Wilms Tumor,,Mono
0,1426,TP53,,Either,Wilms Tumor,Nephroblastoma,,Cancer,Kidney,9,Reference for 1?,,,,,,,,1,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Wilm's Tumor,,Cancer,1,1,Wilms Tumor,,Mono
0,1430,CASR,,Either,Endocrine Abnormalities,Hypocalciuric Hypercalcemia,,Benign,Endocrine,1,,,,,,,,,,1,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Hypocalciuric hypercalcemia,,Benign Disease,,,Hypocalciuric Hypercalcemia,,Mono
0,1430,SRGAP1,,Either,Endocrine Abnormalities,Familial Hypocalciuric Hypercalcemia,,Benign,Endocrine,9,,,,,,,,,,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Hypocalciuric hypercalcemia,,Benign Disease,,,Hypocalciuric Hypercalcemia,,Mono
0,1431,CDC73,,Either,Bone Neoplasm,Jaw Tumor,,Neoplasm,Bone,1,ClinGen is definitive or moderate while NCCN is mute.,,,Mentioned,1,,,,1,1,1,,1,,,,,,1,,,,1,,,Masculino,男性,0,0,,,,Jaw tumor,,Cancer,,,Jaw Lesions,,Mono
0,1433,CDC73,,Either,Parathyroid Neoplasm,Parathyroid Adenoma,,Neoplasm,Parathyroid,1,ClinGen is definitive or moderate while NCCN is mute.,,,Mentioned,1,,,,,1,1,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Parathyroid adenoma,,Cancer,,,Parathyroid Neoplasm,,Mono
0,1436,CDKN1B,,Either,Breast Cancer,,,Cancer,Breast,0,Somatic,,,,,,,,,,,,1,,,,,,1,,,,,,,Masculino,男性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
0,1438,CDKN1C,,Male,Genitourinary (Benign),"Cryptorchidism, Hypospadias",,Benign,Genitals,1,,,,,,,,,1,1,1,1,1,,,,,,1,,,,1,,,Masculino,男性,0,0,,,,Genital anomalies,,Benign Disease,,,Genital Anomalies,,Mono
1,1439,ABRAXAS1,,Female,Breast Cancer,,,Cancer,Breast,9,30786683,,,,,,,,,,1,,1,,,,,,1,,,,,,,Femenino,女性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
1,1440,FANCC,,Female,Breast Cancer,,,Cancer,Breast,,,,,,,,,,,,,,,,,,,,1,,,,1,,,Femenino,女性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
0,1441,FANCC,,Either,Pancreatic Cancer,,,Cancer,Pancreas,,,,,,,,,,,,,,,,,,,,1,,,,,páncreas,胰腺,Masculino,男性,0,0,,170,,Pancreatic cancer,,Cancer,,,Pancreatic Cancer,,Mono
0,1447,POLD1,,Either,Colorectal Neoplasia,Adenomatous Polyps,,Neoplasm,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,,1,,,,,,1,,,,1,colorrectal,结直肠,Masculino,男性,0,0,,310,,Adenomatous polyp,,Benign Disease,,1,Polyposis,,Mono
0,1449,POLE,,Either,Colorectal Neoplasia,Adenomatous Polyps,,Neoplasm,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,,1,,,,,,1,,,,1,colorrectal,结直肠,Masculino,男性,0,0,,310,,Adenomatous polyp,,Benign Disease,,1,Colorectal Polyp,,Mono
0,1455,VHL,,Male,Testicular Neoplasm,Epididymal Cystadenomas,,Neoplasm,Testes,1,epididymal cystadenomas in males=60%,,,Mentioned,1,,,,,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,211,,Paraganglioma,,Neoplasm,,,epididymal cystadenomas,,Mono
0,1455,VHL,,Either,Neuroendocrine,Neuroendocrine tumors,,Neoplasm,Neuroendocrine,,,,,Mentioned,1,,,,,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,211,,Paraganglioma,,Neoplasm,,,Neuroendocrine,,Mono
0,1455,VHL,,Either,Pancreas (Benign),Pancreatic Cysts,,Benign,Pancreas,1,Pancreatic lesions are found in ~60% of patients with 5-10% developing pancreatic tumors.,,,Mentioned,1,,,,,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,211,,Paraganglioma,,Neoplasm,,,Pancreatic Tumors,,Mono
0,1455,VHL,,Either,Pheochromocytoma/Paraganglioma,Paraganglioma,,Neoplasm,Nerve,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,,1,1,,,,,,,,,,,1,Low,,1,,,Masculino,男性,0,0,,211,,Paraganglioma,,Neoplasm,,,Neuroendocrine,,Mono
0,1457,APC,,Either,Colorectal Neoplasia,Colorectal Polyps,,Neoplasm,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,,,,,,,,,,1,,,,,,,,,,Colorectal Polyps,,Neoplasm,,1,Colorectal Polyp,,
0,1460,AXIN2,,Either,Colorectal Neoplasia,Adenomatous Polyps,,Neoplasm,Colorectal,1,,,,,,1,,1,,,,,1,,,,,,,,,,,,,,,,,,,,Adenomatous Polyp,,Neoplasm,,,Colorectal Polyp,,
0,1461,CASR,,Either,Endocrine Abnormalities,Neonatal Severe Hyperparathyroid,,Benign,Parathyroid,1,Biallelic,,,,,,,,1,1,1,1,1,,,,,,,,,,1,,,Masculino,男性,,,,,,Hyperparathyroid,,Benign Disease,,,Hyperparathyroid,,
0,1463,FH,,Either,Pheochromocytoma/Paraganglioma,Pheochromocytoma,,Neoplasm,Adrenal,1,ClinGenis definitive or moderate while NCCN is mute.,,,Moderate,1,,,,1,,1,,,,,,,,,,,,1,,,,,,,,,,Pheochromocytoma,,Neoplasm,,,Neuroendocrine,,
0,1464,FH,,Either,Pheochromocytoma/Paraganglioma,Paraganglioma,,Neoplasm,Nerve,1,ClinGenis definitive or moderate while NCCN is mute.,,,Moderate,1,,,,1,,1,,,,,,,,,,,,1,,,,,,,,,,Paraganglioma,,Neoplasm,,,Neuroendocrine,,
0,1467,GREM1,,Either,Colorectal Neoplasia,Adenomatous Polyps,,Neoplasm,Colorectal,1,ClinGen and NCCN,,,Strong,1,1,1,,1,1,1,,1,,,,,,,,,,,,,,,,,,,,Colorectal Polyps,Adenomatous polyps,Neoplasm,,1,Colorectal Polyp,,
0,1475,MET,,Either,Pheochromocytoma/Paraganglioma,Pheochromocytoma,,Neoplasm,Adrenal,9,-1,,,Limited,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pheochromocytoma,,Neoplasm,,,Neuroendocrine,,
0,1476,MET,,Either,Pheochromocytoma/Paraganglioma,Paraganglioma,,Neoplasm,Nerve,9,-1,,,Limited,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,Paraganglioma,,Neoplasm,,,Neuroendocrine,,
0,1483,MUTYH-Biallelic,,Either,Colorectal Neoplasia,Colorectal Polyps,,Neoplasm,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,,,,,,,,,,1,,,,,,,,,,Colorectal Polyps,,Neoplasm,,1,Colorectal Polyp,,
0,1485,MUTYH-Biallelic,,Either,Colorectal Cancer,,,Cancer,Colorectal,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Definitive,1,1,1,1,1,1,1,1,1,,,,,,,1,High,,1,,,,,,,,,,Colorectal Cancer,,Cancer,,1,Colorectal Cancer,,
0,1489,RUNX1,,Either,Blood (Benign),Platelet disorder,,Benign,Blood,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,1,1,1,1,,,,,,,1,,,,1,,,,,,,,,,Familial platelet disorder,,Benign Disease,,,Platelet disorder,,
0,1497,ETV6,,Either,Leukemia,ALL,,Cancer,Blood,,,,,,,,,,1,1,1,1,,,,,,,,1,Low,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,ALL,Cancer,,,Leukemia,,Mono
0,1499,EGLN1,,Either,Blood (Benign),Familial erythrocytosis,,Benign,Blood,,,,,,,,,,1,,,,1,,,,,,,,,,,,白血病,Masculino,男性,0,0,,,,Leukemia,MDS,Cancer,,,Leukemia,,Mono
0,1499,FANCC,,Either,Blood (Benign),Myelodysplasia,,Benign,Blood,,,,,,,,,,,,,,,,,,,,,1,High,,,leucemia,白血病,Masculino,男性,0,0,,,,Leukemia,MDS,Cancer,,,Leukemia,,Mono
0,1503,ATM,,Either,Melanoma,,,Cancer,Skin,9,PMID:33509806,,,,,,,,1,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,4,,Melanoma,,Cancer,1,1,Melanoma,,Mono
0,1505,BRIP1,,Either,Breast Cancer,,,Cancer,Breast,9,CLINGEN and NCCN disagree NCCN :Potential increase in female breast cancer with insufficient evdence for risk management (refuted by lee21018GenIn),,,Refuted,0,1,1,1,1,1,1,1,1,,,,,,,1,Low,,1,,,Masculino,男性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
0,1511,PTCSC2,,Either,Oropharynx (Benign),"Cleft palate
- Bifid epiglottis",,Benign,Oropharynx,9,,,,,,,,,,,1,,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,,,,,,Cleft palate,,Mono
0,1511,PTCSC2,,Either,Thyroid (Benign),Hypothyroid,,Benign,Thyroid,9,,,,,,,,,,,1,,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,,,,,,Hypothyroid,,Mono
0,1511,PTCSC1,,Either,Thyroid Cancer,Papillary Thyroid Cancer,,Cancer,Thyroid,9,PMID:19147577,,,,,,,,,,1,,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Thyroid Cancer,,Mono
0,1511,FOXE1,,Either,Thyroid Cancer,Non-Medullary  thyroid carcinoma,,Cancer,Thyroid,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Thyroid Cancer,,Mono
0,1511,PRKAR1A,,Either,Thyroid Cancer,,,Cancer,Thyroid,1,"PMID:30428497 ClinGen:prkar1a +/− mice exhibited extracardiac tumorigenesis, developed sarcomas and hepatocellular carcinomas as well as thyroid, adrenocortical and mesenchymal tumors, which sharing similar phenotypes to CNC patients",,,Mentioned,1,,,,,1,,,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Thyroid Cancer,,Mono
0,1511,PTCSC2,,Either,Thyroid Cancer,Papillary Thyroid Cancer,,Cancer,Thyroid,0,25303483,,,,,,,,,,1,,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Thyroid Cancer,,Mono
0,1511,PTCSC3,,Either,Thyroid Cancer,Papillary Thyroid Cancer,,Cancer,Thyroid,0,"23599737, 26274343",,,,,,,,,,1,2,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Thyroid Cancer,,Mono
0,1511,SRGAP1,,Either,Thyroid Cancer,,,Cancer,Thyroid,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Thyroid Cancer,,Mono
0,1511,NKX2-1,,Either,Thyroid Cancer,Non-Medullary  thyroid carcinoma,,Cancer,Thyroid,1,,,,,,,,,,1,1,1,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Thyroid Cancer,,Mono
0,1511,SEC23B,,Either,Thyroid Cancer,,,Cancer,Thyroid,1,26522472,,,,,,,,,1,1,,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,,,Cancer,,,Thyroid Cancer,,Mono
0,1511,PRKAR1A,,Either,Dysmorphic Feature,Short Stature,,Benign,Bone,9,,,,,,,,,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Short Stature,,Mono
0,1511,PRKAR1A,,Either,Ear (Benign),Hearing Loss,,Benign,Head and neck,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Hearing Loss,,Mono
0,1511,PRKAR1A,,Either,Eye (Benign),"Epicanthal folds
- Hypertelorism 
- Optic atrophy
- Strabismus
- Blue eyes (Japanese patients)
- Conjunctival and scleral pigmentation",,Benign,Eye,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Eye defects,,Mono
0,1511,PRKAR1A,,Either,Eye Neoplasm,Eyelid myxoma,,Benign,Eye,1,PMID:30428497,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Eyelid myxoma,,Mono
0,1511,PRKAR1A,,Either,Dysmorphic Feature,"Abnormal Facies, Hypoplastic maxilla 
- Prognathism Low nasal bridge 
- Broad, upturned nose
- Dimpled nasal tip",,Benign,Face,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Abnormal Facies,,Mono
0,1511,PRKAR1A,,Either,Teeth (Benign),"Malocclusion
- Delayed tooth eruption
- Hypodontia",,Benign,Head and neck,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Hypodontia,,Mono
0,1511,PRKAR1A,,Either,Bone (Benign),"Spinal canal stenosis
- Scoliosis
- Narrow interpediculate distances
- Small vertebrae",,Benign,Bone,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Spinal canal stenosis,,Mono
0,1511,PRKAR1A,,Either,Bone (Benign),"Short, broad hands
- Short metacarpals
- Short phalanges
- Cone-shaped epiphyses",,Benign,Hand,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Hand (Benign),,Mono
0,1511,PRKAR1A,,Either,Bone (Benign),"Large halluces
- Short metatarsals",,Benign,Bone,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Foot (Benign),,Mono
0,1511,PRKAR1A,,Either,Skin (Benign),"Nevi
- Ephelides
Centrofacial/mucosal -lentigines
- Blue nevi
- Thin skin
- Striae
- Easy bruising",,Benign,Skin,1,PMID:30428497,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Skin (Benign),,Mono
0,1511,PRKAR1A,,Either,Developmental,Intellectual Disability,,Benign,CNS,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Mental retardation,,Mono
0,1511,PRKAR1A,,Either,Brain Tumor,Pituitary Adenoma,,Neoplasm,Pituitary,1,PMID:30428497,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Pituitary Adenoma,,Mono
0,1511,PRKAR1A,,Either,Thyroid Neoplasm,Thyroid follicular hyperplasia,,Neoplasm,Thyroid,9,,,,,,,,,,1,,,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Thyroid Neoplasm,,Mono
0,1511,FOXE1,,Either,Thyroid (Benign),Goiter,,Benign,Thyroid,9,,,,,,,,,,1,,,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Goiter,,Mono
0,1511,SEC23B,,Either,Thyroid (Benign),Goiter,,Benign,Thyroid,9,,,,,,,,,,1,,,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,,,Cancer,,,Goiter,,Mono
0,1511,SEC23B,,Either,Thyroid (Benign),Hashimoto thyroiditis,,Cancer,Thyroid,9,,,,,,,,,,1,,,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,,,Cancer,,,Hashimoto thyroiditis,,Mono
0,1511,PRKAR1A,,Either,Skin (Benign),Lentigines,,Benign,Skin,1,PMID:30428497,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Skin (Benign),,Mono
0,1511,PRKAR1A,,Either,Skin (Benign),Ephelides,,Benign,Skin,1,PMID:30428497,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Skin (Benign),,Mono
0,1511,SEC23B,,Either,Dysmorphic Feature,Macrocephaly,,Benign,Head and neck,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,,,Cancer,,,Macrocephaly,,Mono
0,1511,SEC23B,,Either,Oropharynx (Benign),Papillomatous papules,,Benign,Oropharynx,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,,,Cancer,,,Oral (Benign),,Mono
0,1511,SEC23B,,Either,Breast (Benign),Breast fibroadenoma,,Benign,Breast,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,,,Cancer,,,Breast (Benign),,Mono
0,1511,SEC23B,,Either,Blood Vessel (Benign),Hemangioma,,Benign,Blood Vessel,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,,,Cancer,,,Hemangioma,,Mono
0,1511,SEC23B,,Either,Breast (Benign),Atypical ductal hyperplasia,,Benign,Breast,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,,,Cancer,,,Breast (Benign),,Mono
0,1511,SEC23B,,Either,Gastrointestinal (Benign),Gastrointestinal polyps,,Benign,GI,9,,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,,,Cancer,,,Gastrointestinal polyps,,Mono
0,1511,PRKAR1A,,Either,Pancreatic Neoplasm,Intraductal pancreatic mucinous neoplasia (IPMN),,Neoplasm,Pancreas,1,PMID:30428497  2.5% of patients with CNC develop pancreatic neoplasms,,,,,,,,,,,,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Pancreatic Cancer,,Mono
0,1511,PRKAR1A,,Male,Testicular Neoplasm,Large Cell Calcifying Sertoli Cell Tumor,,Neoplasm,Testes,1,PMID:30428497,,,,,,,,,,,,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Testicular Neoplasm,,Mono
0,1511,PRKAR1A,,Either,Breast (Benign),Breast Myxoma,,Benign,Breast,1,PMID:30428497,,,,,,,,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Breast myxoma,,Mono
0,1511,PRKAR1A,,Either,Brain Tumor,Pituitary Adenoma,,Neoplasm,Pituitary,1,PMID:30428497,,,,,,,,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Pitutary Adenoma,,Mono
0,1511,NKX2-1,,Either,Thyroid (Benign),Hypothyroid,CAHTP,Benign,Thyroid,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,,,,,,Hypothyroid,,Mono
0,1511,HABP2,,Either,Thyroid Cancer,Non-Medullary  thyroid carcinoma,,Cancer,Thyroid,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Thyroid Cancer,,Mono
0,1511,HABP2,,Either,Blood Vessel (Benign),Carotid Stenosis,,Benign,Blood Vessel,0,,,,,,,,,,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,,,Cancer,,,Carotid Stenosis,,Mono
0,1511,PRKAR1A,,Either,Developmental,Global Development Delay,,Benign,Bone,9,,,,,,,,,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,,,Short Stature,,Mono
0,1511,STK11,,Either,Thyroid Cancer,,,Cancer,Thyroid,0,OMIM only NLP negative (JOE),,,,,,,,,1,,,1,,,,,,,1,Mod,,,tiroides,甲状腺,Masculino,男性,0,0,,278,,Thyroid cancer,,Cancer,1,1,Thyroid Cancer,,Mono
0,1513,STK11,,Either,Hepatobiliary Cancer,Cholangiocarcinoma,,Cancer,Bile Duct,1,NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,,,,,1,,,,,,,,,,1,intestino delgado,小肠,Masculino,男性,0,0,,278,,Bile Duct cancer,,Cancer,1,1,Bile Duct Cancer,,Mono
0,1516,GREM1,,Either,Colorectal Neoplasia,Juvenile Polyps,,Neoplasm,Colorectal,1,ClinGen and NCCN,,,Strong,1,1,1,,1,1,1,,1,,,,,,,,,,,,,,,,,,,,Colorectal Polyps,Juvinile polyps,Neoplasm,,1,Colorectal Polyp,,
0,1518,DIS3L2,,Either,Wilms Tumor,Nephroblastoma,,Cancer,Kidney,,biallelic,,,,,,,,,,1,,1,,,,,,1,1,Low,,,riñón,肾,Masculino,男性,0,0,,,,Kidney,,Cancer,,,Wilms tumor,,Mono
0,1521,MEN1,,Either,Adrenal Neoplasm,Adrenal Adenoma,,Neoplasm,Adrenal,1,,,,Mentioned,1,,1,,,1,1,1,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Adrenal Hyperplasia,,Cancer,,,Adrenal Adenoma,,Mono
0,1521,MEN1,,Either,Adrenal Neoplasm,Adrenal Hyperplasia,,Neoplasm,Adrenal,1,"Clingen:Concurrent annual imaging surveillance via abdominal CT or MRI for adrenal adenoma is recommended, also starting by age 10",,,,,,,,1,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Adrenal Hyperplasia,,Cancer,,,Adrenal Hyperplasia,,Mono
0,1522,MLH1,,Either,Skin Cancer (Non-Melanoma),Basal Cell Carcinoma,,Cancer,Skin,0,OMIM only (no reference),,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Sebaceous carcinoma,,Cancer,,1,Basal Cell Carcinoma,,Mono
0,1523,MSH2,,Either,Skin Cancer (Non-Melanoma),Basal Cell Carcinoma,,Cancer,Skin,0,OMIM only (no reference),,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Sebaceous carcinoma,,Cancer,,1,Basal Cell Carcinoma,,Mono
0,1524,MLH1,,Either,Lung Cancer,,,Cancer,Lung,0,Ambry only - not included in paper,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Sebaceous carcinoma,,Cancer,,1,Lung Cancer,,Mono
0,1525,PMS2,,Either,Bladder Cancer,,,Cancer,Urinary Bladder,9,NCCN: Not well established Clingen:The risk of cancer in LS by age 70:  bladder =2-16%,,,Mentioned,1,9,9,9,,,,,1,,,,,,,1,Low,,,Vejiga urinaria,膀胱,Masculino,男性,0,0,,,,Urinary Bladder,,Cancer,,1,Bladder Cancer,,Mono
0,1526,EPCAM,,Either,Upper Urinary Tract Cancer,,,Cancer,Upper Urinary Tract,1,Clingen:The risk of cancer in LS by age 70: upper urinary tract=6%,,,Mentioned,1,,,,,,,,1,,,,,,,1,Low,,,uréter,输尿管,Masculino,男性,0,0,,164,,Ureter,,Cancer,,1,Upper Urinary Tract Cancer,,Mono
0,1527,CTNNA1,,Either,Gastric Cancer,,,Cancer,Gastric,9,"PMID: 29545726,PMID:29330337,PMID:26380059",,,,,,,,1,,1,,1,,,,,,,,,,,gástrico,胃,Masculino,男性,0,0,,,,Gastric cancer,,Cancer,,,Gastric Cancer,,Mono
0,1528,MAP3K6,,Either,Gastric Cancer,,,Cancer,Gastric,9,,,,,,,,,,,1,,1,,,,,,,,,,1,gástrico,胃,Masculino,男性,0,0,,,,Gastric cancer,,Cancer,,,Gastric Cancer,,Mono
0,1529,BRCA2,,Either,Gastric Cancer,,,Cancer,Gastric,9,NCCN maybe (10433620 :stomach cancer (RR = 2.59; 95%CI = 1.46-4.61)) PMID:26182300 PMID:29025585,,,,,9,,9,,,,,1,,,,,,,,,,,gástrico,胃,Masculino,男性,0,0,,,,Gastric cancer,,Cancer,1,,Gastric Cancer,,Mono
0,1531,CTNNA1,,Either,Eye (Benign),Macular Dystrophy,,Benign,Eye,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,,gástrico,胃,Masculino,男性,0,0,,,,Gastric cancer,,Cancer,,,Macular Dystrophy,,Mono
0,1532,DOT1L,,Either,Gastric Cancer,,,Cancer,Gastric,9,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,gástrico,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Gastric Cancer,,Mono
0,1533,DOT1L,,Either,Bone (Benign),Osteoarthritis,,Benign,Bone,0,,,,,,,,,1,,,,1,,,,,,,,,,,gástrico,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Osteoarthritis,,Mono
0,1534,DOT1L,,Either,Leukemia,,,Cancer,Blood,0,,,,,,,,,,,1,,1,,,,,,,,,,,gástrico,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Leukemia,,Mono
0,1535,FBXO24,,Either,Gastric Cancer,,,Cancer,Gastric,9,"Ambry Only PMID:27899187,PMID:25576241",,,,,,,,,,,,1,,,,,,,,,,1,gástrico,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Gastric Cancer,,Mono
0,1536,INSR,,Either,Gastric Cancer,,,Cancer,Gastric,9,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,gástrico,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Gastric Cancer,,Mono
0,1537,INSR,,Either,Endocrine Abnormalities,"Type A insulin resistance, Diabetes Mellitus",,Benign,Pancreas,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,1,gástrico,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Diabetes Mellitus,,Mono
0,1538,INSR,,Either,Ovarian (Benign),Polycystic Ovary Disease,,Benign,Ovary,0,,,,,,,,,1,,,,1,,,,,,,,,,1,gástrico,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Polycystic Ovary,,Mono
0,1539,MSR1,,Either,Ovarian (Benign),Polycystic Ovary Disease,,Benign,Ovary,9,,,,,,,,,,,1,,1,,,,,,,,,,,,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Polycystic Ovary,,Mono
0,1540,MSR1,,Male,Prostate Cancer,,,Cancer,Prostate,9,"Polymorphysm, somatic",,,,,,,,,,2,,1,,,,,,,,,,1,,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Prostate Cancer,,Mono
0,1541,MSR1,,Either,Gastrointestinal (Benign),Barrett Esophagus,,Benign,Esophagus,9,NCCN says not validated,,,,,9,,9,,1,1,1,1,,,,,,,,,,1,,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Barrett Esophagus,,Mono
0,1542,MSR1,,Either,Breast Cancer,,,Cancer,Breast,0,,,,,,,,,,,1,,1,,,,,,,,,,,,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Breast Cancer,,Mono
0,1544,MSR1,,Either,Liver (Benign),Non-Alcoholic Fatty Liver Disease,,Benign,Liver,0,,,,,,,,,,,1,,1,,,,,,,,,,,,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Nonalcoholic Fatty Liver Disease,,Mono
0,1546,PALB2,,Either,Gastric Cancer,,,Cancer,Gastric,1,,,,,,1,,1,,,,,1,,,,,,,,,,,,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,1,,Gastric Cancer,,Mono
0,1546,MSR1,,Either,Gastric Cancer,,,Cancer,Gastric,9,"PMID: 26182300, PMID: 27899187 (review article but we can use refrences to get penetrance data)",,,,,,,,,,,,1,,,,,,,,,,,,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Gastric Cancer,,Mono
0,1547,MYD88,,Either,Lymphoma,CNS,,Cancer,Nodes,0,,,,,,,,,,,1,,,,,,,,,,,,,gástrico,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Lymphoma,,Mono
0,1548,MYD88,,Either,Plasma Cell Neoplasm,Macroglobulinemia,,Neoplasm,Blood,0,,,,,,,,,,,1,1,,,,,,,,,,,,gástrico,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Macroglobulinemia,,Mono
0,1549,PRSS1,,Either,Pancreas (Benign),Pancreatitis,,Benign,Pancreas,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,1,gástrico,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Pancreatitis,,Mono
0,1550,BRCA1,,Either,Skin (Benign),,,Benign,Skin,0,,,,,,,,,,,,,1,,,,,,,,,,,,黑色素瘤,Masculino,男性,0,0,,102,,Melanoma,,Cancer,1,,Keratoderma,,Mono
0,1550,PRSS1,,Either,Gastric Cancer,,,Cancer,Gastric,9,"PMID: 26182300, PMID: 10778967",,,,,,,,,,1,,1,,,,,,,,,,,gástrico,胃,Masculino,男性,0,0,,133,,Gastric cancer,,Cancer,,,Gastric Cancer,,Mono
0,1551,RAD51C,,Either,Gastric Cancer,,,Cancer,Gastric,0,,,,,,,,,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Head and neck squamous cell carcinomas,,Cancer,,,Gastric Cancer,,Mono
0,1552,APC,,Either,Adrenal Cortical Carcinoma,,,Cancer,Adrenal,9,PMID: 9293929 PMID: 29377868,,,,,,,,,1,,,1,,,,,,,,,,,masa suprarrenal,肾上腺肿块,Masculino,男性,0,0,,90,,Adrenal mass,,Benign Disease,,1,Adrenal Cortical Carcinoma,,Mono
0,1553,FH,,Either,Uterus Cancer,Leiomyosarcoma,,Cancer,Uterus,1,"ClinGen:Genetic prevalence is unknown. FH is the only gene known to be associated with hereditary leiomyomatosis and renal cell cancer (HLRCC), and 70% to 90% of individuals with clinically diagnosed HLRCC have identifiable sequence variants in FH.",,,Mentioned,1,,,,1,1,1,1,,,,,,,1,,,,1,,,Masculino,男性,0,0,,,,Leiomyosarcoma,,Cancer,,,Sarcoma,,Mono
0,1555,FH,,Female,Breast Cancer,,,Cancer,Breast,,Ambry only,,,,,,,,,,,,,,,,,,,1,Low,,1,riñón,肾,Masculino,男性,0,0,,,,Kidney,,Cancer,,,Breast Cancer,,Mono
1,1555,MUTYH-Biallelic,,Female,Ovarian Cancer,,,Cancer,Ovary,9,Clingen: still not clear if the lifetime risk of these malignancies is increased.,,,Mentioned,9,,,,,,,,1,1,,,1,,,,,,,ovario,卵巢,Femenino,女性,0,0,Ask2Me,373,,Ovarian cancer,,Cancer,,1,Ovarian Cancer,,Biallelic
0,1556,FH,,Male,Testicular Cancer,Leydig Cell Tumour of the Testis,,Neoplasm,Testes,,Ambry only,,,,,,,,,,,,,,,,,,,1,Low,,1,riñón,肾,Masculino,男性,0,0,,,,Kidney,renal cell carcinoma,Cancer,,,Testicular Cancer,,Mono
1,1556,PTEN,,Female,Ovarian Cancer,,,Cancer,Ovary,0,(Disputed by lee21018GenIn),,,,,,,,1,,,,1,,,,,,,1,High,High,,mama,乳腺,Femenino,女性,0,0,Ask2Me,392,,Breast cancer,,Cancer,1,1,Ovarian Cancer,,Mono
0,1557,FH,,Female,Ovarian Neoplasm,Ovarian Mucinous Cystadenoma,,Neoplasm,Ovary,,Ambry only,,,,,,,,,,,,,,,,,,,1,Low,,1,riñón,肾,Masculino,男性,0,0,,,,Kidney,renal cell carcinoma,Cancer,,,Ovarian Cancer,,Mono
0,1557,GEN1,,Either,Breast Cancer,,,Cancer,Breast,0,,,,Disputed,0,,,,,,,,1,,,,,,,,,,,mama,乳腺,Masculino,男性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
1,1558,GEN1,,Female,Ovarian Cancer,,,Cancer,Ovary,0,,,,No Reported Evidence,0,,,,,,,,1,,,,,,,,,,,ovario,卵巢,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,,,Ovarian Cancer,,Mono
0,1561,MCPH1,,Either,Breast Cancer,,,Cancer,Breast,,,,,Limited,9,,,,,,,,,,,,,,,,,,,mama,乳腺,Masculino,男性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
1,1562,MCPH1,,Female,Ovarian Cancer,,,Cancer,Ovary,,,,,No Reported Evidence,0,,,,,,,,,,,,,,,,,,,ovario,卵巢,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,,,Ovarian Cancer,,Mono
0,1563,PIK3CA,,Either,Breast Cancer,,,Cancer,Breast,,,,,No Reported Evidence,0,,,,,,,,,,,,,,,,,,,mama,乳腺,Masculino,男性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
1,1564,PIK3CA,,Female,Ovarian Cancer,,,Cancer,Ovary,,,,,No Reported Evidence,0,,,,,,,,,,,,,,,,,,,ovario,卵巢,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,,,Ovarian Cancer,,Mono
0,1565,RINT1,,Either,Breast Cancer,,,Cancer,Breast,,,,,Disputed,0,,,,,,,,,,,,,,,,,,,mama,乳腺,Masculino,男性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
1,1566,RINT1,,Female,Ovarian Cancer,,,Cancer,Ovary,,,,,No Reported Evidence,0,,,,,,,,,,,,,,,,,,,ovario,卵巢,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,,,Ovarian Cancer,,Mono
0,1567,SLX4,,Either,Breast Cancer,,,Cancer,Breast,,,,,Limited,9,,,,,,,,,,,,,,,,,,,mama,乳腺,Masculino,男性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
1,1568,SLX4,,Female,Ovarian Cancer,,,Cancer,Ovary,,,,,No Reported Evidence,0,,,,,,,,,,,,,,,,,,,ovario,卵巢,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,,,Ovarian Cancer,,Mono
0,1569,CHEK1,,Either,Breast Cancer,,,Cancer,Breast,,,,,No Reported Evidence,0,,,,,,,,,,,,,,,,,,,mama,乳腺,Masculino,男性,0,0,,,,Breast cancer,,Cancer,,,Breast Cancer,,Mono
1,1570,CHEK1,,Female,Ovarian Cancer,,,Cancer,Ovary,,,,,No Reported Evidence,0,,,,,,,,,,,,,,,,,,,ovario,卵巢,Femenino,女性,0,0,,,,Ovarian cancer,,Cancer,,,Ovarian Cancer,,Mono
0,1571,MUTYH-Biallelic,,Either,Duodenum Neoplasm,Duodenal Polyps,,Neoplasm,Duodenum,1,Clingen: Gastroduodenal polyposis is reported in over 20% of cases.  Duodenal polyps are found in 17-25%.,,,Mentioned,1,1,,1,,,,,1,,,,,,,,,,,duodenal,十二指肠,Masculino,男性,0,0,,147,,Duodenal cancer,,Cancer,,1,Duodenum Polyp,,Biallelic
1,1572,MUTYH,,Female,Breast Cancer,,,Cancer,Breast,0,-Monoallelic,,,No Reported Evidence,0,,,,,,,,1,,,,,,,,,,1,mama,乳腺,Femenino,女性,0,0,,140,,Breast cancer,,Cancer,,1,Breast Cancer,,Mono
0,1578,NF1,,Either,Pheochromocytoma/Paraganglioma,Paraganglioma,,Neoplasm,Nerve,1,ClinGenis definitive or moderate while NCCN is mute.,,,Definitive,1,,,,,,,,1,,,,,,,1,Low,,1,feocromocitoma,嗜铬细胞瘤,Masculino,男性,0,0,,233,,Pheochromocytoma,,Cancer,1,,Neuroendocrine,,Mono
0,1579,NF1,,Either,Eye (Benign),Lisch nodule (Iris Hamartoma),,Benign,Eye,1,,,,Mentioned,1,,,,,1,,,1,,,,,,,,,,,gliomas de la vía óptica,视神经胶质瘤,Masculino,男性,0,0,,157,,Optic pathway gliomas,,Benign Disease,1,,Iris Hamartoma,,Mono
0,1580,SRGAP1,,Either,Skin (Benign),Nevi,,Benign,Skin,9,,,,,,,,,,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Cafe-Au-Lait Spots,,Benign Disease,,,Nevi,,Mono
0,1580,NF1,,Either,Skin (Benign),Skin Freckling -Axillary and Inguinal,,Benign,Skin,1,,,,Mentioned,1,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Cafe-Au-Lait Spots,,Benign Disease,1,,Skin Freckling,,Mono
0,1580,SRGAP1,,Either,Skin (Benign),Skin Pigmentation,,Benign,Skin,9,,,,,,,,,,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Cafe-Au-Lait Spots,,Benign Disease,,,Skin Pigmentation,,Mono
0,1580,SRGAP1,,Either,Skin (Benign),Lentigines,,Benign,Skin,9,,,,,,,,,,,1,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Cafe-Au-Lait Spots,,Benign Disease,,,Lentigines,,Mono
0,1581,MLH1-Biallelic,,Either,Neurofibroma,,Constitutional Mismatch Repair Deficiency Syndrome,Neoplasm,Nerve,1,Clingen is definitive or moderate,,,Definitive,1,,,,1,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Neurofibromas,,Mono
1,1581,NF1,,Female,Ovarian Cancer,,,Cancer,Ovary,0,,,,No Repoted Evidence,0,,,,,,,,1,,,,,,,1,Low,,,mama,乳腺,Femenino,女性,0,0,Ask2Me,187,,Breast cancer,,Cancer,1,,Ovarian Cancer,,Mono
0,1582,MSH2-Biallelic,,Either,Neurofibroma,,Constitutional Mismatch Repair Deficiency Syndrome,Neoplasm,Nerve,1,Clingen is definitive or moderate,,,Definitive,1,,,,,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Neurofibromas,,Mono
0,1582,PTEN,,Either,Gastric Cancer,,,Cancer,Gastric,9,,,,Mentioned,9,9,,9,,,,,1,,,,,,,,,,,gástrico,胃,Masculino,男性,0,0,Ask2Me,394,,Colorectal cancer,,Cancer,1,1,Gastric Cancer,,Mono
1,1583,PTEN,,Female,Cervical Cancer,,,Cancer,Cervix,9,,,,,,,,,,1,,,1,,,,,,,,,,,uterinos,,Femenino,女性,,,,,,Uterine fibroids,,Neoplasm,1,1,Cervical,,Mono
0,1583,MSH6-Biallelic,,Either,Neurofibroma,,Constitutional Mismatch Repair Deficiency Syndrome,Neoplasm,Nerve,1,Clingen is definitive or moderate,,,Definitive,1,,,,1,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Neurofibromas,,Mono
1,1583,PTEN,,Female,Endometrial Cancer,,,Cancer,Uterus,1,,,,Mentioned,1,1,1,1,,1,,,1,1,,,1,,,,,,,uterinos,,Femenino,女性,,,,,,Uterine fibroids,,Neoplasm,1,1,Endometrial,,Mono
0,1584,APC,,Either,Gastric Neoplasm,Gastric Polyps,,Neoplasm,Gastric,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Mentioned,1,1,1,1,,1,1,,1,,,,,,,,,,,,,,,,,,,,Colorectal Polyps,,Neoplasm,,1,Gastric Polyp,,
0,1584,PMS2-Biallelic,,Either,Neurofibroma,,Constitutional Mismatch Repair Deficiency Syndrome,Neoplasm,,1,Clingen is definitive or moderate,,,Definitive,1,,,,1,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Neurofibromas,,Mono
0,1585,APC,,Either,Duodenum Neoplasm,Duodenal Polyps,,Neoplasm,Duodenum,1,Clingen is definitive or moderate AND NCCN management and/or ID present,,,Mentioned,1,1,1,1,,1,1,,1,,,,,,,,,,,,,,,,,,,,Colorectal Polyps,,Neoplasm,,1,Duodenal Polyp,,
0,1585,MSH2-Biallelic,,Either,Lymphoma,,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Nodes,1,Clingen is definitive or moderate,,,Definitive,1,,,,,1,,,,,,,,,,1,Mod,,,linfoma,淋巴瘤,Masculino,男性,0,0,,,,Lymphoma,,Cancer,,,Lymphoma,,Mono
0,1586,APC,,Either,Skin (Benign),Epidermoid Cysts,,Benign,Skin,1,NCCN management or identification is present.  ClinGenSilent.,,,Mentioned,1,1,,1,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,82,,Osteoma,,Neoplasm,,1,Epidermoid Cysts,,Mono
0,1586,MLH1-Biallelic,,Either,Lymphoma,,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Nodes,1,Clingen is definitive or moderate,,,Definitive,1,,,,1,1,,,,,,,,,,1,Mod,,,linfoma,淋巴瘤,Masculino,男性,0,0,,,,Lymphoma,,Cancer,,,Lymphoma,,Mono
0,1587,MSH6-Biallelic,,Either,Lymphoma,,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Nodes,1,Clingen is definitive or moderate,,,Definitive,1,,,,1,1,,,,,,,,,,1,Mod,,,linfoma,淋巴瘤,Masculino,男性,0,0,,,,Lymphoma,,Cancer,,,Lymphoma,,Mono
0,1587,APC,,Either,Adrenal Neoplasm,Adrenal Adenoma,,Neoplasm,Adrenal,1,Clingen: Adrenal masses occur in 7-13% of patients,,,Mentioned,1,1,,1,1,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,82,,Osteoma,,Neoplasm,,1,Adrenal Mass,,Mono
0,1588,PMS2-Biallelic,,Either,Lymphoma,,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Nodes,1,Clingen is definitive or moderate,,,Definitive,1,,,,1,1,,,,,,,,,,1,Mod,,,linfoma,淋巴瘤,Masculino,男性,0,0,,,,Lymphoma,,Cancer,,,Lymphoma,,Mono
0,1589,MLH1-Biallelic,,Either,Small Intestine Cancer,,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Small Bowel,1,clingen is not specific,,OMIM and Gene Card,Definitive,1,,,,,,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Gastrointestinal Carcinoma,,Mono
0,1589,SMAD4,,Either,Duodenum Cancer,,,Cancer,Duodenum,1,Clingen:  risk of gastric and duodenal cancer in JPS is around 15-21%,,,Mentioned,1,,,,,,,,1,,,,,,,1,Low,,,gástrico,胃,Masculino,男性,0,0,,318,,Gastric cancer,,Cancer,,1,Duodenal Cancer,,Mono
0,1590,MSH2-Biallelic,,Either,Small Intestine Cancer,,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Small Bowel,1,clingen is not specific,,OMIM and Gene Card,Definitive,1,,,,,,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Gastrointestinal Carcinoma,,Mono
0,1591,MSH6-Biallelic,,Either,Small Intestine Cancer,,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Small Bowel,1,clingen is not specific,,OMIM and Gene Card,Definitive,1,,,,,,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Gastrointestinal Carcinoma,,Mono
0,1591,TP53,,Either,Gastric Cancer,,,Cancer,Gastric,9,,,,,,9,,9,,1,,,1,,,,,,,,,,1,gástrico,胃,Masculino,男性,0,0,,,,GI hamartoma,,Neoplasm,1,1,Gastric Cancer,,Mono
0,1592,CDK4,,Either,Plasma Cell Cancer,Multiple Myeloma,,Cancer,Blood,0,,,,,,,,,,,1,,1,,,,,,,,,,,melanoma,黑色素瘤,Masculino,男性,,,,,,Lung cancer,,Cancer,,,Multiple Myeloma,,Mono
0,1592,PMS2-Biallelic,,Either,Small Intestine Cancer,,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Small Bowel,1,clingen is not specific,,OMIM and Gene Card,Definitive,1,,,,,,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Gastrointestinal Carcinoma,,Mono
0,1593,MLH1-Biallelic,,Either,Skin Cancer (Non-Melanoma),,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Skin,1,Subtype not specified,,,Definitive,1,,,,,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Skin Tumor,,Mono
0,1594,MSH2-Biallelic,,Either,Skin Cancer (Non-Melanoma),,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Skin,1,Subtype not specified,,,Definitive,1,,,,,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Skin Tumor,,Mono
1,1594,POLD1,,Female,Ovarian Cancer,,,Cancer,Ovary,9,Clingen:Evidence on these associations is still limited,,,Mentioned,9,,,,,,,,1,,,,,,,,,,,,,Femenino,女性,0,0,,,,Endometrial cancer,,Cancer,,1,Ovarian Cancer,,Mono
0,1595,MSH6-Biallelic,,Either,Skin Cancer (Non-Melanoma),,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Skin,1,Subtype not specified,,,Definitive,1,,,,,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Skin Tumor,,Mono
0,1596,PMS2-Biallelic,,Either,Skin Cancer (Non-Melanoma),,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Skin,1,Subtype not specified,,,Definitive,1,,,,,,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Skin Tumor,,Mono
0,1596,POLD1,,Either,Small Intestine Cancer,,,Cancer,Small Bowel,9,Clingen:Evidence on these associations is still limited,,,Mentioned,9,,,,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Brain Tumor,,Cancer,,1,Small Intestine Cance,,Mono
0,1597,POLE,,Either,Brain Tumor,Glioblastoma Multiforme,,Cancer,Brain,9,Clingen:Evidence on these associations is still limited,,,Mentioned,9,,,,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Brain Tumor,glioblastoma multiforme,Cancer,,1,Brain Tumor,,Mono
0,1598,MSH2-Biallelic,,Either,Brain Tumor,Glioblastoma Multiforme,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Brain,,,,,,,,,,,1,1,1,,,,,,,,1,Low,,,cerebro,脑,Masculino,男性,0,0,,41,,Brain Tumor,glioblastoma multiforme,Cancer,,,Brain Tumor,,Mono
0,1598,POLE,,Either,Pancreatic Cancer,,,Cancer,Pancreas,9,Clingen:Evidence on these associations is still limited,,,Mentioned,9,,,,,,,,1,,,,,,,,,,,páncreas,胰腺,Masculino,男性,0,0,,,,Pancreatic cancer,,Cancer,,1,Pancreatic Cancer,,Mono
1,1599,POLE,,Female,Endometrial Cancer,,,Cancer,Uterus,9,Clingen:Evidence on these associations is still limited,,,Mentioned,9,,,,,,,,1,,,,,,,,,,,,,Femenino,女性,0,0,,,,Endometrial cancer,,Cancer,,1,Endometrial Cancer,,Mono
0,1600,PMS2-Biallelic,,Either,Brain Tumor,,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Brain,,,,,,,,,,,1,1,1,,,,,,,,1,Low,,,cerebro,脑,Masculino,男性,0,0,,,,Brain Tumor,,Cancer,,,Brain Tumor,,Mono
0,1600,POLE,,Either,Small Intestine Cancer,,,Cancer,Small Bowel,9,Clingen:Evidence on these associations is still limited,,,Mentioned,9,,,,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Brain Tumor,,Cancer,,1,Small Intestine Cance,,Mono
0,1601,MLH1-Biallelic,,Either,Colorectal Neoplasia,,Constitutional Mismatch Repair Deficiency Syndrome,Neoplasm,Colorectal,,,,OMIM and Gene Card,Definitive,1,,,,,1,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Colorectal Polyps,,Mono
0,1602,MSH2-Biallelic,,Either,Colorectal Neoplasia,,Constitutional Mismatch Repair Deficiency Syndrome,Neoplasm,Colorectal,,,,OMIM and Gene Card,Definitive,1,,,,,1,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Colorectal Polyps,,Mono
0,1603,MSH6-Biallelic,,Either,Colorectal Neoplasia,,Constitutional Mismatch Repair Deficiency Syndrome,Neoplasm,Colorectal,,,,OMIM and Gene Card,Definitive,1,,,,,1,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Colorectal Polyps,,Mono
0,1604,PMS2-Biallelic,,Either,Colorectal Neoplasia,,Constitutional Mismatch Repair Deficiency Syndrome,Neoplasm,Colorectal,,,,OMIM and Gene Card,Definitive,1,,,,,1,1,1,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Colorectal Polyps,,Mono
0,1605,MLH1-Biallelic,,Either,Sarcoma,Rhabdomyosarcoma,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Soft Tissue,,,,,,,,,,,1,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Rhabdomyosarcoma,,Mono
0,1606,MSH2-Biallelic,,Either,Sarcoma,Rhabdomyosarcoma,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Soft Tissue,,,,,,,,,,,1,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Rhabdomyosarcoma,,Mono
0,1607,MSH6-Biallelic,,Either,Sarcoma,Rhabdomyosarcoma,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Soft Tissue,,,,,,,,,,,1,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Rhabdomyosarcoma,,Mono
0,1607,POLD1,,Either,MDPL syndrome,"Lipodystrophy, Deafness, Mandibular Hypoplasia",,Syndrome,,1,Monoallelic syndrome caused by certain varients of this gene,,,,,,,,1,1,1,1,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Mandibular hypoplasia,,Benign Disease,,1,MDPL syndrome,,Mono
0,1608,PMS2-Biallelic,,Either,Sarcoma,Rhabdomyosarcoma,Constitutional Mismatch Repair Deficiency Syndrome,Cancer,Soft Tissue,,,,,,,,,,,1,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Upper Urinary Tract,,Cancer,,,Rhabdomyosarcoma,,Mono
0,1609,BLM,,Male,Prostate Cancer,,,Cancer,Prostate,9,PMID:31816118,,,,,,,,,,,,,,,,,,,,,,1,,,Masculino,男性,0,0,,,,,,Cancer,,,Prostate Cancer,,Mono
0,1610,CASR,,Either,Pancreas (Benign),Pancreatitis,,Benign,Pancreas,1,Ambry only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,,,,,,Hyperparathyroid,,Benign Disease,,,Pancreatitis,,
0,1612,CDC73,,Either,Kidney (Benign),Renal cysts,,Benign,Kidney,1,ClinGen is definitive or moderate while NCCN is mute.,,,Mentioned,1,,,,1,1,1,,1,,,,,,1,,,,1,,,Masculino,男性,0,0,,,,Jaw tumor,,Cancer,,,Kidney Neoplasm,,Mono
0,1612,CDC73,,Either,Kidney Neoplasm,Renal hamartomas,,Neoplasm,Kidney,1,ClinGen is definitive or moderate while NCCN is mute.,,,Mentioned,1,,,,1,1,1,,1,,,,,,1,,,,1,,,Masculino,男性,0,0,,,,Jaw tumor,,Cancer,,,Kidney Neoplasm,,Mono
0,1612,CDC73,,Either,Parathyroid (Benign),Hyperparathyroid,,Benign,Parathyroid,1,ClinGen is definitive or moderate while NCCN is mute.,,,Mentioned,1,,,,1,1,1,1,1,,,,,,1,,,,1,,,Masculino,男性,0,0,,,,Jaw tumor,,Cancer,,,Hyperparathyroid,,Mono
0,1618,DICER1,,Either,Colorectal Cancer,,,Cancer,Colorectal,9,Ambry only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Wilm's tumor,,Cancer,,,Colorectal Cancer,,Mono
0,1619,DICER1,,Either,Breast Cancer,,,Cancer,Breast,0,Ambry only,,,,,,,,,,,,1,,,,,,,,,,1,,,Masculino,男性,0,0,,,,Wilm's tumor,,Cancer,,,Breast Cancer,,Mono
1,1626,STK11,,Female,Ovarian Cancer,,,Cancer,Ovary,0,,,,No Reported Evidence,0,,,,1,,,,1,,,,,,,,,,,ovario,卵巢,Femenino,女性,0,0,,277,,Ovarian cancer,,Cancer,1,1,Ovarian Cancer,,Mono
1,1626,STK11,,Female,Ovarian (Benign),Ovarian Cyst,,Benign,Ovary,9,OMIM only,,,,,,,,,1,,,1,,,,,,,,,,,ovario,卵巢,Femenino,女性,0,0,,277,,Ovarian cancer,,Cancer,1,1,Ovarian (Benign),,Mono
1,1626,STK11,,Female,Ovarian Neoplasm,Non epithelial ovarian tumor,,Neoplasm,Ovary,1,,,,,,1,1,1,,,,,1,,,,,,,,,,,ovario,卵巢,Femenino,女性,0,0,,277,,Ovarian cancer,,Cancer,1,1,Ovarian Neoplam,,Mono
1,1626,STK11,,Female,Ovarian Neoplasm,Sex Cord Tumor,,Neoplasm,Ovary,1,,,,,,1,1,1,,,,,1,,,,,,,1,Mod,,1,ovario,卵巢,Femenino,女性,0,0,,277,,Ovarian cancer,,Cancer,1,1,Ovarian (Benign),,Mono
0,1627,EPCAM,,Either,Bladder Cancer,,,Cancer,Urinary Bladder,1,Clingen:The risk of cancer in LS by age 70:  bladder =2-16%,,,Mentioned,1,,,,,,,,1,,,,,,,1,Low,,,Vejiga urinaria,膀胱,Masculino,男性,0,0,,,,Urinary Bladder,,Cancer,,1,Bladder Cancer,,Mono
0,1628,PMS2,,Either,Lymphoma,,,Cancer,Nodes,0,Gene card only,,,,,,,,,,1,,1,,,,,,,,,,,linfoma,淋巴瘤,Masculino,男性,0,0,,,,Lymphoma,,Cancer,,1,Lymphoma,,Mono
0,1629,MUTYH-Biallelic,,Either,Endometrial Cancer,,,Cancer,Uterus,9,Clingen: still not clear if the lifetime risk of these malignancies is increased.,,,Mentioned,9,,,,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,,1,Endometrial Cancer,,Mono
0,1630,MUTYH-Biallelic,,Either,Skin Cancer (Non-Melanoma),,,Cancer,Skin,9,Clingen: still not clear if the lifetime risk of these malignancies is increased.,,,Mentioned,9,,,,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Thyroid cancer,,Cancer,,1,Skin,,Mono
0,1631,MUTYH-Biallelic,,Either,Gastric Cancer,,,Cancer,Gastric,1,"Clingen: gastric lesions have been found in up to 11% of patients with MAP and an estimated 1% develop stomach cancer, data are currently lacking to support an increased risk of gastric cancer",,,Mentioned,1,,,,,,2,2,1,,,,,,,1,Low,,1,gástrico,胃,Masculino,男性,0,0,,380,,Gastric cancer,,Cancer,,1,Gastric Cancer,,Mono
0,1635,PTCH1,,Either,Lymphomesentric Cyst,,,Benign,,1,Jones et al major and minor criteria,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Lymphomesentric Cyst,,Mono
0,1636,PTCH1,,Either,Lung (Benign),Pleural Cyst,,Benign,Lung,1,Jones et al major and minor criteria,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Plural Cyst,,Mono
0,1637,PTCH1,,Either,Skin (Benign),Palmoplantar Pits,,Benign,Skin,1,Jones et al major and minor criteria,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Palmar/Plantar pits,,Mono
0,1638,PTCH1,,Either,Bone (Benign),Bifid Rib,,Benign,Bone,1,Jones et al major and minor criteria,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Skeletal Anomalys,,Mono
0,1638,PTCH1,,Either,Bone (Benign),Vertebral Defects,,Benign,Bone,1,Jones et al major and minor criteria,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Skeletal Anomalys,,Mono
0,1639,PTCH1,,Either,Eye (Benign),Ocular Anomalys (Cataract),,Benign,Eye,1,Jones et al major and minor criteria,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Ocular Anomalys,,Mono
0,1640,SUFU,,Either,Lymphomesentric Cyst,,,Benign,,1,Jones et al major and minor criteria,,,,,,,,,1,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Lymphomesentric Cyst,,Mono
0,1641,SUFU,,Either,Lung (Benign),Pleural Cyst,,Benign,Lung,1,Jones et al major and minor criteria,,,,,,,,,1,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Plural Cyst,,Mono
0,1642,SUFU,,Either,Skin (Benign),Palmoplantar Pits,,Benign,Skin,1,Jones et al major and minor criteria,,,,,,,,,1,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Palmar/Plantar pits,,Mono
0,1643,SUFU,,Either,Bone (Benign),Vertebral Defects,,Benign,Bone,1,Jones et al major and minor criteria,,,,,,,,,1,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Skeletal Anomalys,,Mono
0,1643,SUFU,,Either,Bone (Benign),Bifid Rib,,Benign,Bone,1,Jones et al major and minor criteria,,,,,,,,,1,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Skeletal Anomalys,,Mono
0,1644,SUFU,,Either,Eye (Benign),Ocular Anomalys (Cataract),,Benign,Eye,1,Jones et al major and minor criteria,,,,,,,,,1,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Ocular Anomalys,,Mono
0,1645,SUFU,,Either,Bone Neoplasm,Keratocystic Odontogenic Tumor,,Neoplasm,Bone,1,Jones et al major and minor criteria,,,,,,,,,1,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Jaw Keratocyst,,Mono
0,1646,PTCH1,,Female,Ovarian (Benign),,,Benign,Ovary,1,Jones et al major and minor criteria,,,,,,,,,1,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Ovarian Neoplasm,,Mono
0,1647,SUFU,,Female,Ovarian (Benign),,,Benign,Ovary,,Jones et al major and minor criteria,,,,,,,,,1,,,,,,,,,,,,,,,,Masculino,男性,0,0,,,,Keratocystic odontogenic tumor,,Benign Disease,,,Ovarian Neoplasm,,Mono
,1648,CHEK2,,Either,Gastric Cancer,,,Cancer,Gastric,1,"Ambry Only PMID: 23296741 ; PMID: 26991782, 23296741",,,,,,,,,,,,1,,,,,,,,,,1,,,,,,,,,,,,,1,1,Gastric Cancer,,
,1649,CHEK2,,Either,Peripheral Nervous System Cancer,Neuroblastoma,,Cancer,PNS,9,Ambry Only,,,,,,,,,,,,1,,,,,,,,,,1,,,,,,,,,,,,,1,1,Neuroblastoma,,
,1650,CHEK2,,Either,Blood (Benign),Thrombocythaemia,,Benign,Blood,0,Ambry Only-not in paper,,,,,,,,,,,,1,,,,,,,,,,1,,,,,,,,,,,,,1,1,Thrombocythaemia,,
,1650,HABP2,,Either,Blood (Benign),Venous thrombosis,,Benign,Blood,1,,,,,,,,,1,1,1,1,1,,,,,,,,,,,,,,,,,,,,,,,,,Venous thrombosis,,
,1651,CHEK2,,Either,Sarcoma,Osteosarcoma,,Cancer,Bone,1,"PMID: 19338683, PMID: 18178638",,,,,,,,,2,1,1,1,,,,,,,,,,1,,,,,,,,,,,,,1,1,Sarcoma (Bone),,
,1652,CHEK2,,Either,Blood (Benign),Polycythaemia Vera,,Benign,Blood,9,Ambry Only   PMID: 26084796,,,,,,,,,,,,1,,,,,,,,,,1,,,,,,,,,,,,,1,1,Polycythaemia Vera,,
,1653,CHEK2,,Either,Lung Cancer,,,Cancer,Lung,0,PMID: 17164383; PMID: 20951091; PMID: 24880342,,,,,,,,,,,,1,,,,,,,,,,1,,,,,,,,,,,,,1,1,Lung Cancer,,
,1654,CHEK2,1100delC,Either,Leukemia,CLL,,Cancer,Blood,9,PMID: 17169815 ; PMID: 26641009,,,,,,,,,,,1,1,,,,,,,1,Low,,1,,,,,,,,,,,,,1,1,Leukemia,,
,1655,CHEK2,,Either,Wilms Tumor,Nephroblastoma,,Cancer,Kidney,9,Ambry Only PMID: 28825729,,,,,,,,,,,,1,,,,,,,,,,1,,,,,,,Ask2Me,,,,,,1,1,Wilms Tumor,,
,1656,CHEK2,`,Either,Adrenal Cortical Carcinoma,,,Cancer,Adrenal,0,PMID: 30623166,,,,,,,,,,1,1,1,,,,,,,,,,,,,,,,,,,,,,,1,1,Adrenocortical carcinoma,,
,1657,CHEK2,other varients,Female,Breast Cancer,,,Cancer,Breast,1,Clingen: RR of truncating mutation is 3.0 (90% CI: 2.6-3.5); missense variant I157T (OR=1.58; 95% CI: 1.42–1.75; p<0.001). NCCN: Based only on frame shift pathogenic varients.  PMID: 15488637; PMID: 16257342; PMID: 18759107; PMID: 28008555; PMID: 28874143,,,Definitive,1,1,1,1,,,1,,1,,,,,,,,,,,,,,,,,Ask2Me,,,,,,1,1,Breast Cancer,,
,1658,CHEK2,,Female,Endometrial Cancer,,,Cancer,Uterus,0,Ambry Only-not in paper,,,,,,,,,,,,1,,,,,,,,,,1,,,,,,,,,,,,,1,1,Endometrial Cancer,,
,1659,CHEK2,,Female,Ovarian Cancer,,,Cancer,Ovary,9,ClinGen  PMID: 30441849; PMID: 30651582; PMID: 30964716 ; PMID: 31050813,,,Disputed,0,,,,,,,,1,,,,,,,,,,1,,,,,,,,,,,,,1,1,Ovarian Cancer,,
,1660,CHEK2,,Male,Prostate Cancer,,,Cancer,Prostate,1,PMID: 12533788 NCCN management or identification is present.  ClinGenSilent.,,,,,1,,1,,1,1,1,1,,,,1,,,1,Low,,1,,,,,,,,,,,,,1,1,Prostate Cancer,,
,1661,CHEK2,,Either,Colorectal Cancer,,,Cancer,Colorectal,1,REVIEW PMID:12690581 PMID: 21807500 PMID: 22901170,,,Limited,9,1,1,1,,1,,,1,1,,,1,,,1,Low,,1,,,,,,,,,,,,,1,1,Colorectal Cancer,,
,1662,CHEK2,1100delC,Either,Kidney Cancer,,,Cancer,Kidney,1,PMID: 26884562,,,,,,,,,,,,1,1,,,1,,,,,,,,,,,,,,,,,,,1,1,Kidney Cancer,,
,1663,CHEK2,,Either,Thyroid Cancer,Papillary Thyroid Cancer,,Cancer,Thyroid,1,PMID: 25583358 ; PMID: 25798211,,,,,,,,,,,,1,,,,,,,,,,1,tiroides,甲状腺,,,,,,,,,,,1,1,Thyroid Cancer,,
,1663,CHEK2,1100delC,Either,Melanoma,,,Cancer,Skin,9,PMID: 21956126,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,1,1,Melanoma,,
,1664,CHEK2,1100delC,Either,Breast Cancer,,,Cancer,Breast,1,1100delC variant is associated with increased risk for breast cancer (OR=2.34; 95% CI: 1.72–3.20; p<0.001),,,Definitive,1,1,,1,,1,1,1,1,1,,,1,,,1,Mod,,1,,,,,,,,,,,,,1,1,Breast Cancer,,
0,1665,PALB2,,Either,Wilms Tumor,Nephroblastoma,,Cancer,Kidney,9,PMID: 28825729,,,,,,,,,,,,1,,,,,,,,,,,,,Masculino,男性,0,0,,151,,Breast cancer,,Cancer,1,,Wilms Tumor,,Mono